data_2rr2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rr2 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.519 0.2 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 37.1 Cg_endo -65.27 -42.32 13.72 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.404 2.07 . . . . 0.0 112.105 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 87.4 m -53.7 136.89 38.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.028 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.74 44.06 1.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.508 0.67 . . . . 0.0 110.669 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -150.77 -161.33 1.32 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.809 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.02 39.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 110.839 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.33 -175.5 4.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.983 0.421 . . . . 0.0 111.414 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.9 m -121.14 147.66 45.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.725 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.5 t -89.92 155.74 18.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -172.2 80.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.78 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -138.6 169.94 16.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.977 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -150.07 -175.38 5.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.87 70.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 111.065 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.77 -26.68 1.93 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.663 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.93 177.7 4.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.908 0.385 . . . . 0.0 111.039 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.415 ' CE1' ' HG3' ' A' ' 9' ' ' PRO . 38.4 t80 -176.0 103.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.715 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -143.68 132.47 22.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.974 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.8 t -109.04 140.16 42.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.68 90.29 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.787 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -167.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.151 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 63.7 mtp -101.73 155.78 35.99 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.841 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.65 93.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.649 2.232 . . . . 0.0 112.091 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.52 39.38 4.46 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.386 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -119.63 118.96 32.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.746 0.308 . . . . 0.0 110.685 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.93 157.2 17.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.008 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.64 143.83 7.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.415 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.415 HG11 ' CZ ' ' A' ' 35' ' ' TYR . 57.3 t -57.94 -40.72 77.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.85 0.357 . . . . 0.0 111.12 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.445 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 13.4 m-85 -125.55 48.8 2.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.781 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 46.91 75.97 0.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.339 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -123.88 -25.73 4.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.325 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.8 mm . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.82 0.343 . . . . 0.0 111.082 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.527 0.203 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 36.1 Cg_endo -64.76 -43.34 12.91 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.423 2.082 . . . . 0.0 112.005 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.473 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 93.2 m -54.86 136.77 46.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.037 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -91.82 43.76 1.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.356 0.598 . . . . 0.0 110.539 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -150.68 -161.67 1.39 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.853 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.85 38.49 0.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.714 0.293 . . . . 0.0 110.825 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.54 -174.74 4.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.005 0.431 . . . . 0.0 111.421 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.1 m -125.51 142.62 51.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.844 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.9 t -90.0 149.42 22.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tt -157.29 66.69 0.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -111.14 110.0 20.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -90.03 -175.92 4.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.3 103.98 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.095 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.02 26.81 57.49 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.15 -178.2 5.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 0.0 110.904 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.422 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 13.9 t80 -177.54 113.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -149.96 123.6 9.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.073 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.3 t -104.45 131.79 51.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.689 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.95 91.72 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.26 -168.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.026 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.4 mtp -91.99 160.35 35.96 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.986 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.73 95.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.557 2.172 . . . . 0.0 112.387 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.23 54.83 3.92 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.366 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -120.26 137.87 53.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.751 0.31 . . . . 0.0 110.684 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -93.35 161.88 14.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.132 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.5 137.96 9.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.447 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.42 HG13 ' CE1' ' A' ' 35' ' ' TYR . 76.0 t -56.59 -48.95 79.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 0.0 111.056 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.473 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 13.2 m-85 -112.61 43.27 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.611 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.2 m 52.09 98.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.953 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -166.71 -39.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.961 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.7 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.213 -179.861 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 p30 . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.573 0.225 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 23' ' ' PHE . 65.5 Cg_exo -52.12 -24.65 20.67 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.551 2.167 . . . . 0.0 112.232 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.9 m -59.42 125.21 22.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.621 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -96.02 42.57 1.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.374 0.607 . . . . 0.0 110.64 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -150.79 -165.62 2.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.994 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -89.94 41.33 1.04 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.88 0.372 . . . . 0.0 110.484 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.14 -176.0 3.36 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.491 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 48.8 m -119.48 154.34 33.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.569 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.8 p -89.85 130.56 36.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 111.132 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.72 69.71 1.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -153.87 135.38 14.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.09 67.66 1.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.816 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.9 mm 52.7 85.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.17 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.46 -82.04 0.13 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.447 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.18 121.8 41.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.828 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.439 ' CZ ' ' HG2' ' A' ' 9' ' ' PRO . 90.5 t80 -77.34 131.01 37.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -139.67 103.11 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.831 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.9 t -92.13 122.49 34.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.667 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.467 HD13 HG22 ' A' ' 26' ' ' ILE . 18.3 mm -89.92 90.17 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.1 m -75.65 -179.67 4.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.067 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.418 ' HE2' ' CD2' ' A' ' 31' ' ' TYR . 28.3 mtm -74.81 155.08 87.06 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.043 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.84 128.75 31.78 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.652 2.235 . . . . 0.0 111.968 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.4 24.25 73.63 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.233 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CD2' ' HE2' ' A' ' 28' ' ' MET . 4.0 t80 -104.11 124.98 50.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.712 0.292 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -90.03 163.14 15.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.72 139.69 9.48 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.435 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.432 HG11 ' CD1' ' A' ' 35' ' ' TYR . 61.1 t -61.88 -56.0 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 111.164 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.432 ' CD1' HG11 ' A' ' 34' ' ' VAL . 8.5 m-85 -102.58 36.37 2.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.983 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.4 m 57.85 104.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.606 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -168.28 -33.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.421 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.4 mm . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.87 0.367 . . . . 0.0 111.097 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.3 t30 . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.613 0.244 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.416 ' HG3' ' CE2' ' A' ' 23' ' ' PHE . 72.8 Cg_endo -76.0 -31.44 4.99 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.466 2.111 . . . . 0.0 112.212 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.9 m -72.09 125.14 26.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -96.75 43.14 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.436 0.636 . . . . 0.0 110.498 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -150.65 -164.55 2.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.083 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.02 38.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 110.483 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.13 -178.18 2.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.39 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.402 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 53.6 m -114.1 153.86 28.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.662 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.1 t -89.97 114.63 26.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.981 0.42 . . . . 0.0 111.086 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.99 56.5 1.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.485 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.41 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 3.7 p-10 -86.11 159.75 19.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.159 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -139.95 -166.57 2.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.722 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.86 112.65 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.969 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.62 -83.87 1.05 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.447 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -100.99 125.44 47.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.416 ' CE2' ' HG3' ' A' ' 9' ' ' PRO . 53.4 p90 -96.12 167.81 10.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.9 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -133.73 126.02 29.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.118 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.9 t -95.7 133.58 39.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.531 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 15' ' ' THR . 9.6 mm -89.79 96.19 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.738 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -72.44 -172.83 1.0 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.277 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 41.5 mtt -94.06 162.04 27.91 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.695 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.22 88.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.519 2.146 . . . . 0.0 112.292 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.69 56.58 2.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.529 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -116.28 137.51 52.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.728 0.299 . . . . 0.0 110.713 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.02 162.66 15.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.961 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.18 145.22 16.53 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.398 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.6 t -58.18 -54.04 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.795 0.331 . . . . 0.0 111.132 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -113.64 42.46 1.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.835 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 56.33 102.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -177.67 -34.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.049 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.6 mm . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.191 -179.868 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.5 t30 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.589 0.233 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HG3' ' CE2' ' A' ' 23' ' ' PHE . 29.8 Cg_endo -63.36 -41.36 27.04 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.415 2.077 . . . . 0.0 112.055 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 99.7 m -65.46 135.59 55.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -92.29 43.85 1.15 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.367 0.603 . . . . 0.0 110.543 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -150.78 -163.02 1.67 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.799 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -89.83 44.62 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 0.0 110.588 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.32 -179.69 5.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.972 0.415 . . . . 0.0 111.276 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.0 m -112.03 149.19 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.49 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.7 t -89.82 126.41 35.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.951 0.405 . . . . 0.0 111.013 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.48 60.19 1.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.73 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -86.28 153.8 21.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.135 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -146.58 -170.91 3.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.695 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.501 HD13 HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -59.26 130.31 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.057 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.71 -113.84 3.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.564 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -89.89 117.65 28.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.889 0.376 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.4 ' CE2' ' HG3' ' A' ' 9' ' ' PRO . 54.1 p90 -71.62 172.2 10.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.049 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -140.85 127.16 19.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.078 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.4 t -103.4 133.0 49.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.425 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 mm -89.69 100.59 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.754 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -82.53 168.89 16.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.386 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.1 mtt -68.76 154.65 94.5 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.026 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -56.95 131.73 47.27 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.622 2.214 . . . . 0.0 112.154 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.41 21.81 72.63 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.606 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -102.96 122.01 43.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 0.0 110.662 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.96 154.29 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.088 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.28 132.59 4.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.502 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.41 HG12 ' CE1' ' A' ' 35' ' ' TYR . 99.6 t -56.99 -30.89 35.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.762 0.315 . . . . 0.0 111.107 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.415 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 33.4 m-85 -136.52 53.49 1.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.987 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 72.8 m 47.48 97.27 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.515 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -173.92 -35.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.338 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.5 mm . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.904 0.383 . . . . 0.0 111.092 179.928 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.592 0.234 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.51 -44.29 6.55 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.417 2.078 . . . . 0.0 112.144 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 95.5 m -63.62 134.9 56.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.934 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -92.36 44.84 1.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.47 0.653 . . . . 0.0 110.469 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -150.66 -161.41 1.33 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.807 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -89.84 37.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.673 0.273 . . . . 0.0 110.69 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.68 -176.73 6.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.908 0.385 . . . . 0.0 111.315 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.6 m -122.04 142.99 49.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.489 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.8 t -103.68 111.48 23.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.326 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mt -110.26 61.99 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.388 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.407 ' CB ' ' CB ' ' A' ' 23' ' ' PHE . 15.3 p-10 -85.75 141.66 29.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.149 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -136.42 -167.84 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.681 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 mp -58.82 105.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.128 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.04 -103.68 2.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.496 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -93.96 156.68 16.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.897 0.38 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.407 ' CB ' ' CB ' ' A' ' 18' ' ' ASP . 16.9 p90 -120.17 171.0 8.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.981 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.11 117.32 7.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.059 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.5 t -89.96 131.99 35.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.595 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 mp -89.77 97.96 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.032 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.07 173.29 12.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.076 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 15.6 mtt -74.9 146.03 82.16 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.095 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.61 114.94 2.07 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.547 2.165 . . . . 0.0 112.223 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.48 19.61 58.16 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.662 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -102.15 126.29 49.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 110.398 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.8 159.41 17.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.17 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.28 131.09 5.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.444 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.428 HG11 ' CZ ' ' A' ' 35' ' ' TYR . 59.0 t -54.1 -31.69 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.04 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.47 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 44.1 m-85 -136.65 51.91 1.97 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.726 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.2 m 50.43 97.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.74 -33.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.474 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 111.0 -179.982 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.515 0.198 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.31 -32.49 61.54 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.277 1.984 . . . . 0.0 111.84 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 68.7 m -74.44 139.32 43.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.939 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -91.52 45.04 1.21 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.381 0.61 . . . . 0.0 110.515 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -150.66 -159.47 1.04 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.836 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -89.98 35.65 0.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.739 0.304 . . . . 0.0 110.754 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.56 -175.67 4.9 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.957 0.408 . . . . 0.0 111.384 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.7 m -127.96 139.86 52.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.618 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.5 p -92.47 125.61 37.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.146 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.89 83.72 2.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.553 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 4.0 p30 -100.43 153.54 19.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.121 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.08 -171.9 3.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.698 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mt -58.87 94.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.044 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.9 -104.79 1.18 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.403 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -89.97 159.4 16.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.847 0.356 . . . . 0.0 110.784 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.406 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 17.9 p90 -127.61 162.16 27.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.006 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -138.11 126.38 23.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.824 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -89.99 141.14 28.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.3 mm -89.78 89.95 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.683 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -167.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.321 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 13.7 mtp -108.22 162.6 19.34 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.25 121.62 10.01 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.518 2.145 . . . . 0.0 112.309 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.45 31.4 80.15 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.585 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -112.06 115.57 29.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.754 0.311 . . . . 0.0 110.515 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -89.92 171.32 9.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.5 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.32 141.66 9.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.295 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.418 HG12 ' CE1' ' A' ' 35' ' ' TYR . 94.7 t -52.72 -41.07 37.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.765 0.317 . . . . 0.0 111.177 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.452 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 33.6 m-85 -134.31 53.62 1.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.728 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 47.76 95.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.313 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -166.56 -36.46 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 0.0 111.196 -179.882 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 p30 . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.454 0.168 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.421 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 74.1 Cg_exo -49.0 -38.53 39.46 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.44 2.093 . . . . 0.0 112.405 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 36' ' ' CYS . 82.3 m -64.9 144.34 57.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.769 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -122.06 52.88 1.25 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.808 0.337 . . . . 0.0 111.745 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -150.24 -91.74 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.997 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.29 30.28 0.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.751 0.31 . . . . 0.0 110.752 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.59 -176.17 0.76 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.519 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.5 m -122.94 160.57 25.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.478 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.4 t -89.89 133.26 34.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.109 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.86 41.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.609 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -81.07 154.98 26.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.103 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -141.94 -174.89 4.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.721 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -53.23 136.51 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.238 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.98 -84.72 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.464 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -94.23 164.49 13.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.788 0.328 . . . . 0.0 110.785 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CE1' ' HG2' ' A' ' 9' ' ' PRO . 49.5 p90 -133.74 178.96 6.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.037 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -149.7 119.09 6.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.002 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.2 t -105.97 136.06 46.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.333 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.8 mm -89.97 92.52 3.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.753 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.3 t -79.17 162.12 25.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.291 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mtp -58.28 143.49 79.49 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.188 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.97 124.26 14.56 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.522 2.148 . . . . 0.0 112.263 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.79 24.74 59.61 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.587 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -96.05 176.08 6.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.802 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.48 162.4 28.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.008 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.23 152.65 14.84 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.5 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.86 -35.45 51.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.909 0.385 . . . . 0.0 111.242 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -117.0 -70.34 0.8 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.283 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER 178.56 68.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.916 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -140.36 -35.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.244 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.2 mm . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.759 0.314 . . . . 0.0 111.114 -179.905 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.558 0.218 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.421 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 66.7 Cg_endo -73.7 -32.44 7.53 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.504 2.136 . . . . 0.0 112.194 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.9 m -69.17 126.44 29.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.4 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -93.95 42.2 1.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.337 0.589 . . . . 0.0 111.139 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -151.07 -161.29 1.3 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.309 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.89 29.95 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.708 0.29 . . . . 0.0 110.898 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.54 -177.01 0.67 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.969 0.414 . . . . 0.0 111.22 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.9 m -117.49 136.03 53.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.793 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.0 t -89.72 85.27 6.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.29 67.03 5.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.654 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -148.94 111.07 4.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.892 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.01 74.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.921 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.2 mt 51.78 61.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.223 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 179.76 -97.58 0.11 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.484 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.52 132.1 36.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.759 0.314 . . . . 0.0 110.838 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.413 ' CE1' ' HG3' ' A' ' 9' ' ' PRO . 44.6 t80 -92.91 133.71 35.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.986 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.17 98.69 2.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.999 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -89.95 123.25 33.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.52 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.7 mm -89.74 108.89 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.687 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.43 -169.81 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.252 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.0 mtt -98.14 161.55 25.09 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.84 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.61 90.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.486 2.124 . . . . 0.0 112.395 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.78 55.89 3.06 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.417 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -110.16 163.56 13.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.763 0.316 . . . . 0.0 110.753 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -117.43 150.67 38.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.929 0.395 . . . . 0.0 111.123 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.24 141.78 10.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.454 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.419 HG12 ' CE1' ' A' ' 35' ' ' TYR . 86.6 t -55.18 -61.99 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 10.7 m-85 -96.62 27.71 3.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 60.44 108.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.701 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -179.83 -32.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.003 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.187 -179.91 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.5 t30 . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.488 0.185 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.56 -29.3 7.52 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.511 2.14 . . . . 0.0 112.122 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.0 m -69.63 127.52 33.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.664 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.74 42.48 1.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.465 0.65 . . . . 0.0 110.453 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -150.74 -164.66 2.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.194 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -91.23 38.4 0.97 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.748 0.309 . . . . 0.0 110.584 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.1 -178.45 3.35 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.446 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.0 m -114.01 153.7 28.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.554 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.7 t -89.87 106.52 18.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.24 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -127.97 61.75 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.333 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.407 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 5.7 p-10 -90.94 156.59 17.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.177 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.67 -166.54 2.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.794 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.5 mm -62.47 130.09 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.06 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.13 -98.05 0.97 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.573 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.01 136.12 33.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 110.784 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.407 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 54.4 p90 -99.04 178.02 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.05 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.89 128.45 19.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.066 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -96.76 134.26 40.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.71 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 mm -89.85 97.36 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.587 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.89 -176.7 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.414 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.408 ' HE2' ' CE2' ' A' ' 31' ' ' TYR . 7.8 mtt -88.07 154.69 52.34 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.867 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.8 92.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.7 2.267 . . . . 0.0 112.11 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.73 37.27 4.78 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.395 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.408 ' CE2' ' HE2' ' A' ' 28' ' ' MET . 3.1 t80 -110.46 131.03 55.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.759 0.314 . . . . 0.0 110.671 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.86 161.03 16.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.144 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.48 141.76 11.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.484 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.01 -61.18 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.763 0.316 . . . . 0.0 111.061 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 17.6 m-85 -101.34 36.44 2.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.713 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 60.03 105.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.71 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -176.39 -35.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.155 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.4 mm . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.048 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.456 0.17 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.21 -46.21 4.65 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.341 2.027 . . . . 0.0 112.089 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.6 m -60.58 135.46 57.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -91.52 45.22 1.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.366 0.603 . . . . 0.0 110.492 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -150.65 -161.55 1.36 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.826 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -89.92 41.13 1.03 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.824 0.345 . . . . 0.0 110.681 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.43 -176.18 3.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.042 0.449 . . . . 0.0 111.245 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.9 m -122.59 151.53 41.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.603 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.1 t -89.93 148.91 22.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.965 0.412 . . . . 0.0 111.128 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.22 49.29 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.499 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 14.2 p-10 -82.9 146.21 28.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.008 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.7 -169.27 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.6 mm -69.54 111.54 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.54 -86.7 0.57 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -107.25 134.99 49.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.764 0.316 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.403 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 44.0 p90 -101.45 170.87 7.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.977 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -143.98 125.67 15.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.969 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.3 t -103.39 138.64 39.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.635 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 26' ' ' ILE . 8.9 mm -89.72 105.87 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.7 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -93.2 170.09 9.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.409 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.547 ' HB2' ' HB2' ' A' ' 31' ' ' TYR . 62.5 mtt -63.84 159.65 52.41 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.99 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.87 -64.74 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.769 2.312 . . . . 0.0 112.866 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.89 66.89 0.26 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.31 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 28' ' ' MET . 2.7 t80 -127.71 157.08 41.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.816 0.341 . . . . 0.0 110.785 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -117.45 152.75 34.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.002 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.88 142.02 6.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.431 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.429 HG13 ' CZ ' ' A' ' 35' ' ' TYR . 61.2 t -58.75 -34.42 51.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.685 0.278 . . . . 0.0 111.074 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.429 ' CZ ' HG13 ' A' ' 34' ' ' VAL . 19.6 m-85 -137.04 53.52 1.89 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.173 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.8 m 49.78 96.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.219 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.13 -36.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.266 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.7 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.05 -179.811 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.538 0.208 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.81 -32.19 14.63 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.408 2.072 . . . . 0.0 112.103 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.1 m -77.7 128.25 33.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.535 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -94.76 43.98 1.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.349 0.595 . . . . 0.0 110.676 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -150.69 -162.31 1.52 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.002 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -90.45 27.49 1.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.344 . . . . 0.0 110.607 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.83 -175.21 1.66 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.506 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.3 m -128.72 128.53 44.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.472 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.3 t -96.72 124.18 40.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.068 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.07 79.36 1.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.502 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -103.78 133.44 48.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.098 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -141.84 75.27 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.1 mt 52.84 94.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.27 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.09 -127.19 7.11 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.462 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -89.94 132.58 35.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.798 0.332 . . . . 0.0 110.852 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -108.97 -172.26 2.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.921 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -148.89 122.61 9.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -89.96 130.18 36.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.632 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.2 mm -89.72 88.66 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.956 0.407 . . . . 0.0 110.66 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -166.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.324 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 47.5 mtp -109.54 161.44 24.06 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.818 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -51.46 92.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.606 2.204 . . . . 0.0 112.285 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.2 52.63 3.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.467 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -120.16 118.17 29.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.722 0.296 . . . . 0.0 110.632 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -90.0 167.99 12.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.123 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.43 136.28 8.55 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.425 HG11 ' CE2' ' A' ' 35' ' ' TYR . 92.4 t -56.34 129.04 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.381 . . . . 0.0 111.077 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.425 ' CE2' HG11 ' A' ' 34' ' ' VAL . 6.7 m-85 58.38 27.21 15.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.995 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 62.41 115.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.04 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -165.68 -54.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.756 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.0 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.267 -179.775 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.539 0.209 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 47.3 Cg_endo -68.0 -33.82 24.83 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.457 2.105 . . . . 0.0 112.102 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 m -65.61 127.22 31.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.527 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -95.09 43.79 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.256 0.55 . . . . 0.0 110.683 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -150.74 -163.85 1.87 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.145 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.5 34.45 0.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.8 0.333 . . . . 0.0 110.544 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.21 -177.29 1.68 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.414 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.2 m -114.04 150.22 34.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.66 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.6 t -89.77 118.05 29.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.023 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 tt -132.66 67.76 1.52 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.714 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -142.65 158.58 43.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.005 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -144.9 -177.1 5.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 tp -58.46 91.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.081 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.13 -27.62 8.06 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.418 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -97.32 175.49 6.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.856 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.449 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 12.5 t80 -174.04 113.77 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.01 127.3 11.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.149 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.5 t -100.52 125.42 46.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.538 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.2 mm -89.8 81.66 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.754 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -169.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.335 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 40.1 mtp -97.59 160.84 27.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.942 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.32 92.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.601 2.201 . . . . 0.0 112.272 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.64 53.73 3.3 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -115.21 132.86 56.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.696 0.284 . . . . 0.0 110.792 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -89.99 153.33 20.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.082 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.91 142.03 9.31 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.397 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.406 HG13 ' CZ ' ' A' ' 35' ' ' TYR . 59.4 t -56.66 -53.93 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.949 0.404 . . . . 0.0 111.219 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.406 ' CZ ' HG13 ' A' ' 34' ' ' VAL . 17.8 m-85 -111.81 41.56 1.9 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.782 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 55.27 101.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.853 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -172.66 -35.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.062 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.3 mm . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.204 -179.92 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 120.395 0.14 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.28 -40.65 24.48 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.408 2.072 . . . . 0.0 112.243 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 94.5 m -67.22 136.54 55.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -112.78 54.34 0.72 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.341 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -150.24 -92.82 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.832 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.3 24.24 0.81 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.322 . . . . 0.0 110.845 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.9 178.35 1.8 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.293 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 16' ' ' CYS . 28.6 m -112.99 158.93 19.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.62 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.402 ' N ' HG22 ' A' ' 15' ' ' THR . 37.8 t -89.72 125.12 35.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.69 52.64 1.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.686 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -150.96 89.41 1.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -149.27 42.04 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.9 tt -169.48 59.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.038 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.39 26.54 59.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.526 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -132.68 -179.22 5.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.851 0.358 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -157.03 105.5 2.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.997 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -150.02 121.68 8.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.3 t -105.08 137.65 42.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.652 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 26' ' ' ILE . 9.5 mm -89.87 87.85 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.833 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.98 -179.81 1.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.168 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.3 mtt -82.38 161.67 58.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.3 89.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.451 2.101 . . . . 0.0 112.397 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.4 67.93 1.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.644 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -113.34 130.7 56.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.69 0.281 . . . . 0.0 110.392 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -89.97 154.08 20.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 0.0 111.228 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.22 143.39 14.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.718 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.421 HG11 ' CD2' ' A' ' 35' ' ' TYR . 84.2 t -66.34 130.81 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.398 . . . . 0.0 111.102 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CD2' HG11 ' A' ' 34' ' ' VAL . 4.2 m-85 61.05 46.26 8.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.169 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 m 46.92 96.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.409 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.62 -65.66 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.2 mm . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.244 -179.808 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.613 0.244 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.02 -40.49 20.21 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.445 2.097 . . . . 0.0 112.131 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 98.5 m -65.81 135.02 54.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.982 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -93.22 45.18 1.16 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.42 0.628 . . . . 0.0 110.379 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -150.48 -161.56 1.37 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.721 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -89.95 42.73 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.787 0.327 . . . . 0.0 110.76 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.59 179.41 5.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.156 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 26.6 m -115.85 160.71 19.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.553 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.6 t -89.9 144.65 25.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.068 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 tp -175.53 64.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.548 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.401 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 7.2 p-10 -98.58 163.44 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.262 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.45 -171.22 3.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.772 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.0 mm -72.65 97.24 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.094 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.23 -98.59 1.05 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.524 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.98 105.23 17.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 110.861 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.401 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 49.5 p90 -75.99 -177.13 3.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.069 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -149.99 129.5 13.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.117 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.9 t -111.24 138.79 47.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.501 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.2 mm -89.73 106.97 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.837 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -94.25 171.23 8.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.424 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 34.1 mtt -76.95 144.08 71.74 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.988 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -57.16 121.98 11.02 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.492 2.128 . . . . 0.0 112.273 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.84 11.03 82.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.944 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -97.46 128.61 44.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.761 0.315 . . . . 0.0 110.413 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.71 160.45 16.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.281 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.15 138.86 6.47 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.43 HG12 ' CZ ' ' A' ' 35' ' ' TYR . 58.9 t -60.39 -33.39 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.935 0.398 . . . . 0.0 110.848 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.43 ' CZ ' HG12 ' A' ' 34' ' ' VAL . 37.5 m-85 -137.58 53.95 1.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.933 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 39.0 m 49.2 96.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.257 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -178.46 -37.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.942 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.1 mm . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.14 -179.908 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.542 0.21 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.18 -37.73 17.64 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.382 2.054 . . . . 0.0 112.022 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 1.8 m -71.47 123.4 22.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.321 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -92.63 44.61 1.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.269 0.557 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -150.9 -160.87 1.23 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.953 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -90.24 25.97 2.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.53 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.26 -175.37 1.52 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.029 0.443 . . . . 0.0 111.39 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.3 m -129.64 128.21 42.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.563 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.7 t -104.67 143.42 33.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.199 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.09 93.2 2.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.582 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.409 ' CB ' ' HB3' ' A' ' 23' ' ' PHE . 14.9 p-10 -107.53 121.6 44.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.961 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -143.26 80.23 1.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.5 mt 55.62 103.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.214 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.61 -132.56 10.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.523 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.35 117.46 34.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.748 0.308 . . . . 0.0 110.95 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.409 ' HB3' ' CB ' ' A' ' 18' ' ' ASP . 46.5 p90 -78.51 172.13 14.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.12 131.87 39.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.194 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.96 125.73 48.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.607 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.417 HD12 HG22 ' A' ' 26' ' ' ILE . 19.2 mm -89.66 94.49 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.954 0.407 . . . . 0.0 110.516 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.14 179.88 7.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.473 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.3 mtt -83.77 154.88 65.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.041 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.38 114.83 2.15 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.575 2.183 . . . . 0.0 112.061 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.31 23.83 55.81 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.376 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -105.29 122.81 46.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.662 0.267 . . . . 0.0 110.461 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -89.86 164.06 14.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.98 0.419 . . . . 0.0 111.337 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.51 134.21 6.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.414 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.6 t -56.85 -33.1 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 111.145 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.423 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 35.5 m-85 -133.98 45.15 2.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.822 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 74.9 m 56.79 101.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.794 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -175.65 -34.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.418 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.5 mm . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 111.233 -179.86 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 120.446 0.165 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.406 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 37.4 Cg_endo -65.87 -25.02 53.08 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.471 2.114 . . . . 0.0 111.989 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.6 128.72 36.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.065 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -97.88 42.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.332 0.587 . . . . 0.0 110.945 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -150.47 -157.64 0.83 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.2 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.85 28.94 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.801 0.334 . . . . 0.0 110.501 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.58 -175.75 2.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.521 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 57.8 m -124.53 132.27 53.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.533 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.8 t -90.02 118.08 29.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.013 0.435 . . . . 0.0 111.247 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.5 72.23 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.43 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -90.22 142.89 27.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.103 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -137.04 -166.15 1.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.697 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.98 102.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.16 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.89 -115.2 3.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.09 142.42 27.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.351 . . . . 0.0 110.806 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -102.83 165.74 10.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -141.02 124.9 17.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.024 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -90.41 142.56 27.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.711 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.4 HD11 HG23 ' A' ' 26' ' ' ILE . 16.6 mm -89.7 91.32 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.772 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.8 m -60.43 176.95 0.31 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.234 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.3 mtp -87.27 161.28 46.57 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.858 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.55 96.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.44 2.093 . . . . 0.0 112.389 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.23 40.61 10.03 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.321 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -115.95 134.92 54.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.742 0.306 . . . . 0.0 110.818 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.25 178.79 4.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.102 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.43 162.04 11.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.537 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.1 t -57.11 -67.8 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.928 0.394 . . . . 0.0 110.95 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.406 ' CD1' ' HB2' ' A' ' 9' ' ' PRO . 43.6 m-85 -98.59 30.66 3.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.865 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.3 m 66.6 51.0 1.15 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -123.93 -2.89 8.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.52 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 120.782 0.325 . . . . 0.0 111.076 -179.8 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.495 0.188 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.95 -28.33 58.14 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.41 2.074 . . . . 0.0 112.01 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 69.3 m -72.18 145.93 47.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.952 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -96.87 42.19 1.09 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.374 0.607 . . . . 0.0 110.398 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -150.76 -161.76 1.41 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.986 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.75 43.37 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.97 0.415 . . . . 0.0 110.349 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.05 -174.09 1.79 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.754 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.2 m -124.23 145.69 49.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.424 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.97 130.63 36.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.171 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.78 59.85 1.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.716 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -91.03 137.34 32.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -127.1 -171.7 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.855 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.23 120.53 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.097 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.4 -103.18 3.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.486 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.55 139.5 31.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.35 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -101.48 176.24 5.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.014 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -149.27 130.15 14.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.82 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.5 t -105.74 109.09 20.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.763 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 mp -90.0 126.58 42.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.95 -161.91 1.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.732 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.522 ' HB2' ' HB2' ' A' ' 31' ' ' TYR . 15.8 mtt -50.51 146.58 9.1 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.114 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.8 -64.64 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.604 2.203 . . . . 0.0 112.5 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.6 57.7 4.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.227 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.522 ' HB2' ' HB2' ' A' ' 28' ' ' MET . 0.7 OUTLIER -124.86 125.71 44.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.866 0.365 . . . . 0.0 110.877 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -97.16 152.37 18.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.777 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.23 146.36 7.08 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.346 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.429 HG11 ' CE2' ' A' ' 35' ' ' TYR . 54.7 t -63.81 -31.16 52.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.912 0.387 . . . . 0.0 111.221 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.429 ' CE2' HG11 ' A' ' 34' ' ' VAL . 31.6 m-85 -142.56 57.54 1.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.05 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 48.88 92.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.006 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -169.71 -39.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.089 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.3 mm . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.063 -179.901 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.602 0.239 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.88 -43.0 13.11 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.376 2.05 . . . . 0.0 112.197 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 68.5 m -59.03 139.25 57.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.083 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -92.8 44.35 1.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.43 0.633 . . . . 0.0 110.482 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -150.58 -161.03 1.25 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.831 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.1 37.74 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.768 0.318 . . . . 0.0 110.655 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.78 -176.81 4.57 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.354 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.9 m -120.28 141.17 50.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.585 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.9 t -89.92 138.06 31.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.144 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.05 69.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.772 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 33.5 p-10 -92.56 155.18 17.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.084 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -135.06 -178.88 5.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.064 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.427 ' CD1' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -57.53 88.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.547 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.74 -93.13 0.58 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.577 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -89.95 137.87 31.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.873 0.368 . . . . 0.0 110.768 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.418 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 23.7 p90 -113.73 166.88 11.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -145.04 126.61 15.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.977 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.0 t -97.08 138.97 33.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.635 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.9 mm -89.79 92.28 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.993 0.425 . . . . 0.0 110.794 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -170.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.066 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.6 mtp -90.34 154.94 46.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.802 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.24 84.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.625 2.216 . . . . 0.0 112.207 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.23 52.49 1.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.499 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -120.68 154.38 35.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.765 0.317 . . . . 0.0 110.521 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.69 160.5 15.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.946 0.403 . . . . 0.0 111.187 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.78 142.88 12.95 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.693 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.8 t -56.88 -41.75 76.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.98 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.407 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 44.2 m-85 -125.36 48.42 2.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.692 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 m 53.11 96.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.098 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -166.72 -39.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.07 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.5 mm . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.007 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.609 0.242 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.429 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 38.2 Cg_endo -65.88 -40.75 15.76 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.517 2.145 . . . . 0.0 112.198 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 90.6 m -60.5 132.62 54.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.84 44.87 1.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.35 0.595 . . . . 0.0 110.405 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -150.63 -161.3 1.31 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.773 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -89.94 41.63 1.05 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.725 0.298 . . . . 0.0 110.758 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.48 179.09 4.84 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.76 0.314 . . . . 0.0 111.129 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 93.4 m -114.58 157.7 22.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.671 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.5 p -89.91 130.09 36.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.38 51.74 1.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.757 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -144.27 64.82 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -125.98 27.31 6.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.85 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mp -147.75 30.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.898 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.83 25.7 73.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.498 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -139.53 106.16 5.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.353 . . . . 0.0 110.841 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.429 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 23.4 t80 -70.79 112.76 7.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.084 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -150.01 116.06 5.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.9 t -105.22 134.13 48.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.61 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.7 mm -89.79 105.48 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.841 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -88.41 174.33 8.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.227 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.3 mtt -69.83 161.89 71.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.817 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.48 87.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.568 2.179 . . . . 0.0 112.341 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.36 60.91 1.86 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.63 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -111.21 128.3 55.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.67 0.271 . . . . 0.0 110.289 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -89.83 174.08 7.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 111.435 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.29 134.0 1.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.593 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.428 HG11 ' CE2' ' A' ' 35' ' ' TYR . 57.7 t -59.46 132.11 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.895 0.379 . . . . 0.0 110.976 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.428 ' CE2' HG11 ' A' ' 34' ' ' VAL . 7.4 m-85 61.01 47.22 7.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.895 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 50.17 96.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.327 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.71 -50.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.02 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.148 -179.783 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 35.7 t0 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.824 0.345 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.47 106.55 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.168 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 60.57 86.99 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -30.91 71.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.2 t -89.98 94.5 9.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.427 HG23 HD12 ' A' ' 6' ' ' ILE . 27.3 mm -89.91 -45.66 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.019 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.98 52.56 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.745 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.62 118.32 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 37.1 Cg_endo -65.27 -42.32 13.72 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.404 2.07 . . . . 0.0 112.105 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 87.4 m -53.7 136.89 38.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.028 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.74 44.06 1.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.508 0.67 . . . . 0.0 110.669 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -150.77 -161.33 1.32 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.809 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.02 39.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 110.839 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.33 -175.5 4.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.983 0.421 . . . . 0.0 111.414 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.9 m -121.14 147.66 45.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.725 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.5 t -89.92 155.74 18.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -172.2 80.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.78 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -138.6 169.94 16.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.977 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -150.07 -175.38 5.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.87 70.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 111.065 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.77 -26.68 1.93 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.663 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.93 177.7 4.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.908 0.385 . . . . 0.0 111.039 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.415 ' CE1' ' HG3' ' A' ' 9' ' ' PRO . 38.4 t80 -176.0 103.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.715 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -143.68 132.47 22.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.974 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.8 t -109.04 140.16 42.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.68 90.29 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.787 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -167.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.151 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 63.7 mtp -101.73 155.78 35.99 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.841 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.65 93.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.649 2.232 . . . . 0.0 112.091 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.52 39.38 4.46 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.386 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -119.63 118.96 32.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.746 0.308 . . . . 0.0 110.685 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.93 157.2 17.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.008 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.64 143.83 7.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.415 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.415 HG11 ' CZ ' ' A' ' 35' ' ' TYR . 57.3 t -57.94 -40.72 77.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.85 0.357 . . . . 0.0 111.12 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.445 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 13.4 m-85 -125.55 48.8 2.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.781 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 46.91 75.97 0.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.339 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -123.88 -25.73 4.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.325 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.8 mm . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.82 0.343 . . . . 0.0 111.082 -179.966 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.835 0.35 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 t -100.33 79.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.032 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -160.47 -46.11 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 59.88 30.37 19.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.022 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 40.7 t -140.49 83.96 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.3 mm -89.95 -44.97 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.737 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 t -143.39 52.66 1.34 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.569 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 62.29 119.63 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.757 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 36.1 Cg_endo -64.76 -43.34 12.91 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.423 2.082 . . . . 0.0 112.005 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.473 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 93.2 m -54.86 136.77 46.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.037 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -91.82 43.76 1.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.356 0.598 . . . . 0.0 110.539 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -150.68 -161.67 1.39 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.853 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.85 38.49 0.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.714 0.293 . . . . 0.0 110.825 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.54 -174.74 4.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.005 0.431 . . . . 0.0 111.421 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.1 m -125.51 142.62 51.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.844 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.9 t -90.0 149.42 22.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tt -157.29 66.69 0.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -111.14 110.0 20.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -90.03 -175.92 4.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.3 103.98 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.095 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.02 26.81 57.49 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.15 -178.2 5.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 0.0 110.904 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.422 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 13.9 t80 -177.54 113.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -149.96 123.6 9.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.073 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.3 t -104.45 131.79 51.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.689 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 mp -89.95 91.72 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.941 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.26 -168.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.026 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.4 mtp -91.99 160.35 35.96 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.986 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.73 95.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.557 2.172 . . . . 0.0 112.387 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.23 54.83 3.92 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.366 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -120.26 137.87 53.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.751 0.31 . . . . 0.0 110.684 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -93.35 161.88 14.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.132 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.5 137.96 9.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.447 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.42 HG13 ' CE1' ' A' ' 35' ' ' TYR . 76.0 t -56.59 -48.95 79.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 0.0 111.056 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.473 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 13.2 m-85 -112.61 43.27 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.611 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.2 m 52.09 98.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.953 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -166.71 -39.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.961 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.7 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.213 -179.861 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.828 0.347 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.7 m -97.44 141.89 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.056 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -95.92 164.26 12.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -100.27 42.55 1.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.925 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.58 22.66 13.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.154 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.3 mm -108.19 -27.98 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 0.0 110.893 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.6 t -139.97 56.43 1.63 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.462 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -52.34 107.15 0.77 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.389 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HG2' ' CZ ' ' A' ' 23' ' ' PHE . 65.5 Cg_exo -52.12 -24.65 20.67 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.551 2.167 . . . . 0.0 112.232 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.9 m -59.42 125.21 22.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.621 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -96.02 42.57 1.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.374 0.607 . . . . 0.0 110.64 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -150.79 -165.62 2.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.994 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -89.94 41.33 1.04 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.88 0.372 . . . . 0.0 110.484 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.14 -176.0 3.36 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.491 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 48.8 m -119.48 154.34 33.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.569 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.8 p -89.85 130.56 36.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 111.132 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.72 69.71 1.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -153.87 135.38 14.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.09 67.66 1.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.816 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.9 mm 52.7 85.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.17 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.46 -82.04 0.13 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.447 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.18 121.8 41.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.828 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.439 ' CZ ' ' HG2' ' A' ' 9' ' ' PRO . 90.5 t80 -77.34 131.01 37.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -139.67 103.11 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.831 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.9 t -92.13 122.49 34.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.667 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.467 HD13 HG22 ' A' ' 26' ' ' ILE . 18.3 mm -89.92 90.17 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.1 m -75.65 -179.67 4.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.067 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.418 ' HE2' ' CD2' ' A' ' 31' ' ' TYR . 28.3 mtm -74.81 155.08 87.06 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.043 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.84 128.75 31.78 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.652 2.235 . . . . 0.0 111.968 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.4 24.25 73.63 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.233 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CD2' ' HE2' ' A' ' 28' ' ' MET . 4.0 t80 -104.11 124.98 50.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.712 0.292 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -90.03 163.14 15.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.72 139.69 9.48 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.435 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.432 HG11 ' CD1' ' A' ' 35' ' ' TYR . 61.1 t -61.88 -56.0 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 111.164 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.432 ' CD1' HG11 ' A' ' 34' ' ' VAL . 8.5 m-85 -102.58 36.37 2.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.983 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.4 m 57.85 104.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.606 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -168.28 -33.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.421 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.4 mm . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.87 0.367 . . . . 0.0 111.097 -179.999 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.859 0.362 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.88 105.41 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.218 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -128.02 30.53 5.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -114.38 30.88 6.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 t -117.88 29.04 8.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.925 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.5 mt -91.63 -29.37 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.059 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.1 t -120.17 91.73 3.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.715 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -54.38 108.15 1.06 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.416 ' HG3' ' CE2' ' A' ' 23' ' ' PHE . 72.8 Cg_endo -76.0 -31.44 4.99 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.466 2.111 . . . . 0.0 112.212 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.9 m -72.09 125.14 26.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -96.75 43.14 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.436 0.636 . . . . 0.0 110.498 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -150.65 -164.55 2.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.083 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.02 38.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 110.483 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.13 -178.18 2.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.39 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.402 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 53.6 m -114.1 153.86 28.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.662 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.1 t -89.97 114.63 26.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.981 0.42 . . . . 0.0 111.086 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.99 56.5 1.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.485 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.41 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 3.7 p-10 -86.11 159.75 19.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.159 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -139.95 -166.57 2.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.722 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -73.86 112.65 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.969 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.62 -83.87 1.05 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.447 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -100.99 125.44 47.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.416 ' CE2' ' HG3' ' A' ' 9' ' ' PRO . 53.4 p90 -96.12 167.81 10.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.9 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -133.73 126.02 29.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.118 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.9 t -95.7 133.58 39.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.531 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 15' ' ' THR . 9.6 mm -89.79 96.19 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.738 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -72.44 -172.83 1.0 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.277 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 41.5 mtt -94.06 162.04 27.91 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.695 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.22 88.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.519 2.146 . . . . 0.0 112.292 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.69 56.58 2.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.529 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -116.28 137.51 52.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.728 0.299 . . . . 0.0 110.713 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.02 162.66 15.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.961 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.18 145.22 16.53 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.398 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.6 t -58.18 -54.04 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.795 0.331 . . . . 0.0 111.132 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -113.64 42.46 1.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.835 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 56.33 102.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -177.67 -34.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.049 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.6 mm . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.191 -179.868 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.822 0.344 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p -146.18 134.26 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.157 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -93.78 -175.97 3.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.917 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.84 32.79 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.017 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.9 t -110.63 27.01 10.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.121 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -95.93 -27.91 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.926 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 t -127.44 104.47 7.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.669 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -56.08 118.59 21.64 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.958 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.4 ' HG3' ' CE2' ' A' ' 23' ' ' PHE . 29.8 Cg_endo -63.36 -41.36 27.04 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.415 2.077 . . . . 0.0 112.055 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 99.7 m -65.46 135.59 55.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -92.29 43.85 1.15 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.367 0.603 . . . . 0.0 110.543 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -150.78 -163.02 1.67 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.799 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -89.83 44.62 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 0.0 110.588 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.32 -179.69 5.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.972 0.415 . . . . 0.0 111.276 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.0 m -112.03 149.19 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.49 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.7 t -89.82 126.41 35.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.951 0.405 . . . . 0.0 111.013 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.48 60.19 1.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.73 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -86.28 153.8 21.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.135 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -146.58 -170.91 3.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.695 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.501 HD13 HG21 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -59.26 130.31 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.057 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.71 -113.84 3.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.564 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -89.89 117.65 28.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.889 0.376 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.4 ' CE2' ' HG3' ' A' ' 9' ' ' PRO . 54.1 p90 -71.62 172.2 10.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.049 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -140.85 127.16 19.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.078 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.4 t -103.4 133.0 49.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.425 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 mm -89.69 100.59 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.754 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -82.53 168.89 16.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.386 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.1 mtt -68.76 154.65 94.5 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.026 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -56.95 131.73 47.27 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.622 2.214 . . . . 0.0 112.154 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.41 21.81 72.63 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.606 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -102.96 122.01 43.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 0.0 110.662 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.96 154.29 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.088 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.28 132.59 4.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.502 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.41 HG12 ' CE1' ' A' ' 35' ' ' TYR . 99.6 t -56.99 -30.89 35.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.762 0.315 . . . . 0.0 111.107 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.415 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 33.4 m-85 -136.52 53.49 1.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.987 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 72.8 m 47.48 97.27 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.515 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -173.92 -35.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.338 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.5 mm . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.904 0.383 . . . . 0.0 111.092 179.928 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.767 0.318 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p -131.7 137.11 55.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.187 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.26 162.86 13.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -117.14 -39.88 3.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 31.3 t -136.3 87.83 2.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.0 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 mt -91.37 -45.24 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.064 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -144.2 55.42 1.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.866 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 61.38 114.76 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.51 -44.29 6.55 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.417 2.078 . . . . 0.0 112.144 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 95.5 m -63.62 134.9 56.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.934 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -92.36 44.84 1.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.47 0.653 . . . . 0.0 110.469 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -150.66 -161.41 1.33 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.807 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -89.84 37.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.673 0.273 . . . . 0.0 110.69 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -81.68 -176.73 6.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.908 0.385 . . . . 0.0 111.315 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.6 m -122.04 142.99 49.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.489 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.8 t -103.68 111.48 23.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.326 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mt -110.26 61.99 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.388 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.407 ' CB ' ' CB ' ' A' ' 23' ' ' PHE . 15.3 p-10 -85.75 141.66 29.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.149 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -136.42 -167.84 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.681 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.1 mp -58.82 105.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.128 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.04 -103.68 2.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.496 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -93.96 156.68 16.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.897 0.38 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.407 ' CB ' ' CB ' ' A' ' 18' ' ' ASP . 16.9 p90 -120.17 171.0 8.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.981 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.11 117.32 7.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.059 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.5 t -89.96 131.99 35.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.595 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.0 mp -89.77 97.96 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.032 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.07 173.29 12.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.076 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 15.6 mtt -74.9 146.03 82.16 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.095 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.61 114.94 2.07 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.547 2.165 . . . . 0.0 112.223 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.48 19.61 58.16 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.662 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -102.15 126.29 49.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 110.398 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.8 159.41 17.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.17 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.28 131.09 5.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.444 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.428 HG11 ' CZ ' ' A' ' 35' ' ' TYR . 59.0 t -54.1 -31.69 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.04 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.47 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 44.1 m-85 -136.65 51.91 1.97 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.726 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 73.2 m 50.43 97.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.74 -33.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.474 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 111.0 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.7 p30 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.823 0.344 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 m -113.51 79.22 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.099 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -141.09 74.25 1.45 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.979 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -110.79 -29.31 8.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 18.6 p -89.9 125.55 35.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.9 mm -89.92 -51.34 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.0 t -140.34 49.64 1.72 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.697 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.82 118.46 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.996 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.31 -32.49 61.54 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.277 1.984 . . . . 0.0 111.84 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 68.7 m -74.44 139.32 43.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.939 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -91.52 45.04 1.21 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.381 0.61 . . . . 0.0 110.515 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -150.66 -159.47 1.04 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.836 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -89.98 35.65 0.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.739 0.304 . . . . 0.0 110.754 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.56 -175.67 4.9 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.957 0.408 . . . . 0.0 111.384 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.7 m -127.96 139.86 52.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.618 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.5 p -92.47 125.61 37.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.146 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.89 83.72 2.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.553 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.406 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 4.0 p30 -100.43 153.54 19.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.121 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.08 -171.9 3.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.698 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mt -58.87 94.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.044 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.9 -104.79 1.18 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.403 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -89.97 159.4 16.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.847 0.356 . . . . 0.0 110.784 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.406 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 17.9 p90 -127.61 162.16 27.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.006 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -138.11 126.38 23.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.824 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -89.99 141.14 28.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.3 mm -89.78 89.95 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.683 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -167.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.321 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 13.7 mtp -108.22 162.6 19.34 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.25 121.62 10.01 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.518 2.145 . . . . 0.0 112.309 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.45 31.4 80.15 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.585 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -112.06 115.57 29.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.754 0.311 . . . . 0.0 110.515 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -89.92 171.32 9.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.5 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.32 141.66 9.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.295 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.418 HG12 ' CE1' ' A' ' 35' ' ' TYR . 94.7 t -52.72 -41.07 37.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.765 0.317 . . . . 0.0 111.177 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.452 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 33.6 m-85 -134.31 53.62 1.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.728 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 47.76 95.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.313 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -166.56 -36.46 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 0.0 111.196 -179.882 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.892 0.377 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.0 t -128.56 116.85 43.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.056 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -147.94 21.82 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.077 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -117.02 -22.15 8.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.248 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.7 t -96.26 29.59 2.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.752 0.311 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.4 mm -101.95 -25.4 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.135 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.0 t -129.15 85.27 2.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -54.39 108.43 1.14 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.421 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 74.1 Cg_exo -49.0 -38.53 39.46 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.44 2.093 . . . . 0.0 112.405 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 36' ' ' CYS . 82.3 m -64.9 144.34 57.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.769 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -122.06 52.88 1.25 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.808 0.337 . . . . 0.0 111.745 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -150.24 -91.74 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.997 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.29 30.28 0.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.751 0.31 . . . . 0.0 110.752 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.59 -176.17 0.76 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.519 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.5 m -122.94 160.57 25.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.478 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.4 t -89.89 133.26 34.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.109 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.86 41.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.609 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -81.07 154.98 26.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.103 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -141.94 -174.89 4.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.721 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -53.23 136.51 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.238 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.98 -84.72 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.464 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -94.23 164.49 13.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.788 0.328 . . . . 0.0 110.785 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CE1' ' HG2' ' A' ' 9' ' ' PRO . 49.5 p90 -133.74 178.96 6.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.037 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -149.7 119.09 6.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.002 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.2 t -105.97 136.06 46.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.333 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.8 mm -89.97 92.52 3.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.753 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.3 t -79.17 162.12 25.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.291 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mtp -58.28 143.49 79.49 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.188 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.97 124.26 14.56 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.522 2.148 . . . . 0.0 112.263 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.79 24.74 59.61 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.587 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -96.05 176.08 6.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.802 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.48 162.4 28.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.008 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.23 152.65 14.84 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.5 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.86 -35.45 51.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.909 0.385 . . . . 0.0 111.242 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -117.0 -70.34 0.8 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.283 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER 178.56 68.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.916 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -140.36 -35.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.244 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.2 mm . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.759 0.314 . . . . 0.0 111.114 -179.905 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.771 0.319 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.92 158.25 41.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 60.49 85.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.834 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -110.71 -35.45 5.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.808 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.428 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 49.1 t -94.81 71.6 3.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mt -90.03 -35.59 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.153 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.89 51.98 2.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.984 0.421 . . . . 0.0 110.895 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 48.37 91.84 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.318 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.421 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . 66.7 Cg_endo -73.7 -32.44 7.53 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.504 2.136 . . . . 0.0 112.194 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.9 m -69.17 126.44 29.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.4 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -93.95 42.2 1.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.337 0.589 . . . . 0.0 111.139 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -151.07 -161.29 1.3 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.309 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.89 29.95 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.708 0.29 . . . . 0.0 110.898 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.54 -177.01 0.67 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.969 0.414 . . . . 0.0 111.22 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.9 m -117.49 136.03 53.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.793 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.0 t -89.72 85.27 6.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.29 67.03 5.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.654 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -148.94 111.07 4.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.892 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.01 74.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.921 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.2 mt 51.78 61.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.223 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 179.76 -97.58 0.11 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.484 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.52 132.1 36.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.759 0.314 . . . . 0.0 110.838 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 5' ' ' CYS . 44.6 t80 -92.91 133.71 35.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.986 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.17 98.69 2.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.999 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -89.95 123.25 33.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.52 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.7 mm -89.74 108.89 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.687 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.43 -169.81 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.252 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.0 mtt -98.14 161.55 25.09 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.84 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.61 90.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.486 2.124 . . . . 0.0 112.395 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.78 55.89 3.06 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.417 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -110.16 163.56 13.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.763 0.316 . . . . 0.0 110.753 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -117.43 150.67 38.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.929 0.395 . . . . 0.0 111.123 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.24 141.78 10.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.454 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.419 HG12 ' CE1' ' A' ' 35' ' ' TYR . 86.6 t -55.18 -61.99 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 10.7 m-85 -96.62 27.71 3.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 60.44 108.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.701 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -179.83 -32.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.003 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.187 -179.91 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.77 0.319 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 m -135.38 104.43 4.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.154 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.15 -60.13 1.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.98 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.89 29.97 4.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.951 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -101.99 23.7 11.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.052 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 mt -103.49 -26.67 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.982 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.8 t -125.61 86.27 2.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.674 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -49.15 105.74 0.54 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.337 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.56 -29.3 7.52 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.511 2.14 . . . . 0.0 112.122 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.0 m -69.63 127.52 33.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.664 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.74 42.48 1.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.465 0.65 . . . . 0.0 110.453 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -150.74 -164.66 2.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.194 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -91.23 38.4 0.97 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.748 0.309 . . . . 0.0 110.584 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.1 -178.45 3.35 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.446 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.0 m -114.01 153.7 28.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.554 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.7 t -89.87 106.52 18.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.24 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -127.97 61.75 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.333 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.407 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 5.7 p-10 -90.94 156.59 17.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.177 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.67 -166.54 2.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.794 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.5 mm -62.47 130.09 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.06 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.13 -98.05 0.97 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.573 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.01 136.12 33.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 110.784 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.407 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 54.4 p90 -99.04 178.02 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.05 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.89 128.45 19.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.066 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -96.76 134.26 40.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.71 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 mm -89.85 97.36 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.587 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.89 -176.7 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.414 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.408 ' HE2' ' CE2' ' A' ' 31' ' ' TYR . 7.8 mtt -88.07 154.69 52.34 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.867 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.8 92.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.7 2.267 . . . . 0.0 112.11 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.73 37.27 4.78 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.395 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.408 ' CE2' ' HE2' ' A' ' 28' ' ' MET . 3.1 t80 -110.46 131.03 55.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.759 0.314 . . . . 0.0 110.671 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.86 161.03 16.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.144 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.48 141.76 11.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.484 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.01 -61.18 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.763 0.316 . . . . 0.0 111.061 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.422 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 17.6 m-85 -101.34 36.44 2.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.713 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 60.03 105.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.71 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -176.39 -35.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.155 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.4 mm . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.048 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.891 0.376 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t -148.37 138.04 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -112.55 -48.16 3.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.993 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.6 -74.59 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.5 t -149.79 75.26 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.854 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mt -89.88 -39.32 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.789 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 t -142.16 52.5 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.626 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 58.49 107.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.842 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.21 -46.21 4.65 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.341 2.027 . . . . 0.0 112.089 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.6 m -60.58 135.46 57.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -91.52 45.22 1.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.366 0.603 . . . . 0.0 110.492 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -150.65 -161.55 1.36 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.826 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -89.92 41.13 1.03 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.824 0.345 . . . . 0.0 110.681 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.43 -176.18 3.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.042 0.449 . . . . 0.0 111.245 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.9 m -122.59 151.53 41.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.603 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.1 t -89.93 148.91 22.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.965 0.412 . . . . 0.0 111.128 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.22 49.29 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.499 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.403 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 14.2 p-10 -82.9 146.21 28.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.008 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.7 -169.27 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.6 mm -69.54 111.54 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.54 -86.7 0.57 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -107.25 134.99 49.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.764 0.316 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.403 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 44.0 p90 -101.45 170.87 7.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.977 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -143.98 125.67 15.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.969 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.3 t -103.39 138.64 39.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.635 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 26' ' ' ILE . 8.9 mm -89.72 105.87 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.7 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -93.2 170.09 9.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.409 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.547 ' HB2' ' HB2' ' A' ' 31' ' ' TYR . 62.5 mtt -63.84 159.65 52.41 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.99 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.87 -64.74 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.769 2.312 . . . . 0.0 112.866 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.89 66.89 0.26 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.31 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 28' ' ' MET . 2.7 t80 -127.71 157.08 41.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.816 0.341 . . . . 0.0 110.785 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -117.45 152.75 34.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.002 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.88 142.02 6.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.431 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.429 HG13 ' CZ ' ' A' ' 35' ' ' TYR . 61.2 t -58.75 -34.42 51.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.685 0.278 . . . . 0.0 111.074 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.429 ' CZ ' HG13 ' A' ' 34' ' ' VAL . 19.6 m-85 -137.04 53.52 1.89 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.173 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.8 m 49.78 96.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.219 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.13 -36.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.266 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.7 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.05 -179.811 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.843 0.354 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.43 164.0 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -82.44 105.34 13.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -99.2 29.42 3.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.987 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 50.9 t -124.96 57.86 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.841 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mt -91.6 -36.32 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.091 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.14 54.98 1.92 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.046 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 57.2 97.22 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.102 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.81 -32.19 14.63 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.408 2.072 . . . . 0.0 112.103 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.1 m -77.7 128.25 33.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.535 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -94.76 43.98 1.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.349 0.595 . . . . 0.0 110.676 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -150.69 -162.31 1.52 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.002 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -90.45 27.49 1.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.344 . . . . 0.0 110.607 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.83 -175.21 1.66 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.506 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.3 m -128.72 128.53 44.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.472 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.3 t -96.72 124.18 40.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.068 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.07 79.36 1.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.502 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.5 p-10 -103.78 133.44 48.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.098 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -141.84 75.27 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.1 mt 52.84 94.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.27 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.09 -127.19 7.11 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.462 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -89.94 132.58 35.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.798 0.332 . . . . 0.0 110.852 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -108.97 -172.26 2.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.921 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -148.89 122.61 9.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -89.96 130.18 36.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.632 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.2 mm -89.72 88.66 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.956 0.407 . . . . 0.0 110.66 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -166.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.324 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 47.5 mtp -109.54 161.44 24.06 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.818 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -51.46 92.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.606 2.204 . . . . 0.0 112.285 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.2 52.63 3.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.467 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -120.16 118.17 29.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.722 0.296 . . . . 0.0 110.632 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -90.0 167.99 12.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.123 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.43 136.28 8.55 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.425 HG11 ' CE2' ' A' ' 35' ' ' TYR . 92.4 t -56.34 129.04 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.381 . . . . 0.0 111.077 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.425 ' CE2' HG11 ' A' ' 34' ' ' VAL . 6.7 m-85 58.38 27.21 15.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.995 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 62.41 115.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.04 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -165.68 -54.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.756 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.0 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.267 -179.775 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.4 p30 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.807 0.336 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.1 m -94.64 90.76 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.25 160.42 17.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.985 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 64.08 15.98 9.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.399 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.2 t -118.04 21.27 12.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.644 0.259 . . . . 0.0 111.116 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mt -91.25 -30.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.719 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.77 89.4 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.583 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -50.63 109.71 1.43 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.213 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 47.3 Cg_endo -68.0 -33.82 24.83 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.457 2.105 . . . . 0.0 112.102 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.8 m -65.61 127.22 31.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.527 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -95.09 43.79 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.256 0.55 . . . . 0.0 110.683 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -150.74 -163.85 1.87 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.145 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.5 34.45 0.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.8 0.333 . . . . 0.0 110.544 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -71.21 -177.29 1.68 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.414 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 70.2 m -114.04 150.22 34.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.66 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.6 t -89.77 118.05 29.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.023 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 tt -132.66 67.76 1.52 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.714 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -142.65 158.58 43.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.005 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -144.9 -177.1 5.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.9 tp -58.46 91.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.081 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.13 -27.62 8.06 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.418 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -97.32 175.49 6.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.856 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.449 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 12.5 t80 -174.04 113.77 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.01 127.3 11.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.149 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.5 t -100.52 125.42 46.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.538 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.2 mm -89.8 81.66 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.754 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -169.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.335 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 40.1 mtp -97.59 160.84 27.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.942 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.32 92.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.601 2.201 . . . . 0.0 112.272 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.64 53.73 3.3 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -115.21 132.86 56.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.696 0.284 . . . . 0.0 110.792 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -89.99 153.33 20.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.082 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.91 142.03 9.31 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.397 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.406 HG13 ' CZ ' ' A' ' 35' ' ' TYR . 59.4 t -56.66 -53.93 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.949 0.404 . . . . 0.0 111.219 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.406 ' CZ ' HG13 ' A' ' 34' ' ' VAL . 17.8 m-85 -111.81 41.56 1.9 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.782 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 55.27 101.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.853 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -172.66 -35.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.062 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.3 mm . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.204 -179.92 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.816 0.341 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 m -111.63 158.7 12.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.126 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -129.76 -66.96 0.77 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.43 23.44 14.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.067 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.4 t -111.65 28.32 8.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.888 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.6 mm -97.33 -27.21 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.061 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.44 94.49 3.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.808 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -57.43 119.1 29.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.979 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.28 -40.65 24.48 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.408 2.072 . . . . 0.0 112.243 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 94.5 m -67.22 136.54 55.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -112.78 54.34 0.72 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.341 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -150.24 -92.82 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.832 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.3 24.24 0.81 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.322 . . . . 0.0 110.845 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.9 178.35 1.8 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.293 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 16' ' ' CYS . 28.6 m -112.99 158.93 19.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.62 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.402 ' N ' HG22 ' A' ' 15' ' ' THR . 37.8 t -89.72 125.12 35.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.69 52.64 1.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.686 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 43.4 p-10 -150.96 89.41 1.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -149.27 42.04 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.9 tt -169.48 59.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.038 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.39 26.54 59.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.526 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -132.68 -179.22 5.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.851 0.358 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -157.03 105.5 2.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.997 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -150.02 121.68 8.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.3 t -105.08 137.65 42.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.652 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 26' ' ' ILE . 9.5 mm -89.87 87.85 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.833 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.98 -179.81 1.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.168 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.3 mtt -82.38 161.67 58.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.3 89.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.451 2.101 . . . . 0.0 112.397 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.4 67.93 1.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.644 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -113.34 130.7 56.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.69 0.281 . . . . 0.0 110.392 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -89.97 154.08 20.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 0.0 111.228 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.22 143.39 14.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.718 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.421 HG11 ' CD2' ' A' ' 35' ' ' TYR . 84.2 t -66.34 130.81 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.398 . . . . 0.0 111.102 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CD2' HG11 ' A' ' 34' ' ' VAL . 4.2 m-85 61.05 46.26 8.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.169 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 m 46.92 96.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.409 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.62 -65.66 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.2 mm . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.244 -179.808 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.762 0.315 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 m -102.64 170.91 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.182 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.33 -68.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.956 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -120.94 29.79 7.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.9 t -111.8 26.57 10.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 mt -95.62 -28.1 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.975 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.5 t -134.32 111.06 9.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.736 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -58.23 118.41 27.17 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.02 -40.49 20.21 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.445 2.097 . . . . 0.0 112.131 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 98.5 m -65.81 135.02 54.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.982 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -93.22 45.18 1.16 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.42 0.628 . . . . 0.0 110.379 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -150.48 -161.56 1.37 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.721 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -89.95 42.73 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.787 0.327 . . . . 0.0 110.76 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -76.59 179.41 5.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.156 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.406 HG23 ' H1 ' ' A' ' 39' ' ' FUC . 26.6 m -115.85 160.71 19.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.553 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.6 t -89.9 144.65 25.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.068 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.0 tp -175.53 64.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.548 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.401 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 7.2 p-10 -98.58 163.44 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.262 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.45 -171.22 3.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.772 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.0 mm -72.65 97.24 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.094 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.23 -98.59 1.05 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.524 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.98 105.23 17.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 110.861 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.401 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 49.5 p90 -75.99 -177.13 3.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.069 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -149.99 129.5 13.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.117 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.9 t -111.24 138.79 47.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.501 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.2 mm -89.73 106.97 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.837 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -94.25 171.23 8.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.424 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 34.1 mtt -76.95 144.08 71.74 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.988 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -57.16 121.98 11.02 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.492 2.128 . . . . 0.0 112.273 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.84 11.03 82.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.944 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -97.46 128.61 44.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.761 0.315 . . . . 0.0 110.413 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.71 160.45 16.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.281 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.15 138.86 6.47 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.43 HG12 ' CZ ' ' A' ' 35' ' ' TYR . 58.9 t -60.39 -33.39 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.935 0.398 . . . . 0.0 110.848 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.43 ' CZ ' HG12 ' A' ' 34' ' ' VAL . 37.5 m-85 -137.58 53.95 1.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.933 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 39.0 m 49.2 96.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.257 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -178.46 -37.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.942 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.1 mm . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.14 -179.908 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . 0.406 ' H1 ' HG23 ' A' ' 15' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.845 0.355 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.49 128.55 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.186 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.65 164.85 13.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.809 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -134.96 -44.67 0.72 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.041 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 46.6 t -89.87 63.78 6.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.032 0.444 . . . . 0.0 110.878 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.8 mt -97.29 -35.38 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.242 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 t -128.45 52.38 1.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.963 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 m120 52.99 96.33 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.255 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.18 -37.73 17.64 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.382 2.054 . . . . 0.0 112.022 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 1.8 m -71.47 123.4 22.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.321 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -92.63 44.61 1.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.269 0.557 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -150.9 -160.87 1.23 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.953 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -90.24 25.97 2.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.53 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.26 -175.37 1.52 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.029 0.443 . . . . 0.0 111.39 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.3 m -129.64 128.21 42.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.563 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.7 t -104.67 143.42 33.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.199 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.09 93.2 2.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.582 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.409 ' CB ' ' HB3' ' A' ' 23' ' ' PHE . 14.9 p-10 -107.53 121.6 44.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.961 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -143.26 80.23 1.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.5 mt 55.62 103.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.214 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.61 -132.56 10.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.523 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.35 117.46 34.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.748 0.308 . . . . 0.0 110.95 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.409 ' HB3' ' CB ' ' A' ' 18' ' ' ASP . 46.5 p90 -78.51 172.13 14.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.12 131.87 39.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.194 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.96 125.73 48.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.607 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.417 HD12 HG22 ' A' ' 26' ' ' ILE . 19.2 mm -89.66 94.49 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.954 0.407 . . . . 0.0 110.516 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.14 179.88 7.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.473 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.3 mtt -83.77 154.88 65.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.041 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.38 114.83 2.15 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.575 2.183 . . . . 0.0 112.061 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.31 23.83 55.81 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.376 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -105.29 122.81 46.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.662 0.267 . . . . 0.0 110.461 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -89.86 164.06 14.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.98 0.419 . . . . 0.0 111.337 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.51 134.21 6.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.414 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.6 t -56.85 -33.1 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 111.145 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.423 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 35.5 m-85 -133.98 45.15 2.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.822 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 74.9 m 56.79 101.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.794 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -175.65 -34.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.418 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.5 mm . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 111.233 -179.86 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.1 t70 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.845 0.355 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.53 82.95 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.092 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -106.68 143.27 35.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.814 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.422 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 4.0 mm-40 -107.19 -45.7 4.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.2 t -89.96 73.05 7.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.747 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.3 mt -90.05 -39.48 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.968 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.7 t -140.3 51.2 1.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.009 0.433 . . . . 0.0 110.851 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 51.86 98.88 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.314 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.406 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 37.4 Cg_endo -65.87 -25.02 53.08 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.471 2.114 . . . . 0.0 111.989 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.6 128.72 36.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.065 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -97.88 42.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.332 0.587 . . . . 0.0 110.945 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -150.47 -157.64 0.83 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.2 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.85 28.94 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.801 0.334 . . . . 0.0 110.501 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.58 -175.75 2.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.521 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 57.8 m -124.53 132.27 53.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.533 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.8 t -90.02 118.08 29.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.013 0.435 . . . . 0.0 111.247 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.5 72.23 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.43 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -90.22 142.89 27.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.103 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -137.04 -166.15 1.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.697 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.98 102.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.16 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.89 -115.2 3.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.09 142.42 27.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.351 . . . . 0.0 110.806 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 42.9 p90 -102.83 165.74 10.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -141.02 124.9 17.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.024 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -90.41 142.56 27.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.711 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.4 HD11 HG23 ' A' ' 26' ' ' ILE . 16.6 mm -89.7 91.32 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.772 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.8 m -60.43 176.95 0.31 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.234 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.3 mtp -87.27 161.28 46.57 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.858 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.55 96.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.44 2.093 . . . . 0.0 112.389 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.23 40.61 10.03 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.321 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -115.95 134.92 54.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.742 0.306 . . . . 0.0 110.818 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.25 178.79 4.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.102 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.43 162.04 11.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.537 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.1 t -57.11 -67.8 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.928 0.394 . . . . 0.0 110.95 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.406 ' CD1' ' HB2' ' A' ' 9' ' ' PRO . 43.6 m-85 -98.59 30.66 3.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.865 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.3 m 66.6 51.0 1.15 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -123.93 -2.89 8.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.52 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 120.782 0.325 . . . . 0.0 111.076 -179.8 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.7 t0 . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.858 0.361 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p -117.33 119.64 62.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.27 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -159.32 100.97 1.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -137.0 31.6 2.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.8 t -150.02 89.26 1.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.739 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 mt -90.05 -47.73 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.013 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 t -146.32 52.62 1.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 60.92 117.5 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.95 -28.33 58.14 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.41 2.074 . . . . 0.0 112.01 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 69.3 m -72.18 145.93 47.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.952 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -96.87 42.19 1.09 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.374 0.607 . . . . 0.0 110.398 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -150.76 -161.76 1.41 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.986 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.75 43.37 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.97 0.415 . . . . 0.0 110.349 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.05 -174.09 1.79 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.754 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.2 m -124.23 145.69 49.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.424 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.97 130.63 36.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.171 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.78 59.85 1.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.716 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -91.03 137.34 32.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -127.1 -171.7 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.855 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tp -59.23 120.53 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.097 -179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.4 -103.18 3.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.486 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.55 139.5 31.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.35 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -101.48 176.24 5.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.014 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -149.27 130.15 14.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.82 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.5 t -105.74 109.09 20.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.763 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.9 mp -90.0 126.58 42.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.95 -161.91 1.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.732 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.522 ' HB2' ' HB2' ' A' ' 31' ' ' TYR . 15.8 mtt -50.51 146.58 9.1 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.114 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.8 -64.64 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.604 2.203 . . . . 0.0 112.5 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.6 57.7 4.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.227 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.522 ' HB2' ' HB2' ' A' ' 28' ' ' MET . 0.7 OUTLIER -124.86 125.71 44.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.866 0.365 . . . . 0.0 110.877 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -97.16 152.37 18.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.777 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.23 146.36 7.08 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.346 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.429 HG11 ' CE2' ' A' ' 35' ' ' TYR . 54.7 t -63.81 -31.16 52.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.912 0.387 . . . . 0.0 111.221 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.429 ' CE2' HG11 ' A' ' 34' ' ' VAL . 31.6 m-85 -142.56 57.54 1.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.05 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 48.88 92.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.006 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -169.71 -39.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.089 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.3 mm . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.063 -179.901 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.859 0.361 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.4 m -93.18 154.43 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -135.04 -55.63 0.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.776 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -157.97 35.73 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.1 t -144.43 90.21 2.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.9 mp -94.69 -47.89 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.037 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 t -145.6 52.82 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.881 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.41 119.78 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.921 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.88 -43.0 13.11 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.376 2.05 . . . . 0.0 112.197 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 68.5 m -59.03 139.25 57.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.083 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -92.8 44.35 1.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.43 0.633 . . . . 0.0 110.482 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -150.58 -161.03 1.25 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.831 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.1 37.74 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.768 0.318 . . . . 0.0 110.655 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.78 -176.81 4.57 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.354 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.9 m -120.28 141.17 50.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.585 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.9 t -89.92 138.06 31.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.144 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.05 69.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.772 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 33.5 p-10 -92.56 155.18 17.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.084 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -135.06 -178.88 5.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.064 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.427 ' CD1' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -57.53 88.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.547 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.74 -93.13 0.58 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.577 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -89.95 137.87 31.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.873 0.368 . . . . 0.0 110.768 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.418 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 23.7 p90 -113.73 166.88 11.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -145.04 126.61 15.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.977 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.0 t -97.08 138.97 33.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.635 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.9 mm -89.79 92.28 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.993 0.425 . . . . 0.0 110.794 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -170.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.066 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.6 mtp -90.34 154.94 46.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.802 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.24 84.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.625 2.216 . . . . 0.0 112.207 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.23 52.49 1.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.499 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -120.68 154.38 35.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.765 0.317 . . . . 0.0 110.521 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.69 160.5 15.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.946 0.403 . . . . 0.0 111.187 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.78 142.88 12.95 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.693 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.8 t -56.88 -41.75 76.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.98 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.407 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 44.2 m-85 -125.36 48.42 2.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.692 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 m 53.11 96.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.098 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -166.72 -39.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.07 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.5 mm . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.007 179.994 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.863 0.363 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.16 116.43 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -81.59 -176.37 6.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -95.29 19.45 10.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.84 -10.35 24.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.134 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.9 mm -89.76 -27.89 5.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.964 0.411 . . . . 0.0 110.769 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.5 55.7 1.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.423 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -49.49 125.68 16.19 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.236 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.429 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 38.2 Cg_endo -65.88 -40.75 15.76 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.517 2.145 . . . . 0.0 112.198 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 90.6 m -60.5 132.62 54.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.84 44.87 1.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.35 0.595 . . . . 0.0 110.405 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -150.63 -161.3 1.31 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.773 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -89.94 41.63 1.05 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.725 0.298 . . . . 0.0 110.758 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.48 179.09 4.84 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.76 0.314 . . . . 0.0 111.129 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.408 HG22 ' H1 ' ' A' ' 39' ' ' FUC . 93.4 m -114.58 157.7 22.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.671 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.5 p -89.91 130.09 36.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.38 51.74 1.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.757 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -144.27 64.82 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -125.98 27.31 6.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.85 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mp -147.75 30.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.898 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.83 25.7 73.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.498 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -139.53 106.16 5.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.353 . . . . 0.0 110.841 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.429 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 23.4 t80 -70.79 112.76 7.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.084 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -150.01 116.06 5.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.9 t -105.22 134.13 48.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.61 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 13.7 mm -89.79 105.48 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.841 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -88.41 174.33 8.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.227 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.3 mtt -69.83 161.89 71.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.817 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.48 87.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.568 2.179 . . . . 0.0 112.341 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.36 60.91 1.86 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.63 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -111.21 128.3 55.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.67 0.271 . . . . 0.0 110.289 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -89.83 174.08 7.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 111.435 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.29 134.0 1.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.593 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.428 HG11 ' CE2' ' A' ' 35' ' ' TYR . 57.7 t -59.46 132.11 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.895 0.379 . . . . 0.0 110.976 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.428 ' CE2' HG11 ' A' ' 34' ' ' VAL . 7.4 m-85 61.01 47.22 7.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.895 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 50.17 96.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.327 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.71 -50.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.02 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.148 -179.783 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . 0.408 ' H1 ' HG22 ' A' ' 15' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.739 ' N ' HD21 ' A' ' 8' ' ' ASN . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.519 0.2 . . . . 0.0 110.906 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.411 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 37.1 Cg_endo -65.27 -42.32 13.72 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.404 2.07 . . . . 0.0 112.105 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 87.4 m -53.7 136.89 38.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.028 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.74 44.06 1.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.508 0.67 . . . . 0.0 110.669 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -150.77 -161.33 1.32 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.809 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.02 39.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 110.839 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -78.33 -175.5 4.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.983 0.421 . . . . 0.0 111.414 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.9 m -121.14 147.66 45.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.725 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.5 t -89.92 155.74 18.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.683 ' HB2' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -172.2 80.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.78 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -138.6 169.94 16.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.977 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -150.07 -175.38 5.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.599 ' O ' HG23 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -68.87 70.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 111.065 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.77 -26.68 1.93 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.663 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.93 177.7 4.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.908 0.385 . . . . 0.0 111.039 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.411 ' CE1' ' HG3' ' A' ' 9' ' ' PRO . 38.4 t80 -176.0 103.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.715 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -143.68 132.47 22.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.974 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.8 t -109.04 140.16 42.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.683 HD11 ' HB2' ' A' ' 17' ' ' LEU . 4.2 mp -89.68 90.29 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.787 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -167.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.151 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 63.7 mtp -101.73 155.78 35.99 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.841 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.65 93.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.649 2.232 . . . . 0.0 112.091 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.52 39.38 4.46 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.386 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -119.63 118.96 32.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.746 0.308 . . . . 0.0 110.685 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.93 157.2 17.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.008 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.64 143.83 7.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.415 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.667 HG12 ' CE1' ' A' ' 35' ' ' TYR . 57.3 t -57.94 -40.72 77.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.85 0.357 . . . . 0.0 111.12 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.667 ' CE1' HG12 ' A' ' 34' ' ' VAL . 13.4 m-85 -125.55 48.8 2.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.781 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 46.91 75.97 0.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.339 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -123.88 -25.73 4.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.325 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.8 mm . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.82 0.343 . . . . 0.0 111.082 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.527 0.203 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 36.1 Cg_endo -64.76 -43.34 12.91 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.423 2.082 . . . . 0.0 112.005 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.498 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 93.2 m -54.86 136.77 46.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.037 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -91.82 43.76 1.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.356 0.598 . . . . 0.0 110.539 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -150.68 -161.67 1.39 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.853 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.85 38.49 0.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.714 0.293 . . . . 0.0 110.825 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -79.54 -174.74 4.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.005 0.431 . . . . 0.0 111.421 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.464 ' O ' HD12 ' A' ' 26' ' ' ILE . 89.1 m -125.51 142.62 51.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.844 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.9 t -90.0 149.42 22.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.721 ' HB2' HD11 ' A' ' 26' ' ' ILE . 1.1 tt -157.29 66.69 0.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -111.14 110.0 20.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -90.03 -175.92 4.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -56.3 103.98 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.095 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.02 26.81 57.49 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.15 -178.2 5.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 0.0 110.904 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 13.9 t80 -177.54 113.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -149.96 123.6 9.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.073 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.3 t -104.45 131.79 51.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.689 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.721 HD11 ' HB2' ' A' ' 17' ' ' LEU . 3.9 mp -89.95 91.72 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.26 -168.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.026 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.4 mtp -91.99 160.35 35.96 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.986 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.73 95.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.557 2.172 . . . . 0.0 112.387 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.23 54.83 3.92 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.366 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -120.26 137.87 53.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.751 0.31 . . . . 0.0 110.684 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -93.35 161.88 14.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.132 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.5 137.96 9.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.447 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.467 HG12 ' CE1' ' A' ' 35' ' ' TYR . 76.0 t -56.59 -48.95 79.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 0.0 111.056 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.498 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 13.2 m-85 -112.61 43.27 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.611 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.2 m 52.09 98.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.953 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -166.71 -39.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.961 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.7 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.213 -179.861 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 p30 . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.573 0.225 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HG2' ' CZ ' ' A' ' 23' ' ' PHE . 65.5 Cg_exo -52.12 -24.65 20.67 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.551 2.167 . . . . 0.0 112.232 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.9 m -59.42 125.21 22.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.621 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -96.02 42.57 1.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.374 0.607 . . . . 0.0 110.64 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -150.79 -165.62 2.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.994 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -89.94 41.33 1.04 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.88 0.372 . . . . 0.0 110.484 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . . . -76.14 -176.0 3.36 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.491 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.402 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 48.8 m -119.48 154.34 33.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.569 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.8 p -89.85 130.56 36.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 111.132 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.583 HD22 HD11 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -143.72 69.71 1.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -153.87 135.38 14.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.09 67.66 1.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.816 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.9 mm 52.7 85.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.17 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.46 -82.04 0.13 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.447 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.18 121.8 41.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.828 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.419 ' CZ ' ' HG2' ' A' ' 9' ' ' PRO . 90.5 t80 -77.34 131.01 37.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -139.67 103.11 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.831 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.9 t -92.13 122.49 34.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.667 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.583 HD11 HD22 ' A' ' 17' ' ' LEU . 18.3 mm -89.92 90.17 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.1 m -75.65 -179.67 4.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.067 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.557 ' HE3' ' CD2' ' A' ' 31' ' ' TYR . 28.3 mtm -74.81 155.08 87.06 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.043 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.84 128.75 31.78 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.652 2.235 . . . . 0.0 111.968 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.4 24.25 73.63 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.233 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.557 ' CD2' ' HE3' ' A' ' 28' ' ' MET . 4.0 t80 -104.11 124.98 50.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.712 0.292 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -90.03 163.14 15.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.72 139.69 9.48 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.435 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.543 HG12 ' CD1' ' A' ' 35' ' ' TYR . 61.1 t -61.88 -56.0 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 111.164 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.543 ' CD1' HG12 ' A' ' 34' ' ' VAL . 8.5 m-85 -102.58 36.37 2.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.983 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 6.4 m 57.85 104.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.606 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -168.28 -33.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.421 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.4 mm . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.87 0.367 . . . . 0.0 111.097 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.3 t30 . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.613 0.244 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.432 ' HG3' ' CE2' ' A' ' 23' ' ' PHE . 72.8 Cg_endo -76.0 -31.44 4.99 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.466 2.111 . . . . 0.0 112.212 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 1.9 m -72.09 125.14 26.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -96.75 43.14 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.436 0.636 . . . . 0.0 110.498 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.432 ' HB3' ' HE3' ' A' ' 28' ' ' MET . 14.8 m-80 -150.65 -164.55 2.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.083 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.02 38.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 110.483 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -73.13 -178.18 2.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.39 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 53.6 m -114.1 153.86 28.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.662 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.1 t -89.97 114.63 26.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.981 0.42 . . . . 0.0 111.086 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.844 HD13 HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -136.99 56.5 1.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.485 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.439 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 3.7 p-10 -86.11 159.75 19.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.159 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -139.95 -166.57 2.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.722 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.579 ' O ' HG23 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -73.86 112.65 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.969 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.62 -83.87 1.05 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.447 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -100.99 125.44 47.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.439 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 53.4 p90 -96.12 167.81 10.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.9 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -133.73 126.02 29.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.118 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.9 t -95.7 133.58 39.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.531 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.844 HD11 HD13 ' A' ' 17' ' ' LEU . 9.6 mm -89.79 96.19 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.738 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -72.44 -172.83 1.0 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.277 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.432 ' HE3' ' HB3' ' A' ' 12' ' ' ASN . 41.5 mtt -94.06 162.04 27.91 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.695 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.22 88.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.519 2.146 . . . . 0.0 112.292 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.69 56.58 2.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.529 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -116.28 137.51 52.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.728 0.299 . . . . 0.0 110.713 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.02 162.66 15.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.961 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.18 145.22 16.53 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.398 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.6 t -58.18 -54.04 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.795 0.331 . . . . 0.0 111.132 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 38.8 m-85 -113.64 42.46 1.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.835 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 56.33 102.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -177.67 -34.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.049 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.6 mm . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.191 -179.868 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.589 0.233 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.411 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 29.8 Cg_endo -63.36 -41.36 27.04 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.415 2.077 . . . . 0.0 112.055 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 99.7 m -65.46 135.59 55.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -92.29 43.85 1.15 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.367 0.603 . . . . 0.0 110.543 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -150.78 -163.02 1.67 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.799 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -89.83 44.62 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 0.0 110.588 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -77.32 -179.69 5.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.972 0.415 . . . . 0.0 111.276 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.0 m -112.03 149.19 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.49 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.7 t -89.82 126.41 35.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.951 0.405 . . . . 0.0 111.013 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.48 60.19 1.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.73 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 10.1 p-10 -86.28 153.8 21.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.135 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -146.58 -170.91 3.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.695 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.715 HD13 ' N ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -59.26 130.31 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.057 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.715 ' N ' HD13 ' A' ' 20' ' ' ILE . . . 82.71 -113.84 3.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.564 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -89.89 117.65 28.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.889 0.376 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.424 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 54.1 p90 -71.62 172.2 10.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.049 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -140.85 127.16 19.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.078 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.4 t -103.4 133.0 49.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.425 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 mm -89.69 100.59 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.754 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -82.53 168.89 16.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.386 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.1 mtt -68.76 154.65 94.5 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.026 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -56.95 131.73 47.27 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.622 2.214 . . . . 0.0 112.154 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.41 21.81 72.63 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.606 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -102.96 122.01 43.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 0.0 110.662 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.96 154.29 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.088 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.28 132.59 4.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.502 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.438 HG12 ' CE1' ' A' ' 35' ' ' TYR . 99.6 t -56.99 -30.89 35.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.762 0.315 . . . . 0.0 111.107 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CE1' HG12 ' A' ' 34' ' ' VAL . 33.4 m-85 -136.52 53.49 1.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.987 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 72.8 m 47.48 97.27 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.515 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -173.92 -35.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.338 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.5 mm . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.904 0.383 . . . . 0.0 111.092 179.928 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.592 0.234 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.51 -44.29 6.55 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.417 2.078 . . . . 0.0 112.144 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 95.5 m -63.62 134.9 56.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.934 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -92.36 44.84 1.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.47 0.653 . . . . 0.0 110.469 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -150.66 -161.41 1.33 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.807 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -89.84 37.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.673 0.273 . . . . 0.0 110.69 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.45 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -81.68 -176.73 6.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.908 0.385 . . . . 0.0 111.315 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.6 m -122.04 142.99 49.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.489 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.8 t -103.68 111.48 23.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.326 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.505 HD12 HD11 ' A' ' 26' ' ' ILE . 7.1 mt -110.26 61.99 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.388 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.425 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 15.3 p-10 -85.75 141.66 29.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.149 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -136.42 -167.84 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.681 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.456 HD12 ' H ' ' A' ' 20' ' ' ILE . 3.1 mp -58.82 105.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.128 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.04 -103.68 2.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.496 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -93.96 156.68 16.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.897 0.38 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.425 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 16.9 p90 -120.17 171.0 8.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.981 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.11 117.32 7.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.059 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.5 t -89.96 131.99 35.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.595 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.549 ' H ' HD12 ' A' ' 26' ' ' ILE . 4.0 mp -89.77 97.96 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.032 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.07 173.29 12.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.076 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 15.6 mtt -74.9 146.03 82.16 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.095 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.61 114.94 2.07 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.547 2.165 . . . . 0.0 112.223 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.48 19.61 58.16 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.662 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -102.15 126.29 49.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 110.398 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.8 159.41 17.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.17 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.28 131.09 5.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.444 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.0 t -54.1 -31.69 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.04 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.495 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 44.1 m-85 -136.65 51.91 1.97 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.726 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 73.2 m 50.43 97.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.74 -33.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.474 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 111.0 -179.982 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.515 0.198 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 16' ' ' CYS . 34.2 Cg_endo -64.31 -32.49 61.54 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.277 1.984 . . . . 0.0 111.84 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.602 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 68.7 m -74.44 139.32 43.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.939 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -91.52 45.04 1.21 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.381 0.61 . . . . 0.0 110.515 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -150.66 -159.47 1.04 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.836 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -89.98 35.65 0.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.739 0.304 . . . . 0.0 110.754 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -79.56 -175.67 4.9 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.957 0.408 . . . . 0.0 111.384 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.7 m -127.96 139.86 52.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.618 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 17.5 p -92.47 125.61 37.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.146 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.89 83.72 2.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.553 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 4.0 p30 -100.43 153.54 19.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.121 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.08 -171.9 3.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.698 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mt -58.87 94.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.044 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.9 -104.79 1.18 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.403 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -89.97 159.4 16.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.847 0.356 . . . . 0.0 110.784 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.451 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 17.9 p90 -127.61 162.16 27.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.006 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -138.11 126.38 23.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.824 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -89.99 141.14 28.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.3 mm -89.78 89.95 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.683 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -167.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.321 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 13.7 mtp -108.22 162.6 19.34 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.25 121.62 10.01 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.518 2.145 . . . . 0.0 112.309 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.45 31.4 80.15 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.585 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -112.06 115.57 29.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.754 0.311 . . . . 0.0 110.515 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -89.92 171.32 9.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.5 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.32 141.66 9.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.295 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.411 HG12 ' CE1' ' A' ' 35' ' ' TYR . 94.7 t -52.72 -41.07 37.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.765 0.317 . . . . 0.0 111.177 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 33.6 m-85 -134.31 53.62 1.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.728 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 47.76 95.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.313 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -166.56 -36.46 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 0.0 111.196 -179.882 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 p30 . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.454 0.168 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.442 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 74.1 Cg_exo -49.0 -38.53 39.46 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.44 2.093 . . . . 0.0 112.405 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 36' ' ' CYS . 82.3 m -64.9 144.34 57.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.769 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -122.06 52.88 1.25 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.808 0.337 . . . . 0.0 111.745 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -150.24 -91.74 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.997 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.29 30.28 0.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.751 0.31 . . . . 0.0 110.752 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.42 ' HB3' ' CB ' ' A' ' 10' ' ' CYS . . . -68.59 -176.17 0.76 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.519 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.5 m -122.94 160.57 25.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.478 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.4 t -89.89 133.26 34.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.109 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.86 41.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.609 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 2.8 p30 -81.07 154.98 26.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.103 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -141.94 -174.89 4.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.721 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -53.23 136.51 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.238 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.98 -84.72 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.464 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -94.23 164.49 13.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.788 0.328 . . . . 0.0 110.785 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.442 ' CE1' ' HG2' ' A' ' 9' ' ' PRO . 49.5 p90 -133.74 178.96 6.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.037 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -149.7 119.09 6.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.002 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.2 t -105.97 136.06 46.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.333 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.8 mm -89.97 92.52 3.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.753 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.3 t -79.17 162.12 25.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.291 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mtp -58.28 143.49 79.49 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.188 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.97 124.26 14.56 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.522 2.148 . . . . 0.0 112.263 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.79 24.74 59.61 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.587 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -96.05 176.08 6.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.802 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB3' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -129.48 162.4 28.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.008 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.23 152.65 14.84 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.5 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.86 -35.45 51.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.909 0.385 . . . . 0.0 111.242 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -117.0 -70.34 0.8 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.283 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.46 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER 178.56 68.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.916 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -140.36 -35.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.244 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.403 HG22 ' HB3' ' A' ' 32' ' ' GLU . 21.2 mm . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.759 0.314 . . . . 0.0 111.114 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.558 0.218 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.444 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 66.7 Cg_endo -73.7 -32.44 7.53 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.504 2.136 . . . . 0.0 112.194 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 1.9 m -69.17 126.44 29.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.4 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -93.95 42.2 1.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.337 0.589 . . . . 0.0 111.139 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -151.07 -161.29 1.3 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.309 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.89 29.95 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.708 0.29 . . . . 0.0 110.898 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.54 -177.01 0.67 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.969 0.414 . . . . 0.0 111.22 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.9 m -117.49 136.03 53.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.793 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.0 t -89.72 85.27 6.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.29 67.03 5.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.654 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -148.94 111.07 4.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.892 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.01 74.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.921 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 20' ' ' ILE . 10.2 mt 51.78 61.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.223 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 179.76 -97.58 0.11 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.484 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.52 132.1 36.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.759 0.314 . . . . 0.0 110.838 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.444 ' CE1' ' HG3' ' A' ' 9' ' ' PRO . 44.6 t80 -92.91 133.71 35.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.986 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.17 98.69 2.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.999 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -89.95 123.25 33.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.52 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.7 mm -89.74 108.89 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.687 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.43 -169.81 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.252 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.0 mtt -98.14 161.55 25.09 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.84 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.61 90.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.486 2.124 . . . . 0.0 112.395 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.78 55.89 3.06 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.417 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -110.16 163.56 13.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.763 0.316 . . . . 0.0 110.753 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -117.43 150.67 38.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.929 0.395 . . . . 0.0 111.123 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.24 141.78 10.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.454 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.6 t -55.18 -61.99 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.44 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 10.7 m-85 -96.62 27.71 3.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 60.44 108.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.701 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -179.83 -32.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.003 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.187 -179.91 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.5 t30 . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.488 0.185 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.56 -29.3 7.52 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.511 2.14 . . . . 0.0 112.122 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.0 m -69.63 127.52 33.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.664 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.74 42.48 1.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.465 0.65 . . . . 0.0 110.453 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -150.74 -164.66 2.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.194 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -91.23 38.4 0.97 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.748 0.309 . . . . 0.0 110.584 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.1 -178.45 3.35 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.446 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.452 HG22 HD23 ' A' ' 17' ' ' LEU . 52.0 m -114.01 153.7 28.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.554 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.55 ' O ' HD22 ' A' ' 17' ' ' LEU . 53.7 t -89.87 106.52 18.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.24 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.58 ' HG ' HD11 ' A' ' 26' ' ' ILE . 2.7 mm? -127.97 61.75 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.333 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.436 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 5.7 p-10 -90.94 156.59 17.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.177 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.67 -166.54 2.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.794 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.5 mm -62.47 130.09 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.06 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.13 -98.05 0.97 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.573 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.01 136.12 33.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 110.784 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.436 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 54.4 p90 -99.04 178.02 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.05 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.89 128.45 19.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.066 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -96.76 134.26 40.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.71 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.58 HD11 ' HG ' ' A' ' 17' ' ' LEU . 11.2 mm -89.85 97.36 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.587 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.89 -176.7 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.414 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.556 ' HE3' ' CE2' ' A' ' 31' ' ' TYR . 7.8 mtt -88.07 154.69 52.34 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.867 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.8 92.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.7 2.267 . . . . 0.0 112.11 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.73 37.27 4.78 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.395 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.556 ' CE2' ' HE3' ' A' ' 28' ' ' MET . 3.1 t80 -110.46 131.03 55.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.759 0.314 . . . . 0.0 110.671 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.86 161.03 16.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.144 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.48 141.76 11.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.484 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.01 -61.18 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.763 0.316 . . . . 0.0 111.061 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.451 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 17.6 m-85 -101.34 36.44 2.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.713 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 60.03 105.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.71 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -176.39 -35.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.155 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.4 mm . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.048 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.456 0.17 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.21 -46.21 4.65 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.341 2.027 . . . . 0.0 112.089 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 99.6 m -60.58 135.46 57.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -91.52 45.22 1.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.366 0.603 . . . . 0.0 110.492 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -150.65 -161.55 1.36 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.826 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -89.92 41.13 1.03 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.824 0.345 . . . . 0.0 110.681 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -76.43 -176.18 3.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.042 0.449 . . . . 0.0 111.245 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.445 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 72.9 m -122.59 151.53 41.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.603 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.1 t -89.93 148.91 22.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.965 0.412 . . . . 0.0 111.128 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.22 49.29 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.499 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.443 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 14.2 p-10 -82.9 146.21 28.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.008 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.7 -169.27 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.6 mm -69.54 111.54 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.54 -86.7 0.57 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -107.25 134.99 49.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.764 0.316 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.443 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 44.0 p90 -101.45 170.87 7.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.977 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -143.98 125.67 15.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.969 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.3 t -103.39 138.64 39.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.635 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.578 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 8.9 mm -89.72 105.87 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.7 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -93.2 170.09 9.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.409 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.583 ' HB2' ' HB2' ' A' ' 31' ' ' TYR . 62.5 mtt -63.84 159.65 52.41 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.99 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.87 -64.74 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.769 2.312 . . . . 0.0 112.866 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.89 66.89 0.26 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.31 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.583 ' HB2' ' HB2' ' A' ' 28' ' ' MET . 2.7 t80 -127.71 157.08 41.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.816 0.341 . . . . 0.0 110.785 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -117.45 152.75 34.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.002 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.88 142.02 6.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.431 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.557 HG12 ' CE1' ' A' ' 35' ' ' TYR . 61.2 t -58.75 -34.42 51.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.685 0.278 . . . . 0.0 111.074 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.557 ' CE1' HG12 ' A' ' 34' ' ' VAL . 19.6 m-85 -137.04 53.52 1.89 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.173 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.8 m 49.78 96.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.219 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.13 -36.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.266 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.7 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.05 -179.811 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.538 0.208 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.81 -32.19 14.63 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.408 2.072 . . . . 0.0 112.103 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.1 m -77.7 128.25 33.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.535 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -94.76 43.98 1.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.349 0.595 . . . . 0.0 110.676 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -150.69 -162.31 1.52 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.002 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -90.45 27.49 1.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.344 . . . . 0.0 110.607 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.83 -175.21 1.66 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.506 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.3 m -128.72 128.53 44.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.472 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.3 t -96.72 124.18 40.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.068 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.07 79.36 1.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.502 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.416 ' CB ' ' HB3' ' A' ' 23' ' ' PHE . 14.5 p-10 -103.78 133.44 48.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.098 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -141.84 75.27 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.1 mt 52.84 94.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.27 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.09 -127.19 7.11 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.462 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -89.94 132.58 35.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.798 0.332 . . . . 0.0 110.852 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.416 ' HB3' ' CB ' ' A' ' 18' ' ' ASP . 47.7 p90 -108.97 -172.26 2.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -148.89 122.61 9.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -89.96 130.18 36.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.632 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.2 mm -89.72 88.66 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.956 0.407 . . . . 0.0 110.66 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -166.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.324 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 47.5 mtp -109.54 161.44 24.06 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.818 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -51.46 92.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.606 2.204 . . . . 0.0 112.285 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.2 52.63 3.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.467 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -120.16 118.17 29.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.722 0.296 . . . . 0.0 110.632 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -90.0 167.99 12.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.123 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.43 136.28 8.55 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.688 HG12 ' CD2' ' A' ' 35' ' ' TYR . 92.4 t -56.34 129.04 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.381 . . . . 0.0 111.077 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.688 ' CD2' HG12 ' A' ' 34' ' ' VAL . 6.7 m-85 58.38 27.21 15.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.995 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 62.41 115.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.04 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -165.68 -54.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.756 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.0 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.267 -179.775 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.539 0.209 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 47.3 Cg_endo -68.0 -33.82 24.83 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.457 2.105 . . . . 0.0 112.102 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.8 m -65.61 127.22 31.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.527 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -95.09 43.79 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.256 0.55 . . . . 0.0 110.683 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -150.74 -163.85 1.87 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.145 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.5 34.45 0.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.8 0.333 . . . . 0.0 110.544 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -71.21 -177.29 1.68 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.414 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 70.2 m -114.04 150.22 34.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.66 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.6 t -89.77 118.05 29.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.023 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.696 ' CD1' HD11 ' A' ' 26' ' ' ILE . 1.7 tt -132.66 67.76 1.52 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.714 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -142.65 158.58 43.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.005 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -144.9 -177.1 5.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.649 ' O ' HG23 ' A' ' 20' ' ' ILE . 6.9 tp -58.46 91.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.081 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.13 -27.62 8.06 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.418 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -97.32 175.49 6.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.856 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.451 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 12.5 t80 -174.04 113.77 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.01 127.3 11.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.149 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.5 t -100.52 125.42 46.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.538 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.696 HD11 ' CD1' ' A' ' 17' ' ' LEU . 14.2 mm -89.8 81.66 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.754 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -169.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.335 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 40.1 mtp -97.59 160.84 27.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.942 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.32 92.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.601 2.201 . . . . 0.0 112.272 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.64 53.73 3.3 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -115.21 132.86 56.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.696 0.284 . . . . 0.0 110.792 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -89.99 153.33 20.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.082 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.91 142.03 9.31 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.397 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 35' ' ' TYR . 59.4 t -56.66 -53.93 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.949 0.404 . . . . 0.0 111.219 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.421 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 17.8 m-85 -111.81 41.56 1.9 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.782 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 55.27 101.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.853 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -172.66 -35.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.062 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.3 mm . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.204 -179.92 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 120.395 0.14 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.28 -40.65 24.48 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.408 2.072 . . . . 0.0 112.243 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.54 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . 94.5 m -67.22 136.54 55.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -112.78 54.34 0.72 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.341 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -150.24 -92.82 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.832 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.3 24.24 0.81 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.322 . . . . 0.0 110.845 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HB3' ' CB ' ' A' ' 10' ' ' CYS . . . -67.9 178.35 1.8 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.293 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.431 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 28.6 m -112.99 158.93 19.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.62 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.8 t -89.72 125.12 35.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.69 52.64 1.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.686 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 43.4 p-10 -150.96 89.41 1.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.878 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -149.27 42.04 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.552 ' O ' HG23 ' A' ' 20' ' ' ILE . 5.9 tt -169.48 59.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.038 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.39 26.54 59.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.526 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -132.68 -179.22 5.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.851 0.358 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.409 ' HA ' ' HB3' ' A' ' 18' ' ' ASP . 74.1 t80 -157.03 105.5 2.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.997 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -150.02 121.68 8.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.3 t -105.08 137.65 42.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.652 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.431 ' HB ' ' HB ' ' A' ' 15' ' ' THR . 9.5 mm -89.87 87.85 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.833 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.98 -179.81 1.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.168 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.3 mtt -82.38 161.67 58.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.3 89.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.451 2.101 . . . . 0.0 112.397 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.4 67.93 1.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.644 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -113.34 130.7 56.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.69 0.281 . . . . 0.0 110.392 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -89.97 154.08 20.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 0.0 111.228 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.22 143.39 14.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.718 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.574 HG12 ' CG ' ' A' ' 35' ' ' TYR . 84.2 t -66.34 130.81 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.398 . . . . 0.0 111.102 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.574 ' CG ' HG12 ' A' ' 34' ' ' VAL . 4.2 m-85 61.05 46.26 8.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.169 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 m 46.92 96.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.409 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.62 -65.66 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.2 mm . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.244 -179.808 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.613 0.244 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.02 -40.49 20.21 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.445 2.097 . . . . 0.0 112.131 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 98.5 m -65.81 135.02 54.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.982 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -93.22 45.18 1.16 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.42 0.628 . . . . 0.0 110.379 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -150.48 -161.56 1.37 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.721 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -89.95 42.73 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.787 0.327 . . . . 0.0 110.76 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -76.59 179.41 5.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.156 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.411 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 26.6 m -115.85 160.71 19.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.553 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.6 t -89.9 144.65 25.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.068 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.437 HD22 HD11 ' A' ' 26' ' ' ILE . 5.0 tp -175.53 64.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.548 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.429 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 7.2 p-10 -98.58 163.44 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.262 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.45 -171.22 3.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.772 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.0 mm -72.65 97.24 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.094 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.23 -98.59 1.05 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.524 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.98 105.23 17.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 110.861 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.429 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 49.5 p90 -75.99 -177.13 3.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.069 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -149.99 129.5 13.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.117 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.9 t -111.24 138.79 47.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.501 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.54 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 7.2 mm -89.73 106.97 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.837 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -94.25 171.23 8.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.424 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 34.1 mtt -76.95 144.08 71.74 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.988 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -57.16 121.98 11.02 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.492 2.128 . . . . 0.0 112.273 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.84 11.03 82.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.944 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -97.46 128.61 44.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.761 0.315 . . . . 0.0 110.413 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.71 160.45 16.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.281 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.15 138.86 6.47 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.39 -33.39 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.935 0.398 . . . . 0.0 110.848 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.424 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 37.5 m-85 -137.58 53.95 1.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.933 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 39.0 m 49.2 96.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.257 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -178.46 -37.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.942 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.1 mm . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.14 -179.908 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.542 0.21 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.18 -37.73 17.64 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.382 2.054 . . . . 0.0 112.022 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 1.8 m -71.47 123.4 22.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.321 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -92.63 44.61 1.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.269 0.557 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.406 ' HB2' ' CB ' ' A' ' 36' ' ' CYS . 11.2 m-80 -150.9 -160.87 1.23 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.953 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -90.24 25.97 2.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.53 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.616 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . . . -72.26 -175.37 1.52 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.029 0.443 . . . . 0.0 111.39 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.3 m -129.64 128.21 42.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.563 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.7 t -104.67 143.42 33.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.199 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.09 93.2 2.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.582 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.428 ' CB ' ' HB3' ' A' ' 23' ' ' PHE . 14.9 p-10 -107.53 121.6 44.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.961 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -143.26 80.23 1.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.5 mt 55.62 103.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.214 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.61 -132.56 10.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.523 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.35 117.46 34.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.748 0.308 . . . . 0.0 110.95 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.428 ' HB3' ' CB ' ' A' ' 18' ' ' ASP . 46.5 p90 -78.51 172.13 14.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.12 131.87 39.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.194 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.96 125.73 48.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.607 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.2 mm -89.66 94.49 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.954 0.407 . . . . 0.0 110.516 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.14 179.88 7.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.473 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.3 mtt -83.77 154.88 65.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.041 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.38 114.83 2.15 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.575 2.183 . . . . 0.0 112.061 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.31 23.83 55.81 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.376 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -105.29 122.81 46.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.662 0.267 . . . . 0.0 110.461 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -89.86 164.06 14.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.98 0.419 . . . . 0.0 111.337 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.51 134.21 6.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.414 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.6 t -56.85 -33.1 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 111.145 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.451 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 35.5 m-85 -133.98 45.15 2.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.822 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 74.9 m 56.79 101.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.794 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -175.65 -34.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.418 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.5 mm . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 111.233 -179.86 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 120.446 0.165 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 37.4 Cg_endo -65.87 -25.02 53.08 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.471 2.114 . . . . 0.0 111.989 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.6 128.72 36.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.065 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -97.88 42.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.332 0.587 . . . . 0.0 110.945 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -150.47 -157.64 0.83 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.2 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.85 28.94 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.801 0.334 . . . . 0.0 110.501 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.58 -175.75 2.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.521 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.425 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 57.8 m -124.53 132.27 53.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.533 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.8 t -90.02 118.08 29.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.013 0.435 . . . . 0.0 111.247 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.5 72.23 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.43 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 20.6 p-10 -90.22 142.89 27.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.103 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -137.04 -166.15 1.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.697 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.98 102.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.16 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.89 -115.2 3.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.09 142.42 27.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.351 . . . . 0.0 110.806 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.418 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 42.9 p90 -102.83 165.74 10.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -141.02 124.9 17.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.024 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -90.41 142.56 27.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.711 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' A' ' 15' ' ' THR . 16.6 mm -89.7 91.32 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.772 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.8 m -60.43 176.95 0.31 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.234 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.3 mtp -87.27 161.28 46.57 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.858 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.55 96.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.44 2.093 . . . . 0.0 112.389 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.23 40.61 10.03 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.321 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -115.95 134.92 54.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.742 0.306 . . . . 0.0 110.818 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.25 178.79 4.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.102 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.43 162.04 11.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.537 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.1 t -57.11 -67.8 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.928 0.394 . . . . 0.0 110.95 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.425 ' CD1' ' HB2' ' A' ' 9' ' ' PRO . 43.6 m-85 -98.59 30.66 3.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.865 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.3 m 66.6 51.0 1.15 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -123.93 -2.89 8.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.52 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 120.782 0.325 . . . . 0.0 111.076 -179.8 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.495 0.188 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.95 -28.33 58.14 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.41 2.074 . . . . 0.0 112.01 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 69.3 m -72.18 145.93 47.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.952 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -96.87 42.19 1.09 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.374 0.607 . . . . 0.0 110.398 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -150.76 -161.76 1.41 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.986 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.75 43.37 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.97 0.415 . . . . 0.0 110.349 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.727 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . . . -74.05 -174.09 1.79 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.754 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.2 m -124.23 145.69 49.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.424 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.97 130.63 36.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.171 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.78 59.85 1.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.716 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.413 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 10.3 p-10 -91.03 137.34 32.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -127.1 -171.7 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.855 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.5 ' O ' HG23 ' A' ' 20' ' ' ILE . 1.1 tp -59.23 120.53 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.097 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.4 -103.18 3.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.486 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.55 139.5 31.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.35 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.413 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 40.8 p90 -101.48 176.24 5.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.014 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -149.27 130.15 14.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.82 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.5 t -105.74 109.09 20.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.763 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.567 ' H ' HD12 ' A' ' 26' ' ' ILE . 3.9 mp -90.0 126.58 42.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.727 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 0.5 OUTLIER -124.95 -161.91 1.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.732 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.53 ' HB2' ' HB2' ' A' ' 31' ' ' TYR . 15.8 mtt -50.51 146.58 9.1 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.114 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.8 -64.64 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.604 2.203 . . . . 0.0 112.5 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.6 57.7 4.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.227 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 28' ' ' MET . 0.7 OUTLIER -124.86 125.71 44.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.866 0.365 . . . . 0.0 110.877 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -97.16 152.37 18.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.777 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.23 146.36 7.08 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.346 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.407 HG12 ' CE1' ' A' ' 35' ' ' TYR . 54.7 t -63.81 -31.16 52.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.912 0.387 . . . . 0.0 111.221 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.418 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 31.6 m-85 -142.56 57.54 1.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.05 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 48.88 92.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.006 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -169.71 -39.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.089 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.3 mm . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.063 -179.901 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.602 0.239 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.88 -43.0 13.11 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.376 2.05 . . . . 0.0 112.197 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 68.5 m -59.03 139.25 57.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.083 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -92.8 44.35 1.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.43 0.633 . . . . 0.0 110.482 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -150.58 -161.03 1.25 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.831 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.1 37.74 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.768 0.318 . . . . 0.0 110.655 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -77.78 -176.81 4.57 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.354 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.429 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 86.9 m -120.28 141.17 50.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.585 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.9 t -89.92 138.06 31.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.144 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.05 69.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.772 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 33.5 p-10 -92.56 155.18 17.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.084 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -135.06 -178.88 5.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.064 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.427 ' CD1' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -57.53 88.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.547 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.74 -93.13 0.58 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.577 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -89.95 137.87 31.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.873 0.368 . . . . 0.0 110.768 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.46 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 23.7 p90 -113.73 166.88 11.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -145.04 126.61 15.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.977 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.0 t -97.08 138.97 33.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.635 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.429 ' HB ' ' HB ' ' A' ' 15' ' ' THR . 13.9 mm -89.79 92.28 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.993 0.425 . . . . 0.0 110.794 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -170.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.066 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.6 mtp -90.34 154.94 46.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.802 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.24 84.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.625 2.216 . . . . 0.0 112.207 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.23 52.49 1.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.499 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -120.68 154.38 35.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.765 0.317 . . . . 0.0 110.521 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.69 160.5 15.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.946 0.403 . . . . 0.0 111.187 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.78 142.88 12.95 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.693 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.8 t -56.88 -41.75 76.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.98 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 44.2 m-85 -125.36 48.42 2.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.692 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 m 53.11 96.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.098 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -166.72 -39.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.07 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.5 mm . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.007 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.609 0.242 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 38.2 Cg_endo -65.88 -40.75 15.76 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.517 2.145 . . . . 0.0 112.198 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 90.6 m -60.5 132.62 54.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.84 44.87 1.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.35 0.595 . . . . 0.0 110.405 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -150.63 -161.3 1.31 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.773 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -89.94 41.63 1.05 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.725 0.298 . . . . 0.0 110.758 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -74.48 179.09 4.84 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.76 0.314 . . . . 0.0 111.129 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.403 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 93.4 m -114.58 157.7 22.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.671 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.5 p -89.91 130.09 36.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.38 51.74 1.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.757 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -144.27 64.82 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.569 ' C ' HD12 ' A' ' 20' ' ' ILE . 4.4 tt0 -125.98 27.31 6.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.85 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 20' ' ' ILE . 2.0 mp -147.75 30.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.898 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.83 25.7 73.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.498 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -139.53 106.16 5.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.353 . . . . 0.0 110.841 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 23.4 t80 -70.79 112.76 7.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.084 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -150.01 116.06 5.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.9 t -105.22 134.13 48.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.61 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 15' ' ' THR . 13.7 mm -89.79 105.48 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.841 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -88.41 174.33 8.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.227 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.3 mtt -69.83 161.89 71.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.817 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.48 87.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.568 2.179 . . . . 0.0 112.341 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.36 60.91 1.86 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.63 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -111.21 128.3 55.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.67 0.271 . . . . 0.0 110.289 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -89.83 174.08 7.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 111.435 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.29 134.0 1.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.593 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.614 HG12 ' CD2' ' A' ' 35' ' ' TYR . 57.7 t -59.46 132.11 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.895 0.379 . . . . 0.0 110.976 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.614 ' CD2' HG12 ' A' ' 34' ' ' VAL . 7.4 m-85 61.01 47.22 7.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.895 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 50.17 96.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.327 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.71 -50.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.02 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.148 -179.783 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 35.7 t0 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.824 0.345 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.47 106.55 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.168 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 60.57 86.99 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -30.91 71.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.2 t -89.98 94.5 9.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 27.3 mm -89.91 -45.66 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.019 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.98 52.56 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.745 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.62 118.32 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.411 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 37.1 Cg_endo -65.27 -42.32 13.72 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.404 2.07 . . . . 0.0 112.105 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 87.4 m -53.7 136.89 38.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.028 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.74 44.06 1.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.508 0.67 . . . . 0.0 110.669 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -150.77 -161.33 1.32 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.809 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.02 39.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 110.839 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -78.33 -175.5 4.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.983 0.421 . . . . 0.0 111.414 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.9 m -121.14 147.66 45.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.725 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.5 t -89.92 155.74 18.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.683 ' HB2' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -172.2 80.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.78 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -138.6 169.94 16.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.977 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -150.07 -175.38 5.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.599 ' O ' HG23 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -68.87 70.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 111.065 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.77 -26.68 1.93 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.663 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.93 177.7 4.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.908 0.385 . . . . 0.0 111.039 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.411 ' CE1' ' HG3' ' A' ' 9' ' ' PRO . 38.4 t80 -176.0 103.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.715 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -143.68 132.47 22.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.974 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.8 t -109.04 140.16 42.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.683 HD11 ' HB2' ' A' ' 17' ' ' LEU . 4.2 mp -89.68 90.29 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.787 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -167.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.151 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 63.7 mtp -101.73 155.78 35.99 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.841 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.65 93.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.649 2.232 . . . . 0.0 112.091 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.52 39.38 4.46 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.386 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -119.63 118.96 32.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.746 0.308 . . . . 0.0 110.685 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.93 157.2 17.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.008 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.64 143.83 7.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.415 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.667 HG12 ' CE1' ' A' ' 35' ' ' TYR . 57.3 t -57.94 -40.72 77.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.85 0.357 . . . . 0.0 111.12 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.667 ' CE1' HG12 ' A' ' 34' ' ' VAL . 13.4 m-85 -125.55 48.8 2.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.781 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 46.91 75.97 0.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.339 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -123.88 -25.73 4.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.325 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.8 mm . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.82 0.343 . . . . 0.0 111.082 -179.966 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.625 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.835 0.35 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 t -100.33 79.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.032 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -160.47 -46.11 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 59.88 30.37 19.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.022 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 40.7 t -140.49 83.96 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.3 mm -89.95 -44.97 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.737 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 t -143.39 52.66 1.34 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.569 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 62.29 119.63 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.757 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 36.1 Cg_endo -64.76 -43.34 12.91 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.423 2.082 . . . . 0.0 112.005 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.498 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 93.2 m -54.86 136.77 46.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.037 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -91.82 43.76 1.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.356 0.598 . . . . 0.0 110.539 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -150.68 -161.67 1.39 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.853 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.85 38.49 0.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.714 0.293 . . . . 0.0 110.825 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -79.54 -174.74 4.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.005 0.431 . . . . 0.0 111.421 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.464 ' O ' HD12 ' A' ' 26' ' ' ILE . 89.1 m -125.51 142.62 51.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.844 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.9 t -90.0 149.42 22.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.721 ' HB2' HD11 ' A' ' 26' ' ' ILE . 1.1 tt -157.29 66.69 0.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -111.14 110.0 20.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -90.03 -175.92 4.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -56.3 103.98 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.095 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.02 26.81 57.49 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.15 -178.2 5.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 0.0 110.904 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 13.9 t80 -177.54 113.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -149.96 123.6 9.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.073 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.3 t -104.45 131.79 51.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.689 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.721 HD11 ' HB2' ' A' ' 17' ' ' LEU . 3.9 mp -89.95 91.72 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.26 -168.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.026 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.4 mtp -91.99 160.35 35.96 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.986 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.73 95.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.557 2.172 . . . . 0.0 112.387 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.23 54.83 3.92 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.366 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -120.26 137.87 53.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.751 0.31 . . . . 0.0 110.684 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -93.35 161.88 14.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.132 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.5 137.96 9.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.447 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.467 HG12 ' CE1' ' A' ' 35' ' ' TYR . 76.0 t -56.59 -48.95 79.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 0.0 111.056 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.498 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 13.2 m-85 -112.61 43.27 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.611 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.2 m 52.09 98.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.953 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -166.71 -39.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.961 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.7 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.213 -179.861 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.609 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.828 0.347 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.514 HG23 HD11 ' A' ' 20' ' ' ILE . 4.7 m -97.44 141.89 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.056 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -95.92 164.26 12.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -100.27 42.55 1.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.925 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.58 22.66 13.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.154 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.3 mm -108.19 -27.98 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 0.0 110.893 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.6 t -139.97 56.43 1.63 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.462 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -52.34 107.15 0.77 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.389 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HG2' ' CZ ' ' A' ' 23' ' ' PHE . 65.5 Cg_exo -52.12 -24.65 20.67 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.551 2.167 . . . . 0.0 112.232 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.9 m -59.42 125.21 22.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.621 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -96.02 42.57 1.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.374 0.607 . . . . 0.0 110.64 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -150.79 -165.62 2.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.994 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -89.94 41.33 1.04 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.88 0.372 . . . . 0.0 110.484 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . . . -76.14 -176.0 3.36 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.491 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.402 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 48.8 m -119.48 154.34 33.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.569 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.8 p -89.85 130.56 36.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 111.132 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.583 HD22 HD11 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -143.72 69.71 1.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -153.87 135.38 14.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.09 67.66 1.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.816 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.514 HD11 HG23 ' A' ' 2' ' ' VAL . 43.9 mm 52.7 85.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.17 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.46 -82.04 0.13 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.447 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.18 121.8 41.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.828 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.419 ' CZ ' ' HG2' ' A' ' 9' ' ' PRO . 90.5 t80 -77.34 131.01 37.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -139.67 103.11 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.831 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.9 t -92.13 122.49 34.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.667 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.583 HD11 HD22 ' A' ' 17' ' ' LEU . 18.3 mm -89.92 90.17 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.1 m -75.65 -179.67 4.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.067 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.557 ' HE3' ' CD2' ' A' ' 31' ' ' TYR . 28.3 mtm -74.81 155.08 87.06 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.043 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.84 128.75 31.78 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.652 2.235 . . . . 0.0 111.968 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.4 24.25 73.63 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.233 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.557 ' CD2' ' HE3' ' A' ' 28' ' ' MET . 4.0 t80 -104.11 124.98 50.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.712 0.292 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -90.03 163.14 15.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.72 139.69 9.48 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.435 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.543 HG12 ' CD1' ' A' ' 35' ' ' TYR . 61.1 t -61.88 -56.0 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 111.164 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.543 ' CD1' HG12 ' A' ' 34' ' ' VAL . 8.5 m-85 -102.58 36.37 2.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.983 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 6.4 m 57.85 104.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.606 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -168.28 -33.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.421 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.4 mm . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.87 0.367 . . . . 0.0 111.097 -179.999 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.451 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.859 0.362 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.88 105.41 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.218 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -128.02 30.53 5.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -114.38 30.88 6.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 t -117.88 29.04 8.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.925 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.5 mt -91.63 -29.37 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.059 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.1 t -120.17 91.73 3.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.715 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -54.38 108.15 1.06 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.432 ' HG3' ' CE2' ' A' ' 23' ' ' PHE . 72.8 Cg_endo -76.0 -31.44 4.99 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.466 2.111 . . . . 0.0 112.212 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 1.9 m -72.09 125.14 26.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -96.75 43.14 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.436 0.636 . . . . 0.0 110.498 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.432 ' HB3' ' HE3' ' A' ' 28' ' ' MET . 14.8 m-80 -150.65 -164.55 2.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.083 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.02 38.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 110.483 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -73.13 -178.18 2.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.39 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 53.6 m -114.1 153.86 28.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.662 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.1 t -89.97 114.63 26.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.981 0.42 . . . . 0.0 111.086 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.844 HD13 HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -136.99 56.5 1.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.485 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.439 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 3.7 p-10 -86.11 159.75 19.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.159 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -139.95 -166.57 2.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.722 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.579 ' O ' HG23 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -73.86 112.65 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.969 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.62 -83.87 1.05 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.447 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -100.99 125.44 47.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.439 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 53.4 p90 -96.12 167.81 10.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.9 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -133.73 126.02 29.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.118 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.9 t -95.7 133.58 39.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.531 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.844 HD11 HD13 ' A' ' 17' ' ' LEU . 9.6 mm -89.79 96.19 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.738 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -72.44 -172.83 1.0 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.277 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.432 ' HE3' ' HB3' ' A' ' 12' ' ' ASN . 41.5 mtt -94.06 162.04 27.91 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.695 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.22 88.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.519 2.146 . . . . 0.0 112.292 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.69 56.58 2.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.529 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -116.28 137.51 52.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.728 0.299 . . . . 0.0 110.713 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.02 162.66 15.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.961 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.18 145.22 16.53 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.398 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.6 t -58.18 -54.04 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.795 0.331 . . . . 0.0 111.132 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 38.8 m-85 -113.64 42.46 1.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.835 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 56.33 102.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -177.67 -34.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.049 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.6 mm . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.191 -179.868 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.602 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.822 0.344 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p -146.18 134.26 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.157 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -93.78 -175.97 3.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.917 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.84 32.79 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.017 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.9 t -110.63 27.01 10.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.121 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -95.93 -27.91 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.926 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 t -127.44 104.47 7.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.669 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -56.08 118.59 21.64 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.958 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.411 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 29.8 Cg_endo -63.36 -41.36 27.04 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.415 2.077 . . . . 0.0 112.055 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 99.7 m -65.46 135.59 55.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -92.29 43.85 1.15 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.367 0.603 . . . . 0.0 110.543 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -150.78 -163.02 1.67 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.799 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -89.83 44.62 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 0.0 110.588 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -77.32 -179.69 5.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.972 0.415 . . . . 0.0 111.276 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.0 m -112.03 149.19 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.49 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.7 t -89.82 126.41 35.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.951 0.405 . . . . 0.0 111.013 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.48 60.19 1.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.73 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 10.1 p-10 -86.28 153.8 21.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.135 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -146.58 -170.91 3.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.695 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.715 HD13 ' N ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -59.26 130.31 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.057 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.715 ' N ' HD13 ' A' ' 20' ' ' ILE . . . 82.71 -113.84 3.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.564 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -89.89 117.65 28.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.889 0.376 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.424 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 54.1 p90 -71.62 172.2 10.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.049 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -140.85 127.16 19.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.078 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.4 t -103.4 133.0 49.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.425 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 mm -89.69 100.59 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.754 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -82.53 168.89 16.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.386 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.1 mtt -68.76 154.65 94.5 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.026 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -56.95 131.73 47.27 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.622 2.214 . . . . 0.0 112.154 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.41 21.81 72.63 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.606 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -102.96 122.01 43.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 0.0 110.662 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.96 154.29 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.088 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.28 132.59 4.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.502 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.438 HG12 ' CE1' ' A' ' 35' ' ' TYR . 99.6 t -56.99 -30.89 35.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.762 0.315 . . . . 0.0 111.107 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CE1' HG12 ' A' ' 34' ' ' VAL . 33.4 m-85 -136.52 53.49 1.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.987 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 72.8 m 47.48 97.27 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.515 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -173.92 -35.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.338 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.5 mm . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.904 0.383 . . . . 0.0 111.092 179.928 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.767 0.318 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p -131.7 137.11 55.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.187 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.26 162.86 13.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -117.14 -39.88 3.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 31.3 t -136.3 87.83 2.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.0 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 mt -91.37 -45.24 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.064 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -144.2 55.42 1.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.866 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 61.38 114.76 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.51 -44.29 6.55 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.417 2.078 . . . . 0.0 112.144 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 95.5 m -63.62 134.9 56.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.934 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -92.36 44.84 1.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.47 0.653 . . . . 0.0 110.469 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -150.66 -161.41 1.33 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.807 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -89.84 37.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.673 0.273 . . . . 0.0 110.69 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.45 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -81.68 -176.73 6.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.908 0.385 . . . . 0.0 111.315 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.6 m -122.04 142.99 49.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.489 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.8 t -103.68 111.48 23.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.326 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.505 HD12 HD11 ' A' ' 26' ' ' ILE . 7.1 mt -110.26 61.99 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.388 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.425 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 15.3 p-10 -85.75 141.66 29.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.149 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -136.42 -167.84 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.681 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.456 HD12 ' H ' ' A' ' 20' ' ' ILE . 3.1 mp -58.82 105.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.128 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.04 -103.68 2.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.496 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -93.96 156.68 16.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.897 0.38 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.425 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 16.9 p90 -120.17 171.0 8.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.981 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.11 117.32 7.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.059 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.5 t -89.96 131.99 35.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.595 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.549 ' H ' HD12 ' A' ' 26' ' ' ILE . 4.0 mp -89.77 97.96 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.032 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.07 173.29 12.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.076 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 15.6 mtt -74.9 146.03 82.16 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.095 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.61 114.94 2.07 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.547 2.165 . . . . 0.0 112.223 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.48 19.61 58.16 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.662 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -102.15 126.29 49.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 110.398 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.8 159.41 17.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.17 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.28 131.09 5.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.444 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.0 t -54.1 -31.69 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.04 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.495 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 44.1 m-85 -136.65 51.91 1.97 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.726 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 73.2 m 50.43 97.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.74 -33.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.474 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 111.0 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.468 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.7 p30 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.823 0.344 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 m -113.51 79.22 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.099 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -141.09 74.25 1.45 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.979 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -110.79 -29.31 8.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 18.6 p -89.9 125.55 35.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.9 mm -89.92 -51.34 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.0 t -140.34 49.64 1.72 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.697 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.82 118.46 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.996 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 16' ' ' CYS . 34.2 Cg_endo -64.31 -32.49 61.54 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.277 1.984 . . . . 0.0 111.84 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.602 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 68.7 m -74.44 139.32 43.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.939 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -91.52 45.04 1.21 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.381 0.61 . . . . 0.0 110.515 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -150.66 -159.47 1.04 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.836 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -89.98 35.65 0.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.739 0.304 . . . . 0.0 110.754 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -79.56 -175.67 4.9 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.957 0.408 . . . . 0.0 111.384 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.7 m -127.96 139.86 52.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.618 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 17.5 p -92.47 125.61 37.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.146 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.89 83.72 2.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.553 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 4.0 p30 -100.43 153.54 19.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.121 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.08 -171.9 3.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.698 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mt -58.87 94.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.044 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.9 -104.79 1.18 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.403 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -89.97 159.4 16.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.847 0.356 . . . . 0.0 110.784 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.451 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 17.9 p90 -127.61 162.16 27.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.006 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -138.11 126.38 23.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.824 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -89.99 141.14 28.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.482 HG22 ' H61' ' A' ' 39' ' ' FUC . 21.3 mm -89.78 89.95 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.683 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -167.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.321 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 13.7 mtp -108.22 162.6 19.34 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.25 121.62 10.01 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.518 2.145 . . . . 0.0 112.309 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.45 31.4 80.15 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.585 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -112.06 115.57 29.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.754 0.311 . . . . 0.0 110.515 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -89.92 171.32 9.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.5 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.32 141.66 9.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.295 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.411 HG12 ' CE1' ' A' ' 35' ' ' TYR . 94.7 t -52.72 -41.07 37.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.765 0.317 . . . . 0.0 111.177 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 33.6 m-85 -134.31 53.62 1.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.728 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 47.76 95.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.313 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -166.56 -36.46 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 0.0 111.196 -179.882 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.482 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.892 0.377 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.0 t -128.56 116.85 43.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.056 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -147.94 21.82 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.077 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -117.02 -22.15 8.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.248 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.7 t -96.26 29.59 2.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.752 0.311 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.4 mm -101.95 -25.4 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.135 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.0 t -129.15 85.27 2.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.416 ' O ' ' ND2' ' A' ' 8' ' ' ASN . 3.5 p-10 -54.39 108.43 1.14 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.119 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.442 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 74.1 Cg_exo -49.0 -38.53 39.46 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.44 2.093 . . . . 0.0 112.405 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 36' ' ' CYS . 82.3 m -64.9 144.34 57.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.769 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -122.06 52.88 1.25 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.808 0.337 . . . . 0.0 111.745 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -150.24 -91.74 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.997 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.29 30.28 0.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.751 0.31 . . . . 0.0 110.752 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.42 ' HB3' ' CB ' ' A' ' 10' ' ' CYS . . . -68.59 -176.17 0.76 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.519 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.5 m -122.94 160.57 25.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.478 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.4 t -89.89 133.26 34.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.109 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.86 41.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.609 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 2.8 p30 -81.07 154.98 26.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.103 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -141.94 -174.89 4.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.721 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -53.23 136.51 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.238 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.98 -84.72 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.464 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -94.23 164.49 13.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.788 0.328 . . . . 0.0 110.785 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.442 ' CE1' ' HG2' ' A' ' 9' ' ' PRO . 49.5 p90 -133.74 178.96 6.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.037 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -149.7 119.09 6.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.002 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.2 t -105.97 136.06 46.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.333 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.526 HG22 ' H61' ' A' ' 39' ' ' FUC . 16.8 mm -89.97 92.52 3.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.753 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.3 t -79.17 162.12 25.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.291 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mtp -58.28 143.49 79.49 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.188 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.97 124.26 14.56 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.522 2.148 . . . . 0.0 112.263 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.79 24.74 59.61 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.587 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -96.05 176.08 6.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.802 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB3' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -129.48 162.4 28.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.008 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.23 152.65 14.84 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.5 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.86 -35.45 51.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.909 0.385 . . . . 0.0 111.242 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -117.0 -70.34 0.8 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.283 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.46 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER 178.56 68.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.916 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -140.36 -35.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.244 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.403 HG22 ' HB3' ' A' ' 32' ' ' GLU . 21.2 mm . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.759 0.314 . . . . 0.0 111.114 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.526 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.771 0.319 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.92 158.25 41.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 60.49 85.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.834 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -110.71 -35.45 5.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.808 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 49.1 t -94.81 71.6 3.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mt -90.03 -35.59 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.153 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.89 51.98 2.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.984 0.421 . . . . 0.0 110.895 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 48.37 91.84 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.318 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.444 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 66.7 Cg_endo -73.7 -32.44 7.53 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.504 2.136 . . . . 0.0 112.194 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 1.9 m -69.17 126.44 29.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.4 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -93.95 42.2 1.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.337 0.589 . . . . 0.0 111.139 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -151.07 -161.29 1.3 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.309 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.89 29.95 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.708 0.29 . . . . 0.0 110.898 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.54 -177.01 0.67 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.969 0.414 . . . . 0.0 111.22 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.9 m -117.49 136.03 53.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.793 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.0 t -89.72 85.27 6.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.29 67.03 5.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.654 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -148.94 111.07 4.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.892 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.01 74.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.921 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 20' ' ' ILE . 10.2 mt 51.78 61.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.223 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 179.76 -97.58 0.11 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.484 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.52 132.1 36.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.759 0.314 . . . . 0.0 110.838 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.444 ' CE1' ' HG3' ' A' ' 9' ' ' PRO . 44.6 t80 -92.91 133.71 35.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.986 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.17 98.69 2.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.999 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -89.95 123.25 33.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.52 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.521 HG22 ' H61' ' A' ' 39' ' ' FUC . 16.7 mm -89.74 108.89 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.687 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.43 -169.81 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.252 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.0 mtt -98.14 161.55 25.09 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.84 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.61 90.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.486 2.124 . . . . 0.0 112.395 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.78 55.89 3.06 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.417 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -110.16 163.56 13.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.763 0.316 . . . . 0.0 110.753 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -117.43 150.67 38.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.929 0.395 . . . . 0.0 111.123 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.24 141.78 10.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.454 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.6 t -55.18 -61.99 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.44 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 10.7 m-85 -96.62 27.71 3.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 60.44 108.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.701 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -179.83 -32.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.003 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.187 -179.91 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.521 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.77 0.319 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 m -135.38 104.43 4.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.154 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.15 -60.13 1.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.98 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.89 29.97 4.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.951 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -101.99 23.7 11.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.052 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 mt -103.49 -26.67 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.982 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.8 t -125.61 86.27 2.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.674 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -49.15 105.74 0.54 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.337 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.56 -29.3 7.52 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.511 2.14 . . . . 0.0 112.122 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.0 m -69.63 127.52 33.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.664 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.74 42.48 1.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.465 0.65 . . . . 0.0 110.453 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -150.74 -164.66 2.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.194 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -91.23 38.4 0.97 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.748 0.309 . . . . 0.0 110.584 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.1 -178.45 3.35 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.446 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.452 HG22 HD23 ' A' ' 17' ' ' LEU . 52.0 m -114.01 153.7 28.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.554 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.55 ' O ' HD22 ' A' ' 17' ' ' LEU . 53.7 t -89.87 106.52 18.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.24 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.58 ' HG ' HD11 ' A' ' 26' ' ' ILE . 2.7 mm? -127.97 61.75 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.333 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.436 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 5.7 p-10 -90.94 156.59 17.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.177 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.67 -166.54 2.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.794 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.5 mm -62.47 130.09 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.06 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.13 -98.05 0.97 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.573 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.01 136.12 33.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 110.784 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.436 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 54.4 p90 -99.04 178.02 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.05 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.89 128.45 19.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.066 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -96.76 134.26 40.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.71 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.619 HG22 ' H61' ' A' ' 39' ' ' FUC . 11.2 mm -89.85 97.36 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.587 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.89 -176.7 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.414 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.556 ' HE3' ' CE2' ' A' ' 31' ' ' TYR . 7.8 mtt -88.07 154.69 52.34 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.867 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.8 92.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.7 2.267 . . . . 0.0 112.11 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.73 37.27 4.78 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.395 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.556 ' CE2' ' HE3' ' A' ' 28' ' ' MET . 3.1 t80 -110.46 131.03 55.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.759 0.314 . . . . 0.0 110.671 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.86 161.03 16.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.144 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.48 141.76 11.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.484 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.01 -61.18 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.763 0.316 . . . . 0.0 111.061 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.451 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 17.6 m-85 -101.34 36.44 2.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.713 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 60.03 105.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.71 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -176.39 -35.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.155 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.4 mm . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.048 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.619 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.891 0.376 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t -148.37 138.04 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -112.55 -48.16 3.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.993 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.6 -74.59 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.5 t -149.79 75.26 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.854 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mt -89.88 -39.32 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.789 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 t -142.16 52.5 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.626 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 58.49 107.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.842 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.21 -46.21 4.65 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.341 2.027 . . . . 0.0 112.089 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 99.6 m -60.58 135.46 57.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -91.52 45.22 1.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.366 0.603 . . . . 0.0 110.492 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -150.65 -161.55 1.36 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.826 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -89.92 41.13 1.03 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.824 0.345 . . . . 0.0 110.681 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -76.43 -176.18 3.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.042 0.449 . . . . 0.0 111.245 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.445 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 72.9 m -122.59 151.53 41.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.603 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.1 t -89.93 148.91 22.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.965 0.412 . . . . 0.0 111.128 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.22 49.29 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.499 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.443 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 14.2 p-10 -82.9 146.21 28.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.008 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.7 -169.27 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.6 mm -69.54 111.54 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.54 -86.7 0.57 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -107.25 134.99 49.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.764 0.316 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.443 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 44.0 p90 -101.45 170.87 7.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.977 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -143.98 125.67 15.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.969 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.3 t -103.39 138.64 39.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.635 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.578 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 8.9 mm -89.72 105.87 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.7 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -93.2 170.09 9.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.409 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.583 ' HB2' ' HB2' ' A' ' 31' ' ' TYR . 62.5 mtt -63.84 159.65 52.41 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.99 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.87 -64.74 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.769 2.312 . . . . 0.0 112.866 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.89 66.89 0.26 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.31 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.583 ' HB2' ' HB2' ' A' ' 28' ' ' MET . 2.7 t80 -127.71 157.08 41.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.816 0.341 . . . . 0.0 110.785 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -117.45 152.75 34.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.002 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.88 142.02 6.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.431 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.557 HG12 ' CE1' ' A' ' 35' ' ' TYR . 61.2 t -58.75 -34.42 51.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.685 0.278 . . . . 0.0 111.074 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.557 ' CE1' HG12 ' A' ' 34' ' ' VAL . 19.6 m-85 -137.04 53.52 1.89 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.173 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.8 m 49.78 96.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.219 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.13 -36.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.266 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.7 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.05 -179.811 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.558 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.843 0.354 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.43 164.0 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -82.44 105.34 13.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -99.2 29.42 3.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.987 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 50.9 t -124.96 57.86 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.841 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mt -91.6 -36.32 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.091 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.14 54.98 1.92 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.046 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 57.2 97.22 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.102 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.81 -32.19 14.63 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.408 2.072 . . . . 0.0 112.103 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.1 m -77.7 128.25 33.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.535 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -94.76 43.98 1.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.349 0.595 . . . . 0.0 110.676 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -150.69 -162.31 1.52 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.002 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -90.45 27.49 1.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.344 . . . . 0.0 110.607 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.83 -175.21 1.66 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.506 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.3 m -128.72 128.53 44.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.472 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.3 t -96.72 124.18 40.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.068 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.07 79.36 1.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.502 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.416 ' CB ' ' HB3' ' A' ' 23' ' ' PHE . 14.5 p-10 -103.78 133.44 48.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.098 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -141.84 75.27 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.1 mt 52.84 94.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.27 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.09 -127.19 7.11 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.462 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -89.94 132.58 35.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.798 0.332 . . . . 0.0 110.852 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.416 ' HB3' ' CB ' ' A' ' 18' ' ' ASP . 47.7 p90 -108.97 -172.26 2.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -148.89 122.61 9.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -89.96 130.18 36.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.632 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.505 HG22 ' H61' ' A' ' 39' ' ' FUC . 16.2 mm -89.72 88.66 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.956 0.407 . . . . 0.0 110.66 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -166.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.324 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 47.5 mtp -109.54 161.44 24.06 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.818 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -51.46 92.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.606 2.204 . . . . 0.0 112.285 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.2 52.63 3.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.467 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -120.16 118.17 29.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.722 0.296 . . . . 0.0 110.632 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -90.0 167.99 12.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.123 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.43 136.28 8.55 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.688 HG12 ' CD2' ' A' ' 35' ' ' TYR . 92.4 t -56.34 129.04 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.381 . . . . 0.0 111.077 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.688 ' CD2' HG12 ' A' ' 34' ' ' VAL . 6.7 m-85 58.38 27.21 15.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.995 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 62.41 115.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.04 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -165.68 -54.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.756 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.0 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.267 -179.775 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.505 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.518 ' OD1' HG13 ' A' ' 2' ' ' VAL . 2.4 p30 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.807 0.336 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.518 HG13 ' OD1' ' A' ' 1' ' ' ASP . 5.1 m -94.64 90.76 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.25 160.42 17.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.985 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 64.08 15.98 9.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.399 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.2 t -118.04 21.27 12.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.644 0.259 . . . . 0.0 111.116 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mt -91.25 -30.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.719 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.77 89.4 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.583 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -50.63 109.71 1.43 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.213 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 47.3 Cg_endo -68.0 -33.82 24.83 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.457 2.105 . . . . 0.0 112.102 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.8 m -65.61 127.22 31.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.527 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -95.09 43.79 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.256 0.55 . . . . 0.0 110.683 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -150.74 -163.85 1.87 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.145 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.5 34.45 0.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.8 0.333 . . . . 0.0 110.544 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -71.21 -177.29 1.68 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.414 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 70.2 m -114.04 150.22 34.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.66 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.6 t -89.77 118.05 29.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.023 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.696 ' CD1' HD11 ' A' ' 26' ' ' ILE . 1.7 tt -132.66 67.76 1.52 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.714 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -142.65 158.58 43.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.005 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -144.9 -177.1 5.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.649 ' O ' HG23 ' A' ' 20' ' ' ILE . 6.9 tp -58.46 91.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.081 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.13 -27.62 8.06 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.418 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -97.32 175.49 6.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.856 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.451 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 12.5 t80 -174.04 113.77 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.01 127.3 11.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.149 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.5 t -100.52 125.42 46.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.538 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.723 HG22 ' H61' ' A' ' 39' ' ' FUC . 14.2 mm -89.8 81.66 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.754 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -169.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.335 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 40.1 mtp -97.59 160.84 27.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.942 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.32 92.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.601 2.201 . . . . 0.0 112.272 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.64 53.73 3.3 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -115.21 132.86 56.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.696 0.284 . . . . 0.0 110.792 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -89.99 153.33 20.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.082 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.91 142.03 9.31 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.397 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 35' ' ' TYR . 59.4 t -56.66 -53.93 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.949 0.404 . . . . 0.0 111.219 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.421 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 17.8 m-85 -111.81 41.56 1.9 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.782 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 55.27 101.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.853 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -172.66 -35.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.062 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.3 mm . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.204 -179.92 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.723 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.816 0.341 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.612 HG23 HD11 ' A' ' 6' ' ' ILE . 3.3 m -111.63 158.7 12.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.126 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -129.76 -66.96 0.77 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.43 23.44 14.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.067 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.4 t -111.65 28.32 8.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.888 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.612 HD11 HG23 ' A' ' 2' ' ' VAL . 30.6 mm -97.33 -27.21 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.061 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.44 94.49 3.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.808 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -57.43 119.1 29.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.979 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.28 -40.65 24.48 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.408 2.072 . . . . 0.0 112.243 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.54 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . 94.5 m -67.22 136.54 55.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -112.78 54.34 0.72 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.341 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -150.24 -92.82 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.832 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.3 24.24 0.81 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.322 . . . . 0.0 110.845 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HB3' ' CB ' ' A' ' 10' ' ' CYS . . . -67.9 178.35 1.8 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.293 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.431 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 28.6 m -112.99 158.93 19.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.62 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.8 t -89.72 125.12 35.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.69 52.64 1.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.686 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 43.4 p-10 -150.96 89.41 1.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.878 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -149.27 42.04 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.552 ' O ' HG23 ' A' ' 20' ' ' ILE . 5.9 tt -169.48 59.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.038 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.39 26.54 59.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.526 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -132.68 -179.22 5.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.851 0.358 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.409 ' HA ' ' HB3' ' A' ' 18' ' ' ASP . 74.1 t80 -157.03 105.5 2.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.997 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -150.02 121.68 8.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.3 t -105.08 137.65 42.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.652 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.544 HG22 ' H61' ' A' ' 39' ' ' FUC . 9.5 mm -89.87 87.85 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.833 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.98 -179.81 1.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.168 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.3 mtt -82.38 161.67 58.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.3 89.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.451 2.101 . . . . 0.0 112.397 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.4 67.93 1.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.644 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -113.34 130.7 56.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.69 0.281 . . . . 0.0 110.392 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -89.97 154.08 20.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 0.0 111.228 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.22 143.39 14.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.718 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.574 HG12 ' CG ' ' A' ' 35' ' ' TYR . 84.2 t -66.34 130.81 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.398 . . . . 0.0 111.102 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.574 ' CG ' HG12 ' A' ' 34' ' ' VAL . 4.2 m-85 61.05 46.26 8.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.169 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 m 46.92 96.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.409 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.62 -65.66 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.2 mm . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.244 -179.808 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.544 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.762 0.315 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 m -102.64 170.91 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.182 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.33 -68.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.956 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -120.94 29.79 7.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.9 t -111.8 26.57 10.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 mt -95.62 -28.1 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.975 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.5 t -134.32 111.06 9.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.736 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -58.23 118.41 27.17 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.02 -40.49 20.21 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.445 2.097 . . . . 0.0 112.131 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 98.5 m -65.81 135.02 54.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.982 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -93.22 45.18 1.16 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.42 0.628 . . . . 0.0 110.379 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -150.48 -161.56 1.37 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.721 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -89.95 42.73 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.787 0.327 . . . . 0.0 110.76 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -76.59 179.41 5.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.156 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.411 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 26.6 m -115.85 160.71 19.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.553 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.6 t -89.9 144.65 25.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.068 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.437 HD22 HD11 ' A' ' 26' ' ' ILE . 5.0 tp -175.53 64.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.548 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.429 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 7.2 p-10 -98.58 163.44 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.262 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.45 -171.22 3.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.772 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.0 mm -72.65 97.24 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.094 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.23 -98.59 1.05 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.524 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.98 105.23 17.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 110.861 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.429 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 49.5 p90 -75.99 -177.13 3.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.069 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -149.99 129.5 13.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.117 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.9 t -111.24 138.79 47.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.501 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.54 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 7.2 mm -89.73 106.97 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.837 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -94.25 171.23 8.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.424 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 34.1 mtt -76.95 144.08 71.74 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.988 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -57.16 121.98 11.02 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.492 2.128 . . . . 0.0 112.273 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.84 11.03 82.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.944 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -97.46 128.61 44.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.761 0.315 . . . . 0.0 110.413 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.71 160.45 16.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.281 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.15 138.86 6.47 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.39 -33.39 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.935 0.398 . . . . 0.0 110.848 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.424 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 37.5 m-85 -137.58 53.95 1.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.933 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 39.0 m 49.2 96.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.257 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -178.46 -37.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.942 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.1 mm . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.14 -179.908 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.528 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.845 0.355 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.49 128.55 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.186 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.435 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -65.65 164.85 13.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.809 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -134.96 -44.67 0.72 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.041 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 46.6 t -89.87 63.78 6.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.032 0.444 . . . . 0.0 110.878 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.435 HD11 ' HB3' ' A' ' 3' ' ' ASN . 23.8 mt -97.29 -35.38 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.242 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 t -128.45 52.38 1.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.963 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 m120 52.99 96.33 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.255 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.18 -37.73 17.64 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.382 2.054 . . . . 0.0 112.022 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 1.8 m -71.47 123.4 22.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.321 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -92.63 44.61 1.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.269 0.557 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.406 ' HB2' ' CB ' ' A' ' 36' ' ' CYS . 11.2 m-80 -150.9 -160.87 1.23 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.953 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -90.24 25.97 2.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.53 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.616 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . . . -72.26 -175.37 1.52 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.029 0.443 . . . . 0.0 111.39 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.3 m -129.64 128.21 42.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.563 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.7 t -104.67 143.42 33.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.199 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.09 93.2 2.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.582 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.428 ' CB ' ' HB3' ' A' ' 23' ' ' PHE . 14.9 p-10 -107.53 121.6 44.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.961 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -143.26 80.23 1.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.5 mt 55.62 103.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.214 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.61 -132.56 10.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.523 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.35 117.46 34.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.748 0.308 . . . . 0.0 110.95 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.428 ' HB3' ' CB ' ' A' ' 18' ' ' ASP . 46.5 p90 -78.51 172.13 14.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.12 131.87 39.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.194 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.96 125.73 48.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.607 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.2 mm -89.66 94.49 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.954 0.407 . . . . 0.0 110.516 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.14 179.88 7.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.473 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.3 mtt -83.77 154.88 65.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.041 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.38 114.83 2.15 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.575 2.183 . . . . 0.0 112.061 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.31 23.83 55.81 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.376 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -105.29 122.81 46.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.662 0.267 . . . . 0.0 110.461 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -89.86 164.06 14.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.98 0.419 . . . . 0.0 111.337 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.51 134.21 6.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.414 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.6 t -56.85 -33.1 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 111.145 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.451 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 35.5 m-85 -133.98 45.15 2.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.822 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 74.9 m 56.79 101.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.794 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -175.65 -34.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.418 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.5 mm . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 111.233 -179.86 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.1 t70 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.845 0.355 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.53 82.95 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.092 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -106.68 143.27 35.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.814 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 4.0 mm-40 -107.19 -45.7 4.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.2 t -89.96 73.05 7.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.747 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.3 mt -90.05 -39.48 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.968 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.7 t -140.3 51.2 1.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.009 0.433 . . . . 0.0 110.851 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 51.86 98.88 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.314 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 37.4 Cg_endo -65.87 -25.02 53.08 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.471 2.114 . . . . 0.0 111.989 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.6 128.72 36.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.065 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -97.88 42.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.332 0.587 . . . . 0.0 110.945 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -150.47 -157.64 0.83 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.2 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.85 28.94 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.801 0.334 . . . . 0.0 110.501 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.58 -175.75 2.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.521 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.425 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 57.8 m -124.53 132.27 53.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.533 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.8 t -90.02 118.08 29.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.013 0.435 . . . . 0.0 111.247 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.5 72.23 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.43 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 20.6 p-10 -90.22 142.89 27.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.103 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -137.04 -166.15 1.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.697 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.98 102.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.16 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.89 -115.2 3.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.09 142.42 27.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.351 . . . . 0.0 110.806 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.43 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 42.9 p90 -102.83 165.74 10.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -141.02 124.9 17.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.024 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -90.41 142.56 27.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.711 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.449 HG22 ' H61' ' A' ' 39' ' ' FUC . 16.6 mm -89.7 91.32 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.772 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.8 m -60.43 176.95 0.31 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.234 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.3 mtp -87.27 161.28 46.57 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.858 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.55 96.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.44 2.093 . . . . 0.0 112.389 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.23 40.61 10.03 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.321 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -115.95 134.92 54.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.742 0.306 . . . . 0.0 110.818 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.25 178.79 4.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.102 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.43 162.04 11.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.537 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.1 t -57.11 -67.8 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.928 0.394 . . . . 0.0 110.95 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.425 ' CD1' ' HB2' ' A' ' 9' ' ' PRO . 43.6 m-85 -98.59 30.66 3.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.865 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.3 m 66.6 51.0 1.15 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -123.93 -2.89 8.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.52 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 120.782 0.325 . . . . 0.0 111.076 -179.8 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.449 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.7 t0 . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.858 0.361 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 2' ' ' VAL . 14.5 p -117.33 119.64 62.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.27 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -159.32 100.97 1.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -137.0 31.6 2.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.8 t -150.02 89.26 1.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.739 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 mt -90.05 -47.73 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.013 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 t -146.32 52.62 1.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 60.92 117.5 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.95 -28.33 58.14 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.41 2.074 . . . . 0.0 112.01 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 69.3 m -72.18 145.93 47.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.952 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -96.87 42.19 1.09 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.374 0.607 . . . . 0.0 110.398 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -150.76 -161.76 1.41 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.986 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.75 43.37 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.97 0.415 . . . . 0.0 110.349 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.727 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . . . -74.05 -174.09 1.79 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.754 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.2 m -124.23 145.69 49.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.424 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.97 130.63 36.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.171 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.78 59.85 1.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.716 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.413 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 10.3 p-10 -91.03 137.34 32.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -127.1 -171.7 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.855 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.5 ' O ' HG23 ' A' ' 20' ' ' ILE . 1.1 tp -59.23 120.53 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.097 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.4 -103.18 3.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.486 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.55 139.5 31.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.35 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.413 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 40.8 p90 -101.48 176.24 5.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.014 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -149.27 130.15 14.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.82 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.5 t -105.74 109.09 20.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.763 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.567 ' H ' HD12 ' A' ' 26' ' ' ILE . 3.9 mp -90.0 126.58 42.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.727 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 0.5 OUTLIER -124.95 -161.91 1.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.732 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.53 ' HB2' ' HB2' ' A' ' 31' ' ' TYR . 15.8 mtt -50.51 146.58 9.1 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.114 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.8 -64.64 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.604 2.203 . . . . 0.0 112.5 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.6 57.7 4.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.227 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 28' ' ' MET . 0.7 OUTLIER -124.86 125.71 44.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.866 0.365 . . . . 0.0 110.877 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -97.16 152.37 18.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.777 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.23 146.36 7.08 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.346 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.407 HG12 ' CE1' ' A' ' 35' ' ' TYR . 54.7 t -63.81 -31.16 52.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.912 0.387 . . . . 0.0 111.221 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.418 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 31.6 m-85 -142.56 57.54 1.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.05 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 48.88 92.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.006 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -169.71 -39.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.089 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.3 mm . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.063 -179.901 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.42 ' H61' ' HA ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.859 0.361 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.4 m -93.18 154.43 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -135.04 -55.63 0.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.776 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -157.97 35.73 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.1 t -144.43 90.21 2.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.408 ' H ' HD12 ' A' ' 6' ' ' ILE . 3.9 mp -94.69 -47.89 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.037 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 t -145.6 52.82 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.881 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.41 119.78 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.921 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.88 -43.0 13.11 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.376 2.05 . . . . 0.0 112.197 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 68.5 m -59.03 139.25 57.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.083 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -92.8 44.35 1.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.43 0.633 . . . . 0.0 110.482 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -150.58 -161.03 1.25 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.831 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.1 37.74 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.768 0.318 . . . . 0.0 110.655 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -77.78 -176.81 4.57 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.354 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.429 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 86.9 m -120.28 141.17 50.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.585 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.9 t -89.92 138.06 31.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.144 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.05 69.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.772 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 33.5 p-10 -92.56 155.18 17.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.084 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -135.06 -178.88 5.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.064 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.427 ' CD1' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -57.53 88.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.547 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.74 -93.13 0.58 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.577 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -89.95 137.87 31.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.873 0.368 . . . . 0.0 110.768 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.46 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 23.7 p90 -113.73 166.88 11.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -145.04 126.61 15.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.977 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.0 t -97.08 138.97 33.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.635 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.537 HG22 ' H61' ' A' ' 39' ' ' FUC . 13.9 mm -89.79 92.28 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.993 0.425 . . . . 0.0 110.794 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -170.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.066 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.6 mtp -90.34 154.94 46.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.802 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.24 84.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.625 2.216 . . . . 0.0 112.207 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.23 52.49 1.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.499 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -120.68 154.38 35.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.765 0.317 . . . . 0.0 110.521 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.69 160.5 15.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.946 0.403 . . . . 0.0 111.187 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.78 142.88 12.95 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.693 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.8 t -56.88 -41.75 76.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.98 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 44.2 m-85 -125.36 48.42 2.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.692 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 m 53.11 96.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.098 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -166.72 -39.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.07 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.5 mm . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.007 179.994 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.537 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.863 0.363 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.16 116.43 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -81.59 -176.37 6.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -95.29 19.45 10.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.84 -10.35 24.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.134 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.9 mm -89.76 -27.89 5.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.964 0.411 . . . . 0.0 110.769 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.5 55.7 1.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.423 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -49.49 125.68 16.19 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.236 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 38.2 Cg_endo -65.88 -40.75 15.76 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.517 2.145 . . . . 0.0 112.198 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 90.6 m -60.5 132.62 54.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.84 44.87 1.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.35 0.595 . . . . 0.0 110.405 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -150.63 -161.3 1.31 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.773 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -89.94 41.63 1.05 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.725 0.298 . . . . 0.0 110.758 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -74.48 179.09 4.84 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.76 0.314 . . . . 0.0 111.129 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.403 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 93.4 m -114.58 157.7 22.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.671 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.5 p -89.91 130.09 36.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.38 51.74 1.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.757 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -144.27 64.82 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.569 ' C ' HD12 ' A' ' 20' ' ' ILE . 4.4 tt0 -125.98 27.31 6.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.85 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 20' ' ' ILE . 2.0 mp -147.75 30.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.898 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.83 25.7 73.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.498 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -139.53 106.16 5.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.353 . . . . 0.0 110.841 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 23.4 t80 -70.79 112.76 7.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.084 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -150.01 116.06 5.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.9 t -105.22 134.13 48.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.61 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.644 HG22 ' H61' ' A' ' 39' ' ' FUC . 13.7 mm -89.79 105.48 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.841 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -88.41 174.33 8.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.227 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.3 mtt -69.83 161.89 71.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.817 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.48 87.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.568 2.179 . . . . 0.0 112.341 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.36 60.91 1.86 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.63 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -111.21 128.3 55.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.67 0.271 . . . . 0.0 110.289 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -89.83 174.08 7.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 111.435 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.29 134.0 1.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.593 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.614 HG12 ' CD2' ' A' ' 35' ' ' TYR . 57.7 t -59.46 132.11 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.895 0.379 . . . . 0.0 110.976 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.614 ' CD2' HG12 ' A' ' 34' ' ' VAL . 7.4 m-85 61.01 47.22 7.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.895 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 50.17 96.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.327 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.71 -50.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.02 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.148 -179.783 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.644 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.519 0.2 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.411 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 37.1 Cg_endo -65.27 -42.32 13.72 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.404 2.07 . . . . 0.0 112.105 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 87.4 m -53.7 136.89 38.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.028 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.74 44.06 1.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.508 0.67 . . . . 0.0 110.669 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -150.77 -161.33 1.32 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.809 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.02 39.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 110.839 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -78.33 -175.5 4.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.983 0.421 . . . . 0.0 111.414 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.9 m -121.14 147.66 45.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.725 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.5 t -89.92 155.74 18.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.683 ' HB2' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -172.2 80.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.78 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -138.6 169.94 16.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.977 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -150.07 -175.38 5.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.599 ' O ' HG23 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -68.87 70.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 111.065 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.77 -26.68 1.93 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.663 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.93 177.7 4.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.908 0.385 . . . . 0.0 111.039 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.411 ' CE1' ' HG3' ' A' ' 9' ' ' PRO . 38.4 t80 -176.0 103.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.715 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -143.68 132.47 22.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.974 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.8 t -109.04 140.16 42.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.683 HD11 ' HB2' ' A' ' 17' ' ' LEU . 4.2 mp -89.68 90.29 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.787 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -167.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.151 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 63.7 mtp -101.73 155.78 35.99 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.841 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.65 93.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.649 2.232 . . . . 0.0 112.091 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.52 39.38 4.46 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.386 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -119.63 118.96 32.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.746 0.308 . . . . 0.0 110.685 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.93 157.2 17.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.008 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.64 143.83 7.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.415 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.667 HG12 ' CE1' ' A' ' 35' ' ' TYR . 57.3 t -57.94 -40.72 77.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.85 0.357 . . . . 0.0 111.12 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.667 ' CE1' HG12 ' A' ' 34' ' ' VAL . 13.4 m-85 -125.55 48.8 2.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.781 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 46.91 75.97 0.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.339 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -123.88 -25.73 4.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.325 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.8 mm . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.82 0.343 . . . . 0.0 111.082 -179.966 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.527 0.203 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 36.1 Cg_endo -64.76 -43.34 12.91 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.423 2.082 . . . . 0.0 112.005 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.498 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 93.2 m -54.86 136.77 46.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.037 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -91.82 43.76 1.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.356 0.598 . . . . 0.0 110.539 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -150.68 -161.67 1.39 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.853 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.85 38.49 0.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.714 0.293 . . . . 0.0 110.825 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -79.54 -174.74 4.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.005 0.431 . . . . 0.0 111.421 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.464 ' O ' HD12 ' A' ' 26' ' ' ILE . 89.1 m -125.51 142.62 51.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.844 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.9 t -90.0 149.42 22.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.721 ' HB2' HD11 ' A' ' 26' ' ' ILE . 1.1 tt -157.29 66.69 0.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -111.14 110.0 20.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -90.03 -175.92 4.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -56.3 103.98 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.095 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.02 26.81 57.49 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.15 -178.2 5.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 0.0 110.904 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 13.9 t80 -177.54 113.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -149.96 123.6 9.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.073 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.3 t -104.45 131.79 51.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.689 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.721 HD11 ' HB2' ' A' ' 17' ' ' LEU . 3.9 mp -89.95 91.72 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.26 -168.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.026 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.4 mtp -91.99 160.35 35.96 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.986 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.73 95.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.557 2.172 . . . . 0.0 112.387 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.23 54.83 3.92 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.366 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -120.26 137.87 53.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.751 0.31 . . . . 0.0 110.684 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -93.35 161.88 14.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.132 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.5 137.96 9.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.447 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.467 HG12 ' CE1' ' A' ' 35' ' ' TYR . 76.0 t -56.59 -48.95 79.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 0.0 111.056 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.498 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 13.2 m-85 -112.61 43.27 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.611 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.2 m 52.09 98.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.953 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -166.71 -39.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.961 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.7 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.213 -179.861 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 p30 . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.573 0.225 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HG2' ' CZ ' ' A' ' 23' ' ' PHE . 65.5 Cg_exo -52.12 -24.65 20.67 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.551 2.167 . . . . 0.0 112.232 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.9 m -59.42 125.21 22.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.621 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -96.02 42.57 1.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.374 0.607 . . . . 0.0 110.64 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -150.79 -165.62 2.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.994 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -89.94 41.33 1.04 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.88 0.372 . . . . 0.0 110.484 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . . . -76.14 -176.0 3.36 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.491 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.402 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 48.8 m -119.48 154.34 33.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.569 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.8 p -89.85 130.56 36.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 111.132 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.583 HD22 HD11 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -143.72 69.71 1.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -153.87 135.38 14.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.09 67.66 1.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.816 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 43.9 mm 52.7 85.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.17 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.46 -82.04 0.13 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.447 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.18 121.8 41.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.828 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.419 ' CZ ' ' HG2' ' A' ' 9' ' ' PRO . 90.5 t80 -77.34 131.01 37.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -139.67 103.11 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.831 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.9 t -92.13 122.49 34.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.667 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.583 HD11 HD22 ' A' ' 17' ' ' LEU . 18.3 mm -89.92 90.17 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.1 m -75.65 -179.67 4.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.067 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.557 ' HE3' ' CD2' ' A' ' 31' ' ' TYR . 28.3 mtm -74.81 155.08 87.06 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.043 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.84 128.75 31.78 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.652 2.235 . . . . 0.0 111.968 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.4 24.25 73.63 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.233 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.557 ' CD2' ' HE3' ' A' ' 28' ' ' MET . 4.0 t80 -104.11 124.98 50.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.712 0.292 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -90.03 163.14 15.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.72 139.69 9.48 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.435 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.543 HG12 ' CD1' ' A' ' 35' ' ' TYR . 61.1 t -61.88 -56.0 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 111.164 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.543 ' CD1' HG12 ' A' ' 34' ' ' VAL . 8.5 m-85 -102.58 36.37 2.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.983 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 6.4 m 57.85 104.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.606 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -168.28 -33.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.421 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.4 mm . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.87 0.367 . . . . 0.0 111.097 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.3 t30 . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.613 0.244 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.432 ' HG3' ' CE2' ' A' ' 23' ' ' PHE . 72.8 Cg_endo -76.0 -31.44 4.99 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.466 2.111 . . . . 0.0 112.212 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 1.9 m -72.09 125.14 26.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -96.75 43.14 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.436 0.636 . . . . 0.0 110.498 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.432 ' HB3' ' HE3' ' A' ' 28' ' ' MET . 14.8 m-80 -150.65 -164.55 2.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.083 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.02 38.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 110.483 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -73.13 -178.18 2.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.39 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 53.6 m -114.1 153.86 28.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.662 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.1 t -89.97 114.63 26.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.981 0.42 . . . . 0.0 111.086 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.844 HD13 HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -136.99 56.5 1.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.485 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.439 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 3.7 p-10 -86.11 159.75 19.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.159 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -139.95 -166.57 2.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.722 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.579 ' O ' HG23 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -73.86 112.65 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.969 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.62 -83.87 1.05 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.447 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -100.99 125.44 47.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.439 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 53.4 p90 -96.12 167.81 10.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.9 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -133.73 126.02 29.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.118 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.9 t -95.7 133.58 39.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.531 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.844 HD11 HD13 ' A' ' 17' ' ' LEU . 9.6 mm -89.79 96.19 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.738 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -72.44 -172.83 1.0 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.277 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.432 ' HE3' ' HB3' ' A' ' 12' ' ' ASN . 41.5 mtt -94.06 162.04 27.91 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.695 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.22 88.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.519 2.146 . . . . 0.0 112.292 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.69 56.58 2.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.529 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -116.28 137.51 52.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.728 0.299 . . . . 0.0 110.713 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.02 162.66 15.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.961 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.18 145.22 16.53 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.398 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.6 t -58.18 -54.04 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.795 0.331 . . . . 0.0 111.132 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 38.8 m-85 -113.64 42.46 1.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.835 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 56.33 102.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -177.67 -34.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.049 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.6 mm . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.191 -179.868 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.5 t30 . . . . . 0 C--O 1.232 0.173 0 CA-C-O 120.589 0.233 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.411 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 29.8 Cg_endo -63.36 -41.36 27.04 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.415 2.077 . . . . 0.0 112.055 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 99.7 m -65.46 135.59 55.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -92.29 43.85 1.15 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.367 0.603 . . . . 0.0 110.543 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -150.78 -163.02 1.67 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.799 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -89.83 44.62 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 0.0 110.588 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -77.32 -179.69 5.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.972 0.415 . . . . 0.0 111.276 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.0 m -112.03 149.19 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.49 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.7 t -89.82 126.41 35.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.951 0.405 . . . . 0.0 111.013 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.48 60.19 1.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.73 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 10.1 p-10 -86.28 153.8 21.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.135 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -146.58 -170.91 3.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.695 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.715 HD13 ' N ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -59.26 130.31 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.057 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.715 ' N ' HD13 ' A' ' 20' ' ' ILE . . . 82.71 -113.84 3.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.564 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -89.89 117.65 28.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.889 0.376 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.424 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 54.1 p90 -71.62 172.2 10.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.049 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -140.85 127.16 19.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.078 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.4 t -103.4 133.0 49.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.425 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 mm -89.69 100.59 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.754 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -82.53 168.89 16.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.386 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.1 mtt -68.76 154.65 94.5 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.026 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -56.95 131.73 47.27 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.622 2.214 . . . . 0.0 112.154 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.41 21.81 72.63 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.606 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -102.96 122.01 43.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 0.0 110.662 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.96 154.29 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.088 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.28 132.59 4.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.502 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.438 HG12 ' CE1' ' A' ' 35' ' ' TYR . 99.6 t -56.99 -30.89 35.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.762 0.315 . . . . 0.0 111.107 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CE1' HG12 ' A' ' 34' ' ' VAL . 33.4 m-85 -136.52 53.49 1.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.987 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 72.8 m 47.48 97.27 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.515 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -173.92 -35.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.338 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.5 mm . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.904 0.383 . . . . 0.0 111.092 179.928 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.592 0.234 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.51 -44.29 6.55 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.417 2.078 . . . . 0.0 112.144 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 95.5 m -63.62 134.9 56.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.934 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -92.36 44.84 1.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.47 0.653 . . . . 0.0 110.469 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -150.66 -161.41 1.33 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.807 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -89.84 37.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.673 0.273 . . . . 0.0 110.69 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.45 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -81.68 -176.73 6.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.908 0.385 . . . . 0.0 111.315 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.6 m -122.04 142.99 49.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.489 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.8 t -103.68 111.48 23.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.326 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.505 HD12 HD11 ' A' ' 26' ' ' ILE . 7.1 mt -110.26 61.99 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.388 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.425 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 15.3 p-10 -85.75 141.66 29.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.149 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -136.42 -167.84 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.681 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.456 HD12 ' H ' ' A' ' 20' ' ' ILE . 3.1 mp -58.82 105.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.128 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.04 -103.68 2.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.496 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -93.96 156.68 16.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.897 0.38 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.425 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 16.9 p90 -120.17 171.0 8.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.981 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.11 117.32 7.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.059 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.5 t -89.96 131.99 35.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.595 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.549 ' H ' HD12 ' A' ' 26' ' ' ILE . 4.0 mp -89.77 97.96 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.032 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.07 173.29 12.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.076 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 15.6 mtt -74.9 146.03 82.16 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.095 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.61 114.94 2.07 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.547 2.165 . . . . 0.0 112.223 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.48 19.61 58.16 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.662 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -102.15 126.29 49.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 110.398 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.8 159.41 17.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.17 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.28 131.09 5.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.444 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.0 t -54.1 -31.69 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.04 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.495 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 44.1 m-85 -136.65 51.91 1.97 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.726 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 73.2 m 50.43 97.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.74 -33.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.474 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 111.0 -179.982 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.515 0.198 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 16' ' ' CYS . 34.2 Cg_endo -64.31 -32.49 61.54 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.277 1.984 . . . . 0.0 111.84 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.602 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 68.7 m -74.44 139.32 43.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.939 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -91.52 45.04 1.21 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.381 0.61 . . . . 0.0 110.515 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -150.66 -159.47 1.04 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.836 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -89.98 35.65 0.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.739 0.304 . . . . 0.0 110.754 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -79.56 -175.67 4.9 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.957 0.408 . . . . 0.0 111.384 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.7 m -127.96 139.86 52.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.618 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 17.5 p -92.47 125.61 37.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.146 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.89 83.72 2.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.553 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 4.0 p30 -100.43 153.54 19.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.121 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.08 -171.9 3.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.698 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mt -58.87 94.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.044 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.9 -104.79 1.18 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.403 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -89.97 159.4 16.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.847 0.356 . . . . 0.0 110.784 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.451 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 17.9 p90 -127.61 162.16 27.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.006 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -138.11 126.38 23.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.824 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -89.99 141.14 28.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.3 mm -89.78 89.95 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.683 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -167.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.321 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 13.7 mtp -108.22 162.6 19.34 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.25 121.62 10.01 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.518 2.145 . . . . 0.0 112.309 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.45 31.4 80.15 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.585 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -112.06 115.57 29.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.754 0.311 . . . . 0.0 110.515 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -89.92 171.32 9.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.5 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.32 141.66 9.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.295 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.411 HG12 ' CE1' ' A' ' 35' ' ' TYR . 94.7 t -52.72 -41.07 37.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.765 0.317 . . . . 0.0 111.177 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 33.6 m-85 -134.31 53.62 1.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.728 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 47.76 95.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.313 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -166.56 -36.46 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 0.0 111.196 -179.882 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 p30 . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.454 0.168 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.442 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 74.1 Cg_exo -49.0 -38.53 39.46 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.44 2.093 . . . . 0.0 112.405 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 36' ' ' CYS . 82.3 m -64.9 144.34 57.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.769 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -122.06 52.88 1.25 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.808 0.337 . . . . 0.0 111.745 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -150.24 -91.74 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.997 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.29 30.28 0.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.751 0.31 . . . . 0.0 110.752 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.42 ' HB3' ' CB ' ' A' ' 10' ' ' CYS . . . -68.59 -176.17 0.76 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.519 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.5 m -122.94 160.57 25.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.478 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.4 t -89.89 133.26 34.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.109 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.86 41.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.609 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 2.8 p30 -81.07 154.98 26.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.103 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -141.94 -174.89 4.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.721 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -53.23 136.51 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.238 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.98 -84.72 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.464 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -94.23 164.49 13.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.788 0.328 . . . . 0.0 110.785 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.442 ' CE1' ' HG2' ' A' ' 9' ' ' PRO . 49.5 p90 -133.74 178.96 6.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.037 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -149.7 119.09 6.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.002 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.2 t -105.97 136.06 46.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.333 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.8 mm -89.97 92.52 3.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.753 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.3 t -79.17 162.12 25.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.291 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mtp -58.28 143.49 79.49 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.188 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.97 124.26 14.56 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.522 2.148 . . . . 0.0 112.263 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.79 24.74 59.61 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.587 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -96.05 176.08 6.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.802 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB3' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -129.48 162.4 28.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.008 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.23 152.65 14.84 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.5 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.86 -35.45 51.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.909 0.385 . . . . 0.0 111.242 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -117.0 -70.34 0.8 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.283 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.46 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER 178.56 68.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.916 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -140.36 -35.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.244 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.403 HG22 ' HB3' ' A' ' 32' ' ' GLU . 21.2 mm . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.759 0.314 . . . . 0.0 111.114 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.558 0.218 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.444 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 66.7 Cg_endo -73.7 -32.44 7.53 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.504 2.136 . . . . 0.0 112.194 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 1.9 m -69.17 126.44 29.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.4 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -93.95 42.2 1.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.337 0.589 . . . . 0.0 111.139 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -151.07 -161.29 1.3 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.309 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.89 29.95 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.708 0.29 . . . . 0.0 110.898 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.54 -177.01 0.67 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.969 0.414 . . . . 0.0 111.22 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.9 m -117.49 136.03 53.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.793 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.0 t -89.72 85.27 6.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.29 67.03 5.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.654 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -148.94 111.07 4.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.892 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.01 74.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.921 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 20' ' ' ILE . 10.2 mt 51.78 61.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.223 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 179.76 -97.58 0.11 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.484 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.52 132.1 36.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.759 0.314 . . . . 0.0 110.838 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.444 ' CE1' ' HG3' ' A' ' 9' ' ' PRO . 44.6 t80 -92.91 133.71 35.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.986 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.17 98.69 2.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.999 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -89.95 123.25 33.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.52 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.7 mm -89.74 108.89 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.687 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.43 -169.81 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.252 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.0 mtt -98.14 161.55 25.09 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.84 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.61 90.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.486 2.124 . . . . 0.0 112.395 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.78 55.89 3.06 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.417 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -110.16 163.56 13.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.763 0.316 . . . . 0.0 110.753 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -117.43 150.67 38.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.929 0.395 . . . . 0.0 111.123 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.24 141.78 10.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.454 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.6 t -55.18 -61.99 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.44 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 10.7 m-85 -96.62 27.71 3.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 60.44 108.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.701 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -179.83 -32.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.003 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.187 -179.91 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.5 t30 . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.488 0.185 . . . . 0.0 111.337 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.56 -29.3 7.52 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.511 2.14 . . . . 0.0 112.122 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.0 m -69.63 127.52 33.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.664 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.74 42.48 1.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.465 0.65 . . . . 0.0 110.453 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -150.74 -164.66 2.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.194 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -91.23 38.4 0.97 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.748 0.309 . . . . 0.0 110.584 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.1 -178.45 3.35 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.446 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.452 HG22 HD23 ' A' ' 17' ' ' LEU . 52.0 m -114.01 153.7 28.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.554 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.55 ' O ' HD22 ' A' ' 17' ' ' LEU . 53.7 t -89.87 106.52 18.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.24 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.58 ' HG ' HD11 ' A' ' 26' ' ' ILE . 2.7 mm? -127.97 61.75 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.333 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.436 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 5.7 p-10 -90.94 156.59 17.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.177 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.67 -166.54 2.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.794 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.5 mm -62.47 130.09 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.06 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.13 -98.05 0.97 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.573 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.01 136.12 33.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 110.784 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.436 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 54.4 p90 -99.04 178.02 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.05 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.89 128.45 19.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.066 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -96.76 134.26 40.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.71 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.58 HD11 ' HG ' ' A' ' 17' ' ' LEU . 11.2 mm -89.85 97.36 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.587 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.89 -176.7 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.414 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.556 ' HE3' ' CE2' ' A' ' 31' ' ' TYR . 7.8 mtt -88.07 154.69 52.34 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.867 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.8 92.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.7 2.267 . . . . 0.0 112.11 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.73 37.27 4.78 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.395 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.556 ' CE2' ' HE3' ' A' ' 28' ' ' MET . 3.1 t80 -110.46 131.03 55.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.759 0.314 . . . . 0.0 110.671 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.86 161.03 16.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.144 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.48 141.76 11.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.484 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.01 -61.18 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.763 0.316 . . . . 0.0 111.061 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.451 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 17.6 m-85 -101.34 36.44 2.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.713 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 60.03 105.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.71 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -176.39 -35.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.155 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.4 mm . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.048 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 . . . . . 0 CA--C 1.529 0.139 0 CA-C-O 120.456 0.17 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.21 -46.21 4.65 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.341 2.027 . . . . 0.0 112.089 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 99.6 m -60.58 135.46 57.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -91.52 45.22 1.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.366 0.603 . . . . 0.0 110.492 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -150.65 -161.55 1.36 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.826 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -89.92 41.13 1.03 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.824 0.345 . . . . 0.0 110.681 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -76.43 -176.18 3.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.042 0.449 . . . . 0.0 111.245 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.445 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 72.9 m -122.59 151.53 41.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.603 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.1 t -89.93 148.91 22.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.965 0.412 . . . . 0.0 111.128 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.22 49.29 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.499 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.443 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 14.2 p-10 -82.9 146.21 28.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.008 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.7 -169.27 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.6 mm -69.54 111.54 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.54 -86.7 0.57 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -107.25 134.99 49.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.764 0.316 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.443 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 44.0 p90 -101.45 170.87 7.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.977 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -143.98 125.67 15.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.969 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.3 t -103.39 138.64 39.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.635 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.578 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 8.9 mm -89.72 105.87 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.7 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -93.2 170.09 9.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.409 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.583 ' HB2' ' HB2' ' A' ' 31' ' ' TYR . 62.5 mtt -63.84 159.65 52.41 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.99 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.87 -64.74 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.769 2.312 . . . . 0.0 112.866 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.89 66.89 0.26 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.31 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.583 ' HB2' ' HB2' ' A' ' 28' ' ' MET . 2.7 t80 -127.71 157.08 41.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.816 0.341 . . . . 0.0 110.785 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -117.45 152.75 34.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.002 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.88 142.02 6.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.431 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.557 HG12 ' CE1' ' A' ' 35' ' ' TYR . 61.2 t -58.75 -34.42 51.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.685 0.278 . . . . 0.0 111.074 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.557 ' CE1' HG12 ' A' ' 34' ' ' VAL . 19.6 m-85 -137.04 53.52 1.89 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.173 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.8 m 49.78 96.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.219 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.13 -36.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.266 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.7 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.05 -179.811 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.538 0.208 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.81 -32.19 14.63 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.408 2.072 . . . . 0.0 112.103 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.1 m -77.7 128.25 33.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.535 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -94.76 43.98 1.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.349 0.595 . . . . 0.0 110.676 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -150.69 -162.31 1.52 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.002 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -90.45 27.49 1.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.344 . . . . 0.0 110.607 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.83 -175.21 1.66 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.506 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.3 m -128.72 128.53 44.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.472 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.3 t -96.72 124.18 40.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.068 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.07 79.36 1.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.502 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.416 ' CB ' ' HB3' ' A' ' 23' ' ' PHE . 14.5 p-10 -103.78 133.44 48.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.098 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -141.84 75.27 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.1 mt 52.84 94.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.27 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.09 -127.19 7.11 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.462 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -89.94 132.58 35.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.798 0.332 . . . . 0.0 110.852 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.416 ' HB3' ' CB ' ' A' ' 18' ' ' ASP . 47.7 p90 -108.97 -172.26 2.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -148.89 122.61 9.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -89.96 130.18 36.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.632 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.2 mm -89.72 88.66 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.956 0.407 . . . . 0.0 110.66 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -166.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.324 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 47.5 mtp -109.54 161.44 24.06 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.818 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -51.46 92.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.606 2.204 . . . . 0.0 112.285 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.2 52.63 3.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.467 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -120.16 118.17 29.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.722 0.296 . . . . 0.0 110.632 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -90.0 167.99 12.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.123 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.43 136.28 8.55 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.688 HG12 ' CD2' ' A' ' 35' ' ' TYR . 92.4 t -56.34 129.04 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.381 . . . . 0.0 111.077 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.688 ' CD2' HG12 ' A' ' 34' ' ' VAL . 6.7 m-85 58.38 27.21 15.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.995 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 62.41 115.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.04 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -165.68 -54.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.756 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.0 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.267 -179.775 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.539 0.209 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 47.3 Cg_endo -68.0 -33.82 24.83 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.457 2.105 . . . . 0.0 112.102 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.8 m -65.61 127.22 31.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.527 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -95.09 43.79 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.256 0.55 . . . . 0.0 110.683 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -150.74 -163.85 1.87 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.145 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.5 34.45 0.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.8 0.333 . . . . 0.0 110.544 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -71.21 -177.29 1.68 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.414 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 70.2 m -114.04 150.22 34.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.66 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.6 t -89.77 118.05 29.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.023 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.696 ' CD1' HD11 ' A' ' 26' ' ' ILE . 1.7 tt -132.66 67.76 1.52 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.714 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -142.65 158.58 43.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.005 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -144.9 -177.1 5.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.649 ' O ' HG23 ' A' ' 20' ' ' ILE . 6.9 tp -58.46 91.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.081 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.13 -27.62 8.06 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.418 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -97.32 175.49 6.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.856 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.451 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 12.5 t80 -174.04 113.77 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.01 127.3 11.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.149 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.5 t -100.52 125.42 46.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.538 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.696 HD11 ' CD1' ' A' ' 17' ' ' LEU . 14.2 mm -89.8 81.66 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.754 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -169.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.335 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 40.1 mtp -97.59 160.84 27.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.942 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.32 92.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.601 2.201 . . . . 0.0 112.272 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.64 53.73 3.3 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -115.21 132.86 56.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.696 0.284 . . . . 0.0 110.792 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -89.99 153.33 20.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.082 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.91 142.03 9.31 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.397 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 35' ' ' TYR . 59.4 t -56.66 -53.93 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.949 0.404 . . . . 0.0 111.219 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.421 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 17.8 m-85 -111.81 41.56 1.9 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.782 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 55.27 101.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.853 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -172.66 -35.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.062 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.3 mm . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.204 -179.92 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.2 m120 . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 120.395 0.14 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.28 -40.65 24.48 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.408 2.072 . . . . 0.0 112.243 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.54 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . 94.5 m -67.22 136.54 55.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -112.78 54.34 0.72 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.341 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -150.24 -92.82 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.832 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.3 24.24 0.81 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.322 . . . . 0.0 110.845 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HB3' ' CB ' ' A' ' 10' ' ' CYS . . . -67.9 178.35 1.8 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.293 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.431 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 28.6 m -112.99 158.93 19.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.62 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.8 t -89.72 125.12 35.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.69 52.64 1.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.686 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 43.4 p-10 -150.96 89.41 1.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.878 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -149.27 42.04 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.552 ' O ' HG23 ' A' ' 20' ' ' ILE . 5.9 tt -169.48 59.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.038 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.39 26.54 59.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.526 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -132.68 -179.22 5.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.851 0.358 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.409 ' HA ' ' HB3' ' A' ' 18' ' ' ASP . 74.1 t80 -157.03 105.5 2.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.997 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -150.02 121.68 8.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.3 t -105.08 137.65 42.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.652 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.431 ' HB ' ' HB ' ' A' ' 15' ' ' THR . 9.5 mm -89.87 87.85 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.833 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.98 -179.81 1.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.168 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.3 mtt -82.38 161.67 58.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.3 89.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.451 2.101 . . . . 0.0 112.397 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.4 67.93 1.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.644 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -113.34 130.7 56.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.69 0.281 . . . . 0.0 110.392 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -89.97 154.08 20.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 0.0 111.228 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.22 143.39 14.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.718 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.574 HG12 ' CG ' ' A' ' 35' ' ' TYR . 84.2 t -66.34 130.81 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.398 . . . . 0.0 111.102 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.574 ' CG ' HG12 ' A' ' 34' ' ' VAL . 4.2 m-85 61.05 46.26 8.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.169 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 m 46.92 96.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.409 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.62 -65.66 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.2 mm . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.244 -179.808 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.613 0.244 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.02 -40.49 20.21 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.445 2.097 . . . . 0.0 112.131 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 98.5 m -65.81 135.02 54.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.982 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -93.22 45.18 1.16 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.42 0.628 . . . . 0.0 110.379 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -150.48 -161.56 1.37 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.721 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -89.95 42.73 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.787 0.327 . . . . 0.0 110.76 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -76.59 179.41 5.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.156 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.411 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 26.6 m -115.85 160.71 19.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.553 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.6 t -89.9 144.65 25.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.068 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.437 HD22 HD11 ' A' ' 26' ' ' ILE . 5.0 tp -175.53 64.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.548 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.429 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 7.2 p-10 -98.58 163.44 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.262 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.45 -171.22 3.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.772 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.0 mm -72.65 97.24 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.094 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.23 -98.59 1.05 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.524 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.98 105.23 17.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 110.861 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.429 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 49.5 p90 -75.99 -177.13 3.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.069 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -149.99 129.5 13.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.117 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.9 t -111.24 138.79 47.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.501 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.54 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 7.2 mm -89.73 106.97 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.837 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -94.25 171.23 8.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.424 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 34.1 mtt -76.95 144.08 71.74 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.988 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -57.16 121.98 11.02 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.492 2.128 . . . . 0.0 112.273 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.84 11.03 82.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.944 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -97.46 128.61 44.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.761 0.315 . . . . 0.0 110.413 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.71 160.45 16.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.281 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.15 138.86 6.47 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.39 -33.39 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.935 0.398 . . . . 0.0 110.848 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.424 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 37.5 m-85 -137.58 53.95 1.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.933 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 39.0 m 49.2 96.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.257 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -178.46 -37.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.942 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.1 mm . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.14 -179.908 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.542 0.21 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.18 -37.73 17.64 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.382 2.054 . . . . 0.0 112.022 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 1.8 m -71.47 123.4 22.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.321 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -92.63 44.61 1.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.269 0.557 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.406 ' HB2' ' CB ' ' A' ' 36' ' ' CYS . 11.2 m-80 -150.9 -160.87 1.23 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.953 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -90.24 25.97 2.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.53 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.616 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . . . -72.26 -175.37 1.52 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.029 0.443 . . . . 0.0 111.39 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.3 m -129.64 128.21 42.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.563 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.7 t -104.67 143.42 33.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.199 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.09 93.2 2.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.582 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.428 ' CB ' ' HB3' ' A' ' 23' ' ' PHE . 14.9 p-10 -107.53 121.6 44.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.961 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -143.26 80.23 1.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.5 mt 55.62 103.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.214 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.61 -132.56 10.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.523 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.35 117.46 34.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.748 0.308 . . . . 0.0 110.95 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.428 ' HB3' ' CB ' ' A' ' 18' ' ' ASP . 46.5 p90 -78.51 172.13 14.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.12 131.87 39.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.194 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.96 125.73 48.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.607 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.2 mm -89.66 94.49 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.954 0.407 . . . . 0.0 110.516 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.14 179.88 7.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.473 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.3 mtt -83.77 154.88 65.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.041 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.38 114.83 2.15 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.575 2.183 . . . . 0.0 112.061 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.31 23.83 55.81 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.376 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -105.29 122.81 46.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.662 0.267 . . . . 0.0 110.461 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -89.86 164.06 14.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.98 0.419 . . . . 0.0 111.337 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.51 134.21 6.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.414 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.6 t -56.85 -33.1 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 111.145 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.451 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 35.5 m-85 -133.98 45.15 2.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.822 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 74.9 m 56.79 101.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.794 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -175.65 -34.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.418 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.5 mm . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 111.233 -179.86 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 120.446 0.165 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 37.4 Cg_endo -65.87 -25.02 53.08 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.471 2.114 . . . . 0.0 111.989 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.6 128.72 36.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.065 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -97.88 42.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.332 0.587 . . . . 0.0 110.945 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -150.47 -157.64 0.83 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.2 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.85 28.94 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.801 0.334 . . . . 0.0 110.501 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.58 -175.75 2.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.521 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.425 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 57.8 m -124.53 132.27 53.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.533 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.8 t -90.02 118.08 29.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.013 0.435 . . . . 0.0 111.247 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.5 72.23 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.43 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 20.6 p-10 -90.22 142.89 27.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.103 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -137.04 -166.15 1.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.697 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.98 102.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.16 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.89 -115.2 3.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.09 142.42 27.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.351 . . . . 0.0 110.806 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.418 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 42.9 p90 -102.83 165.74 10.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -141.02 124.9 17.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.024 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -90.41 142.56 27.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.711 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' A' ' 15' ' ' THR . 16.6 mm -89.7 91.32 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.772 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.8 m -60.43 176.95 0.31 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.234 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.3 mtp -87.27 161.28 46.57 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.858 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.55 96.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.44 2.093 . . . . 0.0 112.389 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.23 40.61 10.03 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.321 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -115.95 134.92 54.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.742 0.306 . . . . 0.0 110.818 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.25 178.79 4.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.102 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.43 162.04 11.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.537 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.1 t -57.11 -67.8 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.928 0.394 . . . . 0.0 110.95 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.425 ' CD1' ' HB2' ' A' ' 9' ' ' PRO . 43.6 m-85 -98.59 30.66 3.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.865 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.3 m 66.6 51.0 1.15 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -123.93 -2.89 8.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.52 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 120.782 0.325 . . . . 0.0 111.076 -179.8 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 . . . . . 0 CA--C 1.531 0.219 0 CA-C-O 120.495 0.188 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.95 -28.33 58.14 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.41 2.074 . . . . 0.0 112.01 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 69.3 m -72.18 145.93 47.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.952 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -96.87 42.19 1.09 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.374 0.607 . . . . 0.0 110.398 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -150.76 -161.76 1.41 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.986 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.75 43.37 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.97 0.415 . . . . 0.0 110.349 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.727 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . . . -74.05 -174.09 1.79 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.754 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.2 m -124.23 145.69 49.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.424 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.97 130.63 36.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.171 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.78 59.85 1.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.716 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.413 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 10.3 p-10 -91.03 137.34 32.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -127.1 -171.7 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.855 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.5 ' O ' HG23 ' A' ' 20' ' ' ILE . 1.1 tp -59.23 120.53 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.097 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.4 -103.18 3.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.486 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.55 139.5 31.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.35 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.413 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 40.8 p90 -101.48 176.24 5.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.014 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -149.27 130.15 14.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.82 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.5 t -105.74 109.09 20.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.763 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.567 ' H ' HD12 ' A' ' 26' ' ' ILE . 3.9 mp -90.0 126.58 42.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.727 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 0.5 OUTLIER -124.95 -161.91 1.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.732 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.53 ' HB2' ' HB2' ' A' ' 31' ' ' TYR . 15.8 mtt -50.51 146.58 9.1 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.114 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.8 -64.64 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.604 2.203 . . . . 0.0 112.5 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.6 57.7 4.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.227 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 28' ' ' MET . 0.7 OUTLIER -124.86 125.71 44.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.866 0.365 . . . . 0.0 110.877 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -97.16 152.37 18.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.777 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.23 146.36 7.08 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.346 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.407 HG12 ' CE1' ' A' ' 35' ' ' TYR . 54.7 t -63.81 -31.16 52.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.912 0.387 . . . . 0.0 111.221 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.418 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 31.6 m-85 -142.56 57.54 1.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.05 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 48.88 92.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.006 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -169.71 -39.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.089 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.3 mm . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.063 -179.901 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.602 0.239 . . . . 0.0 110.921 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.88 -43.0 13.11 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.376 2.05 . . . . 0.0 112.197 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 68.5 m -59.03 139.25 57.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.083 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -92.8 44.35 1.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.43 0.633 . . . . 0.0 110.482 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -150.58 -161.03 1.25 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.831 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.1 37.74 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.768 0.318 . . . . 0.0 110.655 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -77.78 -176.81 4.57 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.354 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.429 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 86.9 m -120.28 141.17 50.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.585 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.9 t -89.92 138.06 31.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.144 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.05 69.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.772 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 33.5 p-10 -92.56 155.18 17.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.084 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -135.06 -178.88 5.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.064 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.427 ' CD1' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -57.53 88.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.547 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.74 -93.13 0.58 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.577 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -89.95 137.87 31.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.873 0.368 . . . . 0.0 110.768 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.46 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 23.7 p90 -113.73 166.88 11.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -145.04 126.61 15.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.977 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.0 t -97.08 138.97 33.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.635 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.429 ' HB ' ' HB ' ' A' ' 15' ' ' THR . 13.9 mm -89.79 92.28 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.993 0.425 . . . . 0.0 110.794 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -170.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.066 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.6 mtp -90.34 154.94 46.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.802 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.24 84.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.625 2.216 . . . . 0.0 112.207 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.23 52.49 1.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.499 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -120.68 154.38 35.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.765 0.317 . . . . 0.0 110.521 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.69 160.5 15.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.946 0.403 . . . . 0.0 111.187 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.78 142.88 12.95 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.693 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.8 t -56.88 -41.75 76.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.98 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 44.2 m-85 -125.36 48.42 2.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.692 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 m 53.11 96.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.098 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -166.72 -39.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.07 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.5 mm . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.007 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.609 0.242 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 38.2 Cg_endo -65.88 -40.75 15.76 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.517 2.145 . . . . 0.0 112.198 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 90.6 m -60.5 132.62 54.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.84 44.87 1.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.35 0.595 . . . . 0.0 110.405 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -150.63 -161.3 1.31 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.773 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -89.94 41.63 1.05 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.725 0.298 . . . . 0.0 110.758 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -74.48 179.09 4.84 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.76 0.314 . . . . 0.0 111.129 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.403 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 93.4 m -114.58 157.7 22.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.671 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.5 p -89.91 130.09 36.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.38 51.74 1.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.757 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -144.27 64.82 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.569 ' C ' HD12 ' A' ' 20' ' ' ILE . 4.4 tt0 -125.98 27.31 6.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.85 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 20' ' ' ILE . 2.0 mp -147.75 30.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.898 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.83 25.7 73.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.498 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -139.53 106.16 5.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.353 . . . . 0.0 110.841 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 23.4 t80 -70.79 112.76 7.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.084 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -150.01 116.06 5.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.9 t -105.22 134.13 48.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.61 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 15' ' ' THR . 13.7 mm -89.79 105.48 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.841 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -88.41 174.33 8.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.227 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.3 mtt -69.83 161.89 71.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.817 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.48 87.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.568 2.179 . . . . 0.0 112.341 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.36 60.91 1.86 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.63 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -111.21 128.3 55.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.67 0.271 . . . . 0.0 110.289 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -89.83 174.08 7.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 111.435 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.29 134.0 1.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.593 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.614 HG12 ' CD2' ' A' ' 35' ' ' TYR . 57.7 t -59.46 132.11 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.895 0.379 . . . . 0.0 110.976 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.614 ' CD2' HG12 ' A' ' 34' ' ' VAL . 7.4 m-85 61.01 47.22 7.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.895 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 50.17 96.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.327 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.71 -50.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.02 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.148 -179.783 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 35.7 t0 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.824 0.345 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.8 m -117.47 106.55 20.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.168 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 60.57 86.99 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -30.91 71.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.956 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.2 t -89.98 94.5 9.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 27.3 mm -89.91 -45.66 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.019 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.98 52.56 1.49 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.745 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 61.62 118.32 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.411 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 37.1 Cg_endo -65.27 -42.32 13.72 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.404 2.07 . . . . 0.0 112.105 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.505 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 87.4 m -53.7 136.89 38.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.028 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -91.74 44.06 1.16 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.508 0.67 . . . . 0.0 110.669 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -150.77 -161.33 1.32 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.809 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -90.02 39.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.834 0.35 . . . . 0.0 110.839 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.505 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -78.33 -175.5 4.24 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 120.983 0.421 . . . . 0.0 111.414 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.9 m -121.14 147.66 45.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.725 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.5 t -89.92 155.74 18.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.909 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.683 ' HB2' HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -172.2 80.38 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.78 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -138.6 169.94 16.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.977 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -150.07 -175.38 5.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.909 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.599 ' O ' HG23 ' A' ' 20' ' ' ILE . 0.5 OUTLIER -68.87 70.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.94 0.4 . . . . 0.0 111.065 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.77 -26.68 1.93 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.663 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.93 177.7 4.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.908 0.385 . . . . 0.0 111.039 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.411 ' CE1' ' HG3' ' A' ' 9' ' ' PRO . 38.4 t80 -176.0 103.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.715 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -143.68 132.47 22.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.974 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 48.8 t -109.04 140.16 42.94 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.683 HD11 ' HB2' ' A' ' 17' ' ' LEU . 4.2 mp -89.68 90.29 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.787 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -167.64 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.151 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 63.7 mtp -101.73 155.78 35.99 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.841 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.65 93.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.649 2.232 . . . . 0.0 112.091 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.52 39.38 4.46 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.386 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -119.63 118.96 32.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.746 0.308 . . . . 0.0 110.685 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.93 157.2 17.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.008 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.64 143.83 7.79 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.415 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.667 HG12 ' CE1' ' A' ' 35' ' ' TYR . 57.3 t -57.94 -40.72 77.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.85 0.357 . . . . 0.0 111.12 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.667 ' CE1' HG12 ' A' ' 34' ' ' VAL . 13.4 m-85 -125.55 48.8 2.0 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.781 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 46.91 75.97 0.11 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.339 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -123.88 -25.73 4.2 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.325 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.8 mm . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.82 0.343 . . . . 0.0 111.082 -179.966 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.625 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.835 0.35 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.8 t -100.33 79.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.032 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -160.47 -46.11 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 59.88 30.37 19.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.022 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 40.7 t -140.49 83.96 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.906 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.3 mm -89.95 -44.97 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.737 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.3 t -143.39 52.66 1.34 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.569 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 62.29 119.63 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.757 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 36.1 Cg_endo -64.76 -43.34 12.91 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.423 2.082 . . . . 0.0 112.005 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.498 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 93.2 m -54.86 136.77 46.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.037 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -91.82 43.76 1.15 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.356 0.598 . . . . 0.0 110.539 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -150.68 -161.67 1.39 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.853 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -89.85 38.49 0.92 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.714 0.293 . . . . 0.0 110.825 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.482 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -79.54 -174.74 4.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.005 0.431 . . . . 0.0 111.421 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.464 ' O ' HD12 ' A' ' 26' ' ' ILE . 89.1 m -125.51 142.62 51.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.844 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.9 t -90.0 149.42 22.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.939 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.721 ' HB2' HD11 ' A' ' 26' ' ' ILE . 1.1 tt -157.29 66.69 0.51 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.919 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -111.14 110.0 20.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -90.03 -175.92 4.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -56.3 103.98 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.095 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.02 26.81 57.49 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.15 -178.2 5.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.892 0.377 . . . . 0.0 110.904 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.426 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 13.9 t80 -177.54 113.71 0.08 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.867 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.3 mp0 -149.96 123.6 9.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.073 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.3 t -104.45 131.79 51.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.689 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.721 HD11 ' HB2' ' A' ' 17' ' ' LEU . 3.9 mp -89.95 91.72 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.26 -168.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.026 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.4 mtp -91.99 160.35 35.96 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.986 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -50.73 95.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.557 2.172 . . . . 0.0 112.387 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.23 54.83 3.92 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.366 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -120.26 137.87 53.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.751 0.31 . . . . 0.0 110.684 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -93.35 161.88 14.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.132 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.5 137.96 9.96 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.447 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.467 HG12 ' CE1' ' A' ' 35' ' ' TYR . 76.0 t -56.59 -48.95 79.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.846 0.355 . . . . 0.0 111.056 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.498 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 13.2 m-85 -112.61 43.27 1.68 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.611 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.2 m 52.09 98.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.953 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -166.71 -39.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.961 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.7 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.213 -179.861 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.609 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.828 0.347 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.514 HG23 HD11 ' A' ' 20' ' ' ILE . 4.7 m -97.44 141.89 15.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.056 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -95.92 164.26 12.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -100.27 42.55 1.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.925 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -102.58 22.66 13.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.154 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.3 mm -108.19 -27.98 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 0.0 110.893 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.6 t -139.97 56.43 1.63 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.462 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -52.34 107.15 0.77 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.389 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HG2' ' CZ ' ' A' ' 23' ' ' PHE . 65.5 Cg_exo -52.12 -24.65 20.67 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.551 2.167 . . . . 0.0 112.232 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.44 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.9 m -59.42 125.21 22.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.621 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -96.02 42.57 1.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.374 0.607 . . . . 0.0 110.64 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -150.79 -165.62 2.32 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.994 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -89.94 41.33 1.04 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.88 0.372 . . . . 0.0 110.484 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . . . -76.14 -176.0 3.36 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.491 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.402 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 48.8 m -119.48 154.34 33.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.569 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.8 p -89.85 130.56 36.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 0.0 111.132 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.583 HD22 HD11 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -143.72 69.71 1.29 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -153.87 135.38 14.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.09 67.66 1.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.816 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.514 HD11 HG23 ' A' ' 2' ' ' VAL . 43.9 mm 52.7 85.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.17 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.46 -82.04 0.13 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.447 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.18 121.8 41.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.831 0.348 . . . . 0.0 110.828 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.419 ' CZ ' ' HG2' ' A' ' 9' ' ' PRO . 90.5 t80 -77.34 131.01 37.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.926 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -139.67 103.11 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.831 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.9 t -92.13 122.49 34.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.667 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.583 HD11 HD22 ' A' ' 17' ' ' LEU . 18.3 mm -89.92 90.17 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.1 m -75.65 -179.67 4.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.067 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.557 ' HE3' ' CD2' ' A' ' 31' ' ' TYR . 28.3 mtm -74.81 155.08 87.06 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.043 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -54.84 128.75 31.78 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.652 2.235 . . . . 0.0 111.968 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.4 24.25 73.63 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.233 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.557 ' CD2' ' HE3' ' A' ' 28' ' ' MET . 4.0 t80 -104.11 124.98 50.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.712 0.292 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -90.03 163.14 15.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.895 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.72 139.69 9.48 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.435 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.543 HG12 ' CD1' ' A' ' 35' ' ' TYR . 61.1 t -61.88 -56.0 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.897 0.38 . . . . 0.0 111.164 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.543 ' CD1' HG12 ' A' ' 34' ' ' VAL . 8.5 m-85 -102.58 36.37 2.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.983 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 6.4 m 57.85 104.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.606 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -168.28 -33.88 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.421 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.4 mm . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.87 0.367 . . . . 0.0 111.097 -179.999 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.451 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.859 0.362 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.88 105.41 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.218 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -128.02 30.53 5.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -114.38 30.88 6.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 t -117.88 29.04 8.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.925 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.5 mt -91.63 -29.37 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.059 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.1 t -120.17 91.73 3.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.715 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -54.38 108.15 1.06 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.12 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.432 ' HG3' ' CE2' ' A' ' 23' ' ' PHE . 72.8 Cg_endo -76.0 -31.44 4.99 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.466 2.111 . . . . 0.0 112.212 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.432 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 1.9 m -72.09 125.14 26.52 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -96.75 43.14 1.08 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.436 0.636 . . . . 0.0 110.498 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.432 ' HB3' ' HE3' ' A' ' 28' ' ' MET . 14.8 m-80 -150.65 -164.55 2.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.083 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -91.02 38.25 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.812 0.339 . . . . 0.0 110.483 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -73.13 -178.18 2.77 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.39 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 53.6 m -114.1 153.86 28.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.662 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.1 t -89.97 114.63 26.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.981 0.42 . . . . 0.0 111.086 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.844 HD13 HD11 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -136.99 56.5 1.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.485 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.439 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 3.7 p-10 -86.11 159.75 19.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.159 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -139.95 -166.57 2.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.722 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.579 ' O ' HG23 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -73.86 112.65 10.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.969 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.62 -83.87 1.05 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.447 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -100.99 125.44 47.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.439 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 53.4 p90 -96.12 167.81 10.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.9 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -133.73 126.02 29.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.118 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.9 t -95.7 133.58 39.62 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.531 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.844 HD11 HD13 ' A' ' 17' ' ' LEU . 9.6 mm -89.79 96.19 6.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.738 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -72.44 -172.83 1.0 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.277 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.432 ' HE3' ' HB3' ' A' ' 12' ' ' ASN . 41.5 mtt -94.06 162.04 27.91 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.695 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.22 88.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.519 2.146 . . . . 0.0 112.292 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.69 56.58 2.33 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.529 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -116.28 137.51 52.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.728 0.299 . . . . 0.0 110.713 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.02 162.66 15.26 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.961 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.18 145.22 16.53 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.398 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.6 t -58.18 -54.04 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.795 0.331 . . . . 0.0 111.132 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 38.8 m-85 -113.64 42.46 1.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.835 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 56.33 102.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.812 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -177.67 -34.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.049 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.6 mm . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.191 -179.868 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.602 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.822 0.344 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p -146.18 134.26 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.157 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -93.78 -175.97 3.91 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.917 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.84 32.79 4.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.017 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.9 t -110.63 27.01 10.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.121 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -95.93 -27.91 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.926 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 t -127.44 104.47 7.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.669 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -56.08 118.59 21.64 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.958 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.411 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 29.8 Cg_endo -63.36 -41.36 27.04 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.415 2.077 . . . . 0.0 112.055 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 99.7 m -65.46 135.59 55.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.895 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -92.29 43.85 1.15 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.367 0.603 . . . . 0.0 110.543 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -150.78 -163.02 1.67 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.799 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -89.83 44.62 1.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.775 0.321 . . . . 0.0 110.588 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.453 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -77.32 -179.69 5.86 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.972 0.415 . . . . 0.0 111.276 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 56.0 m -112.03 149.19 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.49 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.7 t -89.82 126.41 35.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.951 0.405 . . . . 0.0 111.013 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.48 60.19 1.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.73 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 10.1 p-10 -86.28 153.8 21.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.135 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -146.58 -170.91 3.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.695 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.715 HD13 ' N ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -59.26 130.31 22.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.057 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.715 ' N ' HD13 ' A' ' 20' ' ' ILE . . . 82.71 -113.84 3.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.564 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -89.89 117.65 28.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.889 0.376 . . . . 0.0 110.854 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.424 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 54.1 p90 -71.62 172.2 10.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.049 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -140.85 127.16 19.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.078 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 45.4 t -103.4 133.0 49.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.425 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.0 mm -89.69 100.59 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.754 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -82.53 168.89 16.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.386 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.1 mtt -68.76 154.65 94.5 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.026 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -56.95 131.73 47.27 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.622 2.214 . . . . 0.0 112.154 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.41 21.81 72.63 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.606 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -102.96 122.01 43.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 0.0 110.662 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.96 154.29 19.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.088 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 118.28 132.59 4.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.502 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.438 HG12 ' CE1' ' A' ' 35' ' ' TYR . 99.6 t -56.99 -30.89 35.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.762 0.315 . . . . 0.0 111.107 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CE1' HG12 ' A' ' 34' ' ' VAL . 33.4 m-85 -136.52 53.49 1.92 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.987 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 72.8 m 47.48 97.27 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.515 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -173.92 -35.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.338 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.5 mm . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 120.904 0.383 . . . . 0.0 111.092 179.928 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.767 0.318 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.5 p -131.7 137.11 55.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.187 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.26 162.86 13.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -117.14 -39.88 3.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.969 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 31.3 t -136.3 87.83 2.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.0 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 mt -91.37 -45.24 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.064 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -144.2 55.42 1.29 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.866 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 61.38 114.76 0.02 OUTLIER Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.885 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -66.51 -44.29 6.55 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.417 2.078 . . . . 0.0 112.144 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 95.5 m -63.62 134.9 56.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.934 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -92.36 44.84 1.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.47 0.653 . . . . 0.0 110.469 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.5 m-80 -150.66 -161.41 1.33 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.807 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -89.84 37.88 0.9 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.673 0.273 . . . . 0.0 110.69 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.45 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -81.68 -176.73 6.22 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.908 0.385 . . . . 0.0 111.315 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.6 m -122.04 142.99 49.78 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.489 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 14.8 t -103.68 111.48 23.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.326 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.505 HD12 HD11 ' A' ' 26' ' ' ILE . 7.1 mt -110.26 61.99 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.388 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.425 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 15.3 p-10 -85.75 141.66 29.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.149 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -136.42 -167.84 2.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.681 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.456 HD12 ' H ' ' A' ' 20' ' ' ILE . 3.1 mp -58.82 105.91 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.128 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.04 -103.68 2.03 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.496 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -93.96 156.68 16.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.897 0.38 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.425 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 16.9 p90 -120.17 171.0 8.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.981 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.11 117.32 7.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.059 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.5 t -89.96 131.99 35.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.595 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.549 ' H ' HD12 ' A' ' 26' ' ' ILE . 4.0 mp -89.77 97.96 7.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.032 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -81.07 173.29 12.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.076 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 15.6 mtt -74.9 146.03 82.16 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.095 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.61 114.94 2.07 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.547 2.165 . . . . 0.0 112.223 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.48 19.61 58.16 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.662 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -102.15 126.29 49.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 110.398 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -89.8 159.41 17.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.17 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.28 131.09 5.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.444 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.0 t -54.1 -31.69 21.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.04 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.495 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 44.1 m-85 -136.65 51.91 1.97 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.726 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 73.2 m 50.43 97.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.138 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.74 -33.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.474 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.891 0.377 . . . . 0.0 111.0 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.468 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.7 p30 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.823 0.344 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 m -113.51 79.22 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.099 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.0 p-10 -141.09 74.25 1.45 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.979 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -110.79 -29.31 8.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.948 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 18.6 p -89.9 125.55 35.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.9 mm -89.92 -51.34 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.854 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.0 t -140.34 49.64 1.72 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.697 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 60.82 118.46 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.996 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 16' ' ' CYS . 34.2 Cg_endo -64.31 -32.49 61.54 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.277 1.984 . . . . 0.0 111.84 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.602 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 68.7 m -74.44 139.32 43.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.939 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -91.52 45.04 1.21 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.381 0.61 . . . . 0.0 110.515 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -150.66 -159.47 1.04 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.836 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -89.98 35.65 0.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.739 0.304 . . . . 0.0 110.754 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.602 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -79.56 -175.67 4.9 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 120.957 0.408 . . . . 0.0 111.384 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.7 m -127.96 139.86 52.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.618 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.418 ' HB3' ' HD2' ' A' ' 9' ' ' PRO . 17.5 p -92.47 125.61 37.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.146 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.89 83.72 2.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.553 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 4.0 p30 -100.43 153.54 19.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.121 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.08 -171.9 3.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.698 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.7 mt -58.87 94.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.044 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.9 -104.79 1.18 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.403 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -89.97 159.4 16.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.847 0.356 . . . . 0.0 110.784 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.451 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 17.9 p90 -127.61 162.16 27.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.006 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.7 mp0 -138.11 126.38 23.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.824 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -89.99 141.14 28.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.784 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.482 HG22 ' H61' ' A' ' 39' ' ' FUC . 21.3 mm -89.78 89.95 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.683 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.15 -167.67 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.321 -179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 13.7 mtp -108.22 162.6 19.34 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.25 121.62 10.01 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.518 2.145 . . . . 0.0 112.309 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 65.45 31.4 80.15 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.585 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -112.06 115.57 29.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.754 0.311 . . . . 0.0 110.515 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -89.92 171.32 9.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.5 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.32 141.66 9.74 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.295 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.411 HG12 ' CE1' ' A' ' 35' ' ' TYR . 94.7 t -52.72 -41.07 37.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.765 0.317 . . . . 0.0 111.177 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 33.6 m-85 -134.31 53.62 1.99 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.728 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 47.76 95.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.313 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -166.56 -36.46 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.074 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.938 0.399 . . . . 0.0 111.196 -179.882 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.482 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.892 0.377 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 32.0 t -128.56 116.85 43.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.056 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -147.94 21.82 1.11 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.077 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -117.02 -22.15 8.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.248 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 25.7 t -96.26 29.59 2.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.752 0.311 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.4 mm -101.95 -25.4 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.135 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.0 t -129.15 85.27 2.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -54.39 108.43 1.14 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.119 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.442 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 74.1 Cg_exo -49.0 -38.53 39.46 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.44 2.093 . . . . 0.0 112.405 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 36' ' ' CYS . 82.3 m -64.9 144.34 57.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.769 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -122.06 52.88 1.25 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.808 0.337 . . . . 0.0 111.745 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -150.24 -91.74 0.07 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.997 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -150.29 30.28 0.69 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.751 0.31 . . . . 0.0 110.752 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.42 ' HB3' ' CB ' ' A' ' 10' ' ' CYS . . . -68.59 -176.17 0.76 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.519 -179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.5 m -122.94 160.57 25.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.478 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.4 t -89.89 133.26 34.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.109 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.86 41.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.609 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 2.8 p30 -81.07 154.98 26.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.103 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -141.94 -174.89 4.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.721 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -53.23 136.51 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.238 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 66.98 -84.72 0.11 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.464 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -94.23 164.49 13.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.788 0.328 . . . . 0.0 110.785 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.442 ' CE1' ' HG2' ' A' ' 9' ' ' PRO . 49.5 p90 -133.74 178.96 6.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.037 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -149.7 119.09 6.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.002 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.2 t -105.97 136.06 46.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.333 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.526 HG22 ' H61' ' A' ' 39' ' ' FUC . 16.8 mm -89.97 92.52 3.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.753 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 33.3 t -79.17 162.12 25.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.291 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 1.2 mtp -58.28 143.49 79.49 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.188 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -60.97 124.26 14.56 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.522 2.148 . . . . 0.0 112.263 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.79 24.74 59.61 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.587 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -96.05 176.08 6.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.802 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.403 ' HB3' HG22 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -129.48 162.4 28.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.008 179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.23 152.65 14.84 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.5 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.8 t -57.86 -35.45 51.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.909 0.385 . . . . 0.0 111.242 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -117.0 -70.34 0.8 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.283 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.46 ' HB2' ' SG ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER 178.56 68.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.916 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -140.36 -35.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.244 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.403 HG22 ' HB3' ' A' ' 32' ' ' GLU . 21.2 mm . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.759 0.314 . . . . 0.0 111.114 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.526 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.771 0.319 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.92 158.25 41.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 60.49 85.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.834 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -110.71 -35.45 5.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.808 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.443 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 49.1 t -94.81 71.6 3.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.7 mt -90.03 -35.59 7.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.153 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.89 51.98 2.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.984 0.421 . . . . 0.0 110.895 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 48.37 91.84 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.318 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.444 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 66.7 Cg_endo -73.7 -32.44 7.53 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.504 2.136 . . . . 0.0 112.194 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 1.9 m -69.17 126.44 29.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.4 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -93.95 42.2 1.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.337 0.589 . . . . 0.0 111.139 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -151.07 -161.29 1.3 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.309 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.89 29.95 1.27 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.708 0.29 . . . . 0.0 110.898 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.54 -177.01 0.67 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.969 0.414 . . . . 0.0 111.22 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 22.9 m -117.49 136.03 53.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.793 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.0 t -89.72 85.27 6.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.849 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.29 67.03 5.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.654 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -148.94 111.07 4.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.892 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.01 74.27 0.93 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.921 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.514 ' O ' HG22 ' A' ' 20' ' ' ILE . 10.2 mt 51.78 61.03 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.223 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 179.76 -97.58 0.11 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.484 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.52 132.1 36.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.759 0.314 . . . . 0.0 110.838 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.444 ' CE1' ' HG3' ' A' ' 9' ' ' PRO . 44.6 t80 -92.91 133.71 35.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.986 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -150.17 98.69 2.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.999 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -89.95 123.25 33.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.52 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.521 HG22 ' H61' ' A' ' 39' ' ' FUC . 16.7 mm -89.74 108.89 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.687 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -74.43 -169.81 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.252 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.0 mtt -98.14 161.55 25.09 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.84 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.61 90.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.486 2.124 . . . . 0.0 112.395 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.78 55.89 3.06 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.417 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -110.16 163.56 13.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.763 0.316 . . . . 0.0 110.753 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -117.43 150.67 38.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.929 0.395 . . . . 0.0 111.123 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 106.24 141.78 10.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.454 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 86.6 t -55.18 -61.99 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 120.837 0.351 . . . . 0.0 111.137 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.44 ' CD2' ' HB2' ' A' ' 9' ' ' PRO . 10.7 m-85 -96.62 27.71 3.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 60.44 108.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.701 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -179.83 -32.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.003 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.187 -179.91 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.521 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.77 0.319 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 m -135.38 104.43 4.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.154 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.15 -60.13 1.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.98 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.89 29.97 4.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.951 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 t -101.99 23.7 11.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.052 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.2 mt -103.49 -26.67 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.982 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.8 t -125.61 86.27 2.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.674 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -49.15 105.74 0.54 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.337 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.56 -29.3 7.52 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.511 2.14 . . . . 0.0 112.122 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.0 m -69.63 127.52 33.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.664 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.74 42.48 1.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.465 0.65 . . . . 0.0 110.453 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.5 m-80 -150.74 -164.66 2.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.194 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -91.23 38.4 0.97 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.748 0.309 . . . . 0.0 110.584 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.1 -178.45 3.35 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.446 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.452 HG22 HD23 ' A' ' 17' ' ' LEU . 52.0 m -114.01 153.7 28.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.554 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.55 ' O ' HD22 ' A' ' 17' ' ' LEU . 53.7 t -89.87 106.52 18.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.24 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.58 ' HG ' HD11 ' A' ' 26' ' ' ILE . 2.7 mm? -127.97 61.75 1.43 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.333 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.436 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 5.7 p-10 -90.94 156.59 17.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.177 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.67 -166.54 2.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.794 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 35.5 mm -62.47 130.09 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.06 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.13 -98.05 0.97 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.573 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.01 136.12 33.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 110.784 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.436 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 54.4 p90 -99.04 178.02 5.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.05 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -142.89 128.45 19.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.066 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -96.76 134.26 40.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.71 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.619 HG22 ' H61' ' A' ' 39' ' ' FUC . 11.2 mm -89.85 97.36 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.587 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.89 -176.7 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.414 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.556 ' HE3' ' CE2' ' A' ' 31' ' ' TYR . 7.8 mtt -88.07 154.69 52.34 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.867 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.8 92.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.7 2.267 . . . . 0.0 112.11 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.73 37.27 4.78 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.395 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.556 ' CE2' ' HE3' ' A' ' 28' ' ' MET . 3.1 t80 -110.46 131.03 55.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.759 0.314 . . . . 0.0 110.671 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.86 161.03 16.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.144 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 103.48 141.76 11.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.484 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.5 t -58.01 -61.18 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.763 0.316 . . . . 0.0 111.061 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.451 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 17.6 m-85 -101.34 36.44 2.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.713 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 60.03 105.44 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.71 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -176.39 -35.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.155 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.4 mm . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.048 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.619 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.891 0.376 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t -148.37 138.04 16.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.136 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -112.55 -48.16 3.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.993 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.6 -74.59 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.849 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.5 t -149.79 75.26 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.854 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.1 mt -89.88 -39.32 12.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.789 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 t -142.16 52.5 1.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.626 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 58.49 107.01 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.842 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.21 -46.21 4.65 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.341 2.027 . . . . 0.0 112.089 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.512 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 99.6 m -60.58 135.46 57.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -91.52 45.22 1.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.366 0.603 . . . . 0.0 110.492 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -150.65 -161.55 1.36 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.826 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -89.92 41.13 1.03 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.824 0.345 . . . . 0.0 110.681 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -76.43 -176.18 3.57 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.042 0.449 . . . . 0.0 111.245 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.445 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 72.9 m -122.59 151.53 41.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.603 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.1 t -89.93 148.91 22.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.965 0.412 . . . . 0.0 111.128 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.22 49.29 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.499 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.443 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 14.2 p-10 -82.9 146.21 28.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.008 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.7 -169.27 2.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.6 mm -69.54 111.54 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.081 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 102.54 -86.7 0.57 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.484 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -107.25 134.99 49.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.764 0.316 . . . . 0.0 110.877 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.443 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 44.0 p90 -101.45 170.87 7.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.977 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -143.98 125.67 15.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.969 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 37.3 t -103.39 138.64 39.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.635 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.578 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 8.9 mm -89.72 105.87 16.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.7 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -93.2 170.09 9.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.409 -179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.583 ' HB2' ' HB2' ' A' ' 31' ' ' TYR . 62.5 mtt -63.84 159.65 52.41 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.99 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.87 -64.74 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.769 2.312 . . . . 0.0 112.866 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.89 66.89 0.26 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.31 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.583 ' HB2' ' HB2' ' A' ' 28' ' ' MET . 2.7 t80 -127.71 157.08 41.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.816 0.341 . . . . 0.0 110.785 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -117.45 152.75 34.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.002 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.88 142.02 6.97 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.431 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.557 HG12 ' CE1' ' A' ' 35' ' ' TYR . 61.2 t -58.75 -34.42 51.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.685 0.278 . . . . 0.0 111.074 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.557 ' CE1' HG12 ' A' ' 34' ' ' VAL . 19.6 m-85 -137.04 53.52 1.89 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.173 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 15.8 m 49.78 96.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.219 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.13 -36.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.266 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 25.7 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.05 -179.811 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.558 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.843 0.354 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.3 m -123.43 164.0 21.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.129 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -82.44 105.34 13.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -99.2 29.42 3.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.987 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 50.9 t -124.96 57.86 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.841 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 mt -91.6 -36.32 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.091 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -133.14 54.98 1.92 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.046 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 57.2 97.22 0.04 OUTLIER Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.102 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.81 -32.19 14.63 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.408 2.072 . . . . 0.0 112.103 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.1 m -77.7 128.25 33.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.535 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -94.76 43.98 1.1 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.349 0.595 . . . . 0.0 110.676 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -150.69 -162.31 1.52 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.002 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -90.45 27.49 1.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.344 . . . . 0.0 110.607 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.83 -175.21 1.66 Allowed 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.506 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.3 m -128.72 128.53 44.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.472 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.3 t -96.72 124.18 40.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.068 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.07 79.36 1.45 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.502 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.416 ' CB ' ' HB3' ' A' ' 23' ' ' PHE . 14.5 p-10 -103.78 133.44 48.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.098 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -141.84 75.27 1.49 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.904 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.1 mt 52.84 94.57 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.27 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.09 -127.19 7.11 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.462 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -89.94 132.58 35.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.798 0.332 . . . . 0.0 110.852 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.416 ' HB3' ' CB ' ' A' ' 18' ' ' ASP . 47.7 p90 -108.97 -172.26 2.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.5 mm-40 -148.89 122.61 9.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.0 t -89.96 130.18 36.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.632 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.505 HG22 ' H61' ' A' ' 39' ' ' FUC . 16.2 mm -89.72 88.66 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.956 0.407 . . . . 0.0 110.66 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -166.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.324 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 47.5 mtp -109.54 161.44 24.06 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.818 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -51.46 92.61 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.606 2.204 . . . . 0.0 112.285 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.2 52.63 3.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.467 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -120.16 118.17 29.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.722 0.296 . . . . 0.0 110.632 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -90.0 167.99 12.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.123 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.43 136.28 8.55 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.463 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.688 HG12 ' CD2' ' A' ' 35' ' ' TYR . 92.4 t -56.34 129.04 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.901 0.381 . . . . 0.0 111.077 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.688 ' CD2' HG12 ' A' ' 34' ' ' VAL . 6.7 m-85 58.38 27.21 15.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.995 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER 62.41 115.19 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.04 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -165.68 -54.59 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.756 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.0 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.267 -179.775 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.505 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.518 ' OD1' HG13 ' A' ' 2' ' ' VAL . 2.4 p30 . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.807 0.336 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.518 HG13 ' OD1' ' A' ' 1' ' ' ASP . 5.1 m -94.64 90.76 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.067 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.25 160.42 17.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.985 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 64.08 15.98 9.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.399 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.2 t -118.04 21.27 12.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.644 0.259 . . . . 0.0 111.116 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 mt -91.25 -30.07 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.719 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.77 89.4 3.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.583 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -50.63 109.71 1.43 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.213 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 47.3 Cg_endo -68.0 -33.82 24.83 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.457 2.105 . . . . 0.0 112.102 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 2.8 m -65.61 127.22 31.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.527 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -95.09 43.79 1.09 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.256 0.55 . . . . 0.0 110.683 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -150.74 -163.85 1.87 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.145 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.5 34.45 0.89 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.8 0.333 . . . . 0.0 110.544 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -71.21 -177.29 1.68 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.414 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 70.2 m -114.04 150.22 34.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.66 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.6 t -89.77 118.05 29.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.023 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.696 ' CD1' HD11 ' A' ' 26' ' ' ILE . 1.7 tt -132.66 67.76 1.52 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.714 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 4.8 p30 -142.65 158.58 43.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.005 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -144.9 -177.1 5.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.873 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.649 ' O ' HG23 ' A' ' 20' ' ' ILE . 6.9 tp -58.46 91.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.081 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.13 -27.62 8.06 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.418 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -97.32 175.49 6.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.871 0.367 . . . . 0.0 110.856 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.451 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 12.5 t80 -174.04 113.77 0.19 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.01 127.3 11.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.149 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.5 t -100.52 125.42 46.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.538 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.723 HG22 ' H61' ' A' ' 39' ' ' FUC . 14.2 mm -89.8 81.66 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.754 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -169.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.335 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 40.1 mtp -97.59 160.84 27.73 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.942 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.32 92.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.601 2.201 . . . . 0.0 112.272 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.64 53.73 3.3 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.496 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -115.21 132.86 56.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.696 0.284 . . . . 0.0 110.792 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -89.99 153.33 20.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.082 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 109.91 142.03 9.31 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.397 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 35' ' ' TYR . 59.4 t -56.66 -53.93 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.949 0.404 . . . . 0.0 111.219 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.421 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 17.8 m-85 -111.81 41.56 1.9 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.782 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER 55.27 101.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.853 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -172.66 -35.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.062 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.3 mm . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.204 -179.92 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.723 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.816 0.341 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.612 HG23 HD11 ' A' ' 6' ' ' ILE . 3.3 m -111.63 158.7 12.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.126 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -129.76 -66.96 0.77 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.43 23.44 14.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.067 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.4 t -111.65 28.32 8.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.888 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.612 HD11 HG23 ' A' ' 2' ' ' VAL . 30.6 mm -97.33 -27.21 3.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.061 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.44 94.49 3.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.808 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -57.43 119.1 29.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.979 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.28 -40.65 24.48 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.408 2.072 . . . . 0.0 112.243 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.54 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . 94.5 m -67.22 136.54 55.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -112.78 54.34 0.72 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.341 -179.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -150.24 -92.82 0.07 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.832 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.3 24.24 0.81 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.777 0.322 . . . . 0.0 110.845 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HB3' ' CB ' ' A' ' 10' ' ' CYS . . . -67.9 178.35 1.8 Allowed 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.293 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.431 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 28.6 m -112.99 158.93 19.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.62 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.8 t -89.72 125.12 35.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.081 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.69 52.64 1.51 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.686 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.409 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 43.4 p-10 -150.96 89.41 1.53 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.878 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -149.27 42.04 0.91 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.896 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.552 ' O ' HG23 ' A' ' 20' ' ' ILE . 5.9 tt -169.48 59.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.038 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.39 26.54 59.44 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.526 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -132.68 -179.22 5.33 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.851 0.358 . . . . 0.0 110.831 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.409 ' HA ' ' HB3' ' A' ' 18' ' ' ASP . 74.1 t80 -157.03 105.5 2.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.997 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -150.02 121.68 8.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.929 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.3 t -105.08 137.65 42.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.652 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.544 HG22 ' H61' ' A' ' 39' ' ' FUC . 9.5 mm -89.87 87.85 2.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.833 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.98 -179.81 1.61 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.168 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.3 mtt -82.38 161.67 58.76 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.862 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.3 89.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.451 2.101 . . . . 0.0 112.397 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.4 67.93 1.58 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.644 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -113.34 130.7 56.21 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.69 0.281 . . . . 0.0 110.392 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -89.97 154.08 20.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 0.0 111.228 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.22 143.39 14.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.718 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.574 HG12 ' CG ' ' A' ' 35' ' ' TYR . 84.2 t -66.34 130.81 32.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.937 0.398 . . . . 0.0 111.102 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.574 ' CG ' HG12 ' A' ' 34' ' ' VAL . 4.2 m-85 61.05 46.26 8.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.169 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 m 46.92 96.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.409 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -143.62 -65.66 0.37 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.028 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.2 mm . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.244 -179.808 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.544 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.762 0.315 . . . . 0.0 110.936 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.8 m -102.64 170.91 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.182 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -161.33 -68.53 0.06 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.956 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -120.94 29.79 7.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.9 t -111.8 26.57 10.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.6 mt -95.62 -28.1 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.975 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.5 t -134.32 111.06 9.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.736 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -58.23 118.41 27.17 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.02 -40.49 20.21 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.445 2.097 . . . . 0.0 112.131 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 98.5 m -65.81 135.02 54.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.982 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -93.22 45.18 1.16 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.42 0.628 . . . . 0.0 110.379 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -150.48 -161.56 1.37 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.721 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -89.95 42.73 1.11 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.787 0.327 . . . . 0.0 110.76 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.54 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -76.59 179.41 5.99 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.156 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.411 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 26.6 m -115.85 160.71 19.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.553 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.6 t -89.9 144.65 25.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.068 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.437 HD22 HD11 ' A' ' 26' ' ' ILE . 5.0 tp -175.53 64.97 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.548 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.429 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 7.2 p-10 -98.58 163.44 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.262 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.45 -171.22 3.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.772 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.0 mm -72.65 97.24 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.094 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 111.23 -98.59 1.05 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.524 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.98 105.23 17.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.859 0.361 . . . . 0.0 110.861 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.429 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 49.5 p90 -75.99 -177.13 3.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.069 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -149.99 129.5 13.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.117 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.9 t -111.24 138.79 47.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.501 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.54 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 7.2 mm -89.73 106.97 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.837 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -94.25 171.23 8.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.424 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 34.1 mtt -76.95 144.08 71.74 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.988 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -57.16 121.98 11.02 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.492 2.128 . . . . 0.0 112.273 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.84 11.03 82.22 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.944 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -97.46 128.61 44.38 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.761 0.315 . . . . 0.0 110.413 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.71 160.45 16.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.281 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.15 138.86 6.47 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.53 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.9 t -60.39 -33.39 53.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.935 0.398 . . . . 0.0 110.848 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.424 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 37.5 m-85 -137.58 53.95 1.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.933 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 39.0 m 49.2 96.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.257 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -178.46 -37.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.942 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.1 mm . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.14 -179.908 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.528 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.845 0.355 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.49 128.55 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.186 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.435 ' HB3' HD11 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -65.65 164.85 13.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.809 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -134.96 -44.67 0.72 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.041 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 46.6 t -89.87 63.78 6.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.032 0.444 . . . . 0.0 110.878 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.435 HD11 ' HB3' ' A' ' 3' ' ' ASN . 23.8 mt -97.29 -35.38 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.242 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 t -128.45 52.38 1.91 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.963 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 m120 52.99 96.33 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.255 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.18 -37.73 17.64 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.382 2.054 . . . . 0.0 112.022 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 35' ' ' TYR . 1.8 m -71.47 123.4 22.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.321 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -92.63 44.61 1.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.269 0.557 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.406 ' HB2' ' CB ' ' A' ' 36' ' ' CYS . 11.2 m-80 -150.9 -160.87 1.23 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.953 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -90.24 25.97 2.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.763 0.316 . . . . 0.0 110.53 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.616 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . . . -72.26 -175.37 1.52 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.029 0.443 . . . . 0.0 111.39 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.3 m -129.64 128.21 42.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.563 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.7 t -104.67 143.42 33.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.199 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.09 93.2 2.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.582 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.428 ' CB ' ' HB3' ' A' ' 23' ' ' PHE . 14.9 p-10 -107.53 121.6 44.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.961 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -143.26 80.23 1.67 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.5 mt 55.62 103.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.214 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.61 -132.56 10.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.523 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.35 117.46 34.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.748 0.308 . . . . 0.0 110.95 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.428 ' HB3' ' CB ' ' A' ' 18' ' ' ASP . 46.5 p90 -78.51 172.13 14.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -134.12 131.87 39.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.194 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.96 125.73 48.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.607 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.2 mm -89.66 94.49 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.954 0.407 . . . . 0.0 110.516 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.14 179.88 7.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.473 -179.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.3 mtt -83.77 154.88 65.08 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.041 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.38 114.83 2.15 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.575 2.183 . . . . 0.0 112.061 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.31 23.83 55.81 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.376 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -105.29 122.81 46.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.662 0.267 . . . . 0.0 110.461 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -89.86 164.06 14.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.98 0.419 . . . . 0.0 111.337 -179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.51 134.21 6.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.414 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.6 t -56.85 -33.1 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 111.145 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.451 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 35.5 m-85 -133.98 45.15 2.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.822 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 74.9 m 56.79 101.76 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.794 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -175.65 -34.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.418 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.5 mm . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 120.856 0.36 . . . . 0.0 111.233 -179.86 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.1 t70 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.845 0.355 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.53 82.95 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.092 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -106.68 143.27 35.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.814 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.43 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 4.0 mm-40 -107.19 -45.7 4.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.2 t -89.96 73.05 7.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.747 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.3 mt -90.05 -39.48 12.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.968 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.7 t -140.3 51.2 1.68 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.009 0.433 . . . . 0.0 110.851 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 51.86 98.88 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.314 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HB2' ' CD1' ' A' ' 35' ' ' TYR . 37.4 Cg_endo -65.87 -25.02 53.08 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.471 2.114 . . . . 0.0 111.989 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.7 m -72.6 128.72 36.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.065 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -97.88 42.0 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.332 0.587 . . . . 0.0 110.945 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -150.47 -157.64 0.83 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.2 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.85 28.94 2.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.801 0.334 . . . . 0.0 110.501 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.58 -175.75 2.98 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.521 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.425 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 57.8 m -124.53 132.27 53.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.533 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.8 t -90.02 118.08 29.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.013 0.435 . . . . 0.0 111.247 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.5 72.23 1.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.43 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 20.6 p-10 -90.22 142.89 27.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.103 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -137.04 -166.15 1.86 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.697 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 pp -59.98 102.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.16 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 110.89 -115.2 3.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.531 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -90.09 142.42 27.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.351 . . . . 0.0 110.806 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.43 ' CE1' ' HB3' ' A' ' 4' ' ' GLU . 42.9 p90 -102.83 165.74 10.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -141.02 124.9 17.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.024 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.8 t -90.41 142.56 27.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.711 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.449 HG22 ' H61' ' A' ' 39' ' ' FUC . 16.6 mm -89.7 91.32 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.772 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.8 m -60.43 176.95 0.31 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.234 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 3.3 mtp -87.27 161.28 46.57 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.858 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.55 96.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.44 2.093 . . . . 0.0 112.389 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.23 40.61 10.03 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.321 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -115.95 134.92 54.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.742 0.306 . . . . 0.0 110.818 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.25 178.79 4.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.102 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.43 162.04 11.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.537 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 65.1 t -57.11 -67.8 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.928 0.394 . . . . 0.0 110.95 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.425 ' CD1' ' HB2' ' A' ' 9' ' ' PRO . 43.6 m-85 -98.59 30.66 3.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.865 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.3 m 66.6 51.0 1.15 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -123.93 -2.89 8.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.52 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 120.782 0.325 . . . . 0.0 111.076 -179.8 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.449 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 4.7 t0 . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.858 0.361 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.508 ' O ' HG13 ' A' ' 2' ' ' VAL . 14.5 p -117.33 119.64 62.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.27 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.7 m-20 -159.32 100.97 1.54 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -137.0 31.6 2.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.89 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.8 t -150.02 89.26 1.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.739 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 mt -90.05 -47.73 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.013 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 t -146.32 52.62 1.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 60.92 117.5 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.95 -28.33 58.14 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.41 2.074 . . . . 0.0 112.01 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 69.3 m -72.18 145.93 47.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.952 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -96.87 42.19 1.09 Allowed 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.374 0.607 . . . . 0.0 110.398 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -150.76 -161.76 1.41 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.986 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.75 43.37 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.97 0.415 . . . . 0.0 110.349 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.727 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . . . -74.05 -174.09 1.79 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.754 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.2 m -124.23 145.69 49.2 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.424 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.1 t -89.97 130.63 36.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.171 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.78 59.85 1.06 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.716 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.413 ' CB ' ' HB2' ' A' ' 23' ' ' PHE . 10.3 p-10 -91.03 137.34 32.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -127.1 -171.7 2.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.855 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.5 ' O ' HG23 ' A' ' 20' ' ' ILE . 1.1 tp -59.23 120.53 5.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.097 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.4 -103.18 3.01 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.486 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.55 139.5 31.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.35 . . . . 0.0 110.834 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.413 ' HB2' ' CB ' ' A' ' 18' ' ' ASP . 40.8 p90 -101.48 176.24 5.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.014 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -149.27 130.15 14.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.82 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.5 t -105.74 109.09 20.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.763 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.567 ' H ' HD12 ' A' ' 26' ' ' ILE . 3.9 mp -90.0 126.58 42.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.101 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.727 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 0.5 OUTLIER -124.95 -161.91 1.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.732 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.53 ' HB2' ' HB2' ' A' ' 31' ' ' TYR . 15.8 mtt -50.51 146.58 9.1 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.114 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -49.8 -64.64 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.604 2.203 . . . . 0.0 112.5 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.6 57.7 4.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.227 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 28' ' ' MET . 0.7 OUTLIER -124.86 125.71 44.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.866 0.365 . . . . 0.0 110.877 -179.494 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -97.16 152.37 18.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.777 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.23 146.36 7.08 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.346 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.407 HG12 ' CE1' ' A' ' 35' ' ' TYR . 54.7 t -63.81 -31.16 52.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.912 0.387 . . . . 0.0 111.221 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.418 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 31.6 m-85 -142.56 57.54 1.44 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.05 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 48.88 92.31 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.006 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -169.71 -39.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.089 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.3 mm . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.063 -179.901 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.42 ' H61' ' HA ' ' A' ' 27' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.859 0.361 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.4 m -93.18 154.43 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -135.04 -55.63 0.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.776 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -157.97 35.73 0.25 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.1 t -144.43 90.21 2.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.408 ' H ' HD12 ' A' ' 6' ' ' ILE . 3.9 mp -94.69 -47.89 13.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.037 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.5 t -145.6 52.82 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.881 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 61.41 119.78 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.921 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.88 -43.0 13.11 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.376 2.05 . . . . 0.0 112.197 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.531 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 68.5 m -59.03 139.25 57.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.083 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -92.8 44.35 1.15 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.43 0.633 . . . . 0.0 110.482 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -150.58 -161.03 1.25 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.021 -0.991 . . . . 0.0 109.831 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.1 37.74 0.9 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.768 0.318 . . . . 0.0 110.655 179.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -77.78 -176.81 4.57 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.354 -179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.429 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 86.9 m -120.28 141.17 50.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.585 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.9 t -89.92 138.06 31.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.144 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.05 69.89 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.772 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.46 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 33.5 p-10 -92.56 155.18 17.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.084 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -135.06 -178.88 5.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.064 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.427 ' CD1' ' O ' ' A' ' 20' ' ' ILE . 0.6 OUTLIER -57.53 88.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.547 -179.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.74 -93.13 0.58 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.577 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -89.95 137.87 31.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.873 0.368 . . . . 0.0 110.768 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.46 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . 23.7 p90 -113.73 166.88 11.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.949 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -145.04 126.61 15.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.977 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.0 t -97.08 138.97 33.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.635 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.537 HG22 ' H61' ' A' ' 39' ' ' FUC . 13.9 mm -89.79 92.28 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.993 0.425 . . . . 0.0 110.794 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.53 -170.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.066 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.6 mtp -90.34 154.94 46.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.802 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.24 84.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.625 2.216 . . . . 0.0 112.207 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.23 52.49 1.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.499 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -120.68 154.38 35.63 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.765 0.317 . . . . 0.0 110.521 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.69 160.5 15.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.946 0.403 . . . . 0.0 111.187 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.78 142.88 12.95 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.693 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.8 t -56.88 -41.75 76.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.98 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 10' ' ' CYS . 44.2 m-85 -125.36 48.42 2.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.692 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.5 m 53.11 96.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.098 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -166.72 -39.67 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.07 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.5 mm . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.007 179.994 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.537 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.863 0.363 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -141.16 116.43 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.114 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -81.59 -176.37 6.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -95.29 19.45 10.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.127 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -97.84 -10.35 24.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.134 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.9 mm -89.76 -27.89 5.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.964 0.411 . . . . 0.0 110.769 179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.5 55.7 1.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.423 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -49.49 125.68 16.19 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.236 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HG3' ' CZ ' ' A' ' 23' ' ' PHE . 38.2 Cg_endo -65.88 -40.75 15.76 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.517 2.145 . . . . 0.0 112.198 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 90.6 m -60.5 132.62 54.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.916 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -91.84 44.87 1.19 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.35 0.595 . . . . 0.0 110.405 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -150.63 -161.3 1.31 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.773 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -89.94 41.63 1.05 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.725 0.298 . . . . 0.0 110.758 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 10' ' ' CYS . . . -74.48 179.09 4.84 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.76 0.314 . . . . 0.0 111.129 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.403 ' HB ' ' HB ' ' A' ' 26' ' ' ILE . 93.4 m -114.58 157.7 22.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.671 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 30.5 p -89.91 130.09 36.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.38 51.74 1.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.757 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -144.27 64.82 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.569 ' C ' HD12 ' A' ' 20' ' ' ILE . 4.4 tt0 -125.98 27.31 6.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.85 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.615 ' N ' HD12 ' A' ' 20' ' ' ILE . 2.0 mp -147.75 30.96 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.898 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.83 25.7 73.2 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.498 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -139.53 106.16 5.35 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.353 . . . . 0.0 110.841 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.436 ' CZ ' ' HG3' ' A' ' 9' ' ' PRO . 23.4 t80 -70.79 112.76 7.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.084 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -150.01 116.06 5.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 7.9 t -105.22 134.13 48.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.61 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.644 HG22 ' H61' ' A' ' 39' ' ' FUC . 13.7 mm -89.79 105.48 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.841 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -88.41 174.33 8.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.227 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 31.3 mtt -69.83 161.89 71.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.817 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.48 87.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.568 2.179 . . . . 0.0 112.341 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.36 60.91 1.86 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.63 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -111.21 128.3 55.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.67 0.271 . . . . 0.0 110.289 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -89.83 174.08 7.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 111.435 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.29 134.0 1.26 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.593 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.614 HG12 ' CD2' ' A' ' 35' ' ' TYR . 57.7 t -59.46 132.11 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.895 0.379 . . . . 0.0 110.976 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.614 ' CD2' HG12 ' A' ' 34' ' ' VAL . 7.4 m-85 61.01 47.22 7.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.895 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 m 50.17 96.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.327 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.71 -50.24 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.02 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.2 mm . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.148 -179.783 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.644 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_